≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Psoriasis vulgaris

DOID EFO Endpoint Browser PheWeb

L12_PSORI_VULG

psoriasis: An autoimmune condition characterized by red, well-delineated plaques with silvery scales that are usually on the extensor surfaces and scalp. They can occasionally present with these manifestations: pustules; erythema and scaling in intertriginous areas, and erythroderma, that are often distributed on extensor surfaces and scalp.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — L40.0
  • Hospital discharge: ICD-9 — 6961A
  • Cause of death: ICD-10 — L40.0
  • Cause of death: ICD-9 — 6961A
  • KELA reimbursements: KELA codes — ANY
  • KELA reimbursements: ICD-10 — L40.0

3 out of 7 registries used, show all original rules.

8897

4. Check minimum number of events

None

8897

5. Include endpoints

None

8897

6. Filter based on genotype QC (FinnGen only)

8563

Control definitions (FinnGen only)

Control exclude
L12_PAPULOSQUAMOUS

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
L40
Name in latin
Psoriasis vulgaris

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 54747 24396 30005
Only index persons 50019 22879 27140
Unadjusted period prevalence (%)
Whole population 0.77 0.70 0.84
Only index persons 0.95 0.84 1.04
Median age at first event (years)
Whole population 51.19 52.17 50.35
Only index persons 50.44 51.58 49.48

-FinnGen-

Key figures

All Female Male
Number of individuals 8563 4197 4366
Unadjusted period prevalence (%) 1.75 1.49 2.00
Median age at first event (years) 53.23 52.08 54.34

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
8897
Matched controls
88970
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
69619
ICD-8 Finland
Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)
+∞
314.4
300
*
D02AE01
ATC
carbamide; topical
6.3
307.7
1392
2552
A07EC01
ATC
sulfasalazine; oral, rectal
4.6
307.7
1353
3338
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
801.3
307.7
1991
32
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.9
307.7
2751
11951
L04AB04
ATC
adalimumab; parenteral
11.5
307.7
740
699
L40.5
ICD-10 Finland
Arthropathic psoriasis
588.5
307.7
1673
35
L40.0
ICD-10 Finland
Psoriasis vulgaris
13206.4
307.7
8699
295
L04AC13
ATC
ixekizumab; parenteral
138.0
307.7
345
26
D02AX
ATC
Other emollients and protectives
6.9
307.7
635
980
D07AC01
ATC
betamethasone; topical
10.5
307.7
6893
21906
L40.4
ICD-10 Finland
Guttate psoriasis
196.4
307.7
483
26
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
5.6
307.7
2162
4822
M07.3
ICD-10 Finland
Other psoriatic arthropathies
402.8
307.7
806
22
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
20.9
307.7
382
191
E0000UV, ,
ATC
9.5
307.7
7065
25749
E000001, ,
ATC
6.6
307.7
4036
9948
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
40.1
307.7
877
242
S91
ICPC
Psoriasis
127.3
307.7
976
86
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
8.1
307.7
702
935
D07AB08
ATC
desonide; topical
5.0
307.7
2033
4976
319
Kela drug reimbursment
Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)
5472.2
307.7
997
*
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
45.5
307.7
209
47
D07XC01
ATC
betamethasone; topical
29.5
307.7
5673
5004
E000003, ,
ATC
9.8
307.7
1278
1490
TQW80
NOMESCO Finland
Local dermatologic skincare
12.1
307.7
889
811
L04AX03
ATC
methotrexate; systemic
14.8
307.7
3573
3859
L01BA01
ATC
methotrexate; systemic
9.2
307.7
919
1103
E000006, ,
ATC
4.6
307.7
1091
2633
L04AC05
ATC
ustekinumab; parenteral
37.1
307.7
339
95
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
7.7
307.7
721
1007
377
Kela drug reimbursment
Apremilast and dimethyl fumarate (psoriasis)
3782.2
307.7
373
*
L04AA32
ATC
apremilast; oral
+∞
307.7
334
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
5.6
307.7
1358
2765
XQ848
NOMESCO Finland
Dermatological photography
6.4
307.7
624
1036
E000002, ,
ATC
5.1
307.7
2034
4919
E000007, ,
ATC
4.7
307.7
884
2037
L40.9
ICD-10 Finland
Psoriasis, unspecified
119.6
307.7
1601
163
D07AB02
ATC
hydrocortisone butyrate; topical
4.5
307.7
4600
17021
L40.8
ICD-10 Finland
Other psoriasis
183.2
307.7
724
43
134
Kela drug reimbursment
General erythroderma
123.6
307.7
356
30
L04AC18
ATC
risankizumab; parenteral
485.6
307.7
329
7
L04AA13
ATC
[U] leflunomide
7.7
307.7
510
696
D07AD01
ATC
clobetasol; topical
10.7
307.7
4598
8066
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
4.6
307.7
1127
2734
D05AX02
ATC
calcipotriol; topical
101.3
307.7
3745
634
D05AX03
ATC
calcitriol; topical
128.1
307.7
1414
131
D05AA
ATC
Tars
55.2
307.7
406
77
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.3
307.7
1759
3959
D07AC13
ATC
mometasone; topical
5.8
307.7
5078
16550
6961A
ICD-9 Finland
Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]
+∞
307.7
407
*
D05AX52
ATC
calcipotriol, combinations; topical
130.1
307.7
5678
1190
L40
ICD-10 Finland
Psoriasis
67.0
307.7
1844
346
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
3.6
307.7
3376
13060
L04AC10
ATC
secukinumab; parenteral
67.1
307.7
367
57
D05BB02
ATC
acitretin; oral
123.2
307.7
2353
259
D09AB01
ATC
zinc bandage without supplements; topical
7.9
302.2
424
561
L04AC16
ATC
guselkumab; systemic
2880.4
300.4
289
*
L04AD01
ATC
ciclosporin; systemic
7.6
294.0
424
579
L04AB01
ATC
etanercept; parenteral
8.7
292.7
376
447
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.8
278.3
1673
6796
D07AA02
ATC
hydrocortisone; topical
2.7
264.8
1664
6902
D07BC01
ATC
betamethasone and antiseptics; topical
2.9
263.3
1485
5819
M07.0*L40.5
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
1190.0
238.4
232
*
H02AB06
ATC
prednisolone; systemic
2.1
236.9
4699
31283
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.9
233.0
1265
4837
L88
ICPC
Rheumatoid/seropositive arthritis
4.3
224.7
605
1473
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
220.4
4645
31306
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.0
212.7
1080
3971
D07XB01
ATC
flumetasone; topical
12.5
196.2
194
159
D05AC01
ATC
dithranol; topical
86.8
195.4
103
12
A46
ICD-10 Finland
Erysipelas
2.3
177.2
1629
7932
D05AX05
ATC
tazarotene; topical
232.2
177.0
182
8
L04AA01
ATC
[U] ciclosporin
6.9
166.6
260
386
E000004, ,
ATC
5.3
160.0
327
632
XQ802
NOMESCO Finland
Epicutan test
3.7
159.2
533
1512
6960A
ICD-9 Finland
Psoriasis and similar disorders, Psoriatic arthropathy
+∞
153.6
147
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.5
145.7
1035
4470
D07CC01
ATC
betamethasone and antibiotics; topical
2.3
144.2
1291
6174
L30.3
ICD-10 Finland
Infective dermatitis
3.6
138.6
478
1381
J01DB01
ATC
cefalexin; oral
2.1
137.3
7517
64218
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.5
135.4
968
4187
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
5.2
134.7
283
560
M25.5
ICD-10 Finland
Pain in joint
1.8
132.3
3164
21145
D07AC14
ATC
methylprednisolone aceponate; topical
3.2
130.0
543
1769
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.3
127.2
1033
4724
L43.8
ICD-10 Finland
Other lichen planus
11.7
126.5
130
113
M07.0
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
420.2
125.1
125
*
M13.9
ICD-10 Finland
Arthritis, unspecified
2.5
118.2
815
3458
L04AC21
ATC
bimekizumab; systemic
241.2
116.1
119
5
299, ,
Kela drug reimbursment
+∞
114.8
110
*
L04AB06
ATC
golimumab; parenteral
7.1
113.1
171
245
J01FF01
ATC
clindamycin; systemic
1.8
111.7
2498
16211
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
4.4
111.5
283
655
M07.2*L40.5
ICD-10 Finland
Psoriatic spondylitis
+∞
110.6
106
*
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
5.0
107.0
236
487
L26
ICD-10 Finland
Exfoliative dermatitis
20.2
104.6
80
40
L04AB05
ATC
certolizumab pegol; parenteral
10.7
96.8
105
99
L40.1
ICD-10 Finland
Generalized pustular psoriasis
938.6
95.1
93
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
94.0
3704
27512
L04AA11
ATC
[U] etanercept
11.0
91.1
97
89
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
90.2
2123
13836
A10BA02
ATC
metformin; oral
1.7
89.9
2476
16810
QXA70
NOMESCO Finland
Guidance related to rash and skin care
29.2
87.1
58
20
J01DA01
ATC
[U] cefalexin
1.6
85.8
5256
42806
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
3.6
85.6
294
845
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.9
83.6
1121
6154
NH3EA
NOMESCO Finland
Feet X-ray examination with load
3.9
83.4
246
637
WQ066, ,
NOMESCO Finland
41.9
83.0
50
12
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
5.2
82.3
171
335
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
81.7
2323
15831
S29
ICPC
Skin symptom/complaint other
1.7
80.9
1823
11693
D05AX
ATC
Other antipsoriatics for topical use
209.4
80.4
83
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
76.3
2165
14704
E66.01
ICD-10 Finland
Obesity due to excess calories
2.0
76.1
917
4845
L43.0
ICD-10 Finland
Hypertrophic lichen planus
22.1
74.7
55
25
XQ800
NOMESCO Finland
Prick test
2.2
74.3
682
3252
Z3231
NOMESCO Finland
Registered nurse
1.6
73.9
2295
15910
N05BB01
ATC
hydroxyzine; systemic
2.3
73.5
561
2477
H02AB07
ATC
prednisone; oral
1.8
73.0
1141
6565
TNG10
NOMESCO Finland
Puncture of knee
4.9
72.4
159
327
D11AH04
ATC
alitretinoin; oral
20.5
72.3
55
27
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
71.6
2433
17199
D07AB01
ATC
clobetasone; topical
3.0
70.1
315
1067
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.3
69.8
266
817
ZY010
NOMESCO Finland
Hospital outpatient
2.4
68.3
498
2154
T90
ICPC
Diabetes non-insulin dependent
1.6
67.9
2091
14417
N02AX02
ATC
tramadol; systemic, rectal
1.5
67.1
3656
28472
A02BC02
ATC
pantoprazole; systemic
1.5
66.9
5829
49772
69600
ICD-8 Finland
Psoriasis and similar disorders, Psoriatic arthropathy
+∞
66.7
64
*
L30.0
ICD-10 Finland
Nummular dermatitis
2.6
66.4
405
1612
D07AC03
ATC
desoximetasone; topical
3.9
65.9
193
497
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.2
64.7
569
2664
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
64.2
2510
18218
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
5.0
64.1
138
279
C03CA01
ATC
furosemide; systemic
1.5
61.9
2204
15652
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
61.7
851
4692
RJ411, ,
NOMESCO Finland
6.7
61.3
97
146
M04AA01
ATC
allopurinol; systemic
1.8
60.8
1084
6466
L20.0
ICD-10 Finland
Besnier prurigo
2.1
60.5
652
3299
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
58.8
2536
18716
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
58.1
4968
41681
L43.9
ICD-10 Finland
Lichen planus, unspecified
5.2
57.9
119
231
G47.3
ICD-10 Finland
Sleep apnoea
1.5
57.5
2109
15035
S97
ICPC
Chronic ulcer skin
2.1
57.3
560
2730
WQ021, ,
NOMESCO Finland
15.9
57.2
49
31
D01AC02
ATC
miconazole; topical
2.0
56.6
654
3392
R06AE07
ATC
cetirizine; oral
1.4
56.4
3588
28477
S18
ICPC
Laceration/cut
1.4
55.4
3931
31788
XQ845
NOMESCO Finland
Dermatoscopy
3.3
54.9
210
647
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.8
54.6
915
5351
S76
ICPC
Skin infection other
2.2
54.6
501
2384
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
7.9
54.4
74
94
S21
ICPC
Skin texture symptom/complaint
1.6
54.3
1287
8275
N02BE01
ATC
paracetamol; systemic, rectal
1.6
54.0
7698
70835
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
53.7
1145
7161
L04AK01
ATC
leflunomide; oral
5.7
53.7
99
174
L20
ICPC
Joint symptom/complaint NOS
2.4
51.3
359
1523
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
51.0
1026
6311
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.0
50.6
573
2948
L30.8
ICD-10 Finland
Other specified dermatitis
2.6
50.5
289
1114
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.5
50.2
315
1270
E66.00
ICD-10 Finland
Metabolic syndrome
2.0
49.8
531
2672
RJ421, ,
NOMESCO Finland
7.6
49.6
70
93
E66.8
ICD-10 Finland
Other obesity
2.1
49.3
519
2600
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
48.9
1968
14228
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.8
48.4
752
4293
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
48.3
1018
6336
M01AH05
ATC
etoricoxib; oral
1.4
48.1
5277
45502
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.4
48.0
342
1462
RJ420, ,
NOMESCO Finland
7.1
47.8
71
100
291
Kela drug reimbursment
Tofacitinib
9.1
47.7
58
64
D07XB02
ATC
triamcinolone; topical
3.8
47.6
148
398
D01AE15
ATC
terbinafine; topical
1.9
47.6
619
3338
SPAT1263
SPAT
Sampling
1.4
47.5
3257
25958
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
46.6
1559
10830
R03AC02
ATC
salbutamol; inhalant
1.4
46.4
4473
37665
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.9
46.1
624
3409
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.0
46.0
530
2742
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
46.0
4634
39275
M54.5
ICD-10 Finland
Low back pain
1.4
45.8
3027
23933
L04AX01
ATC
azathioprine; systemic
2.2
45.3
383
1762
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
45.3
3054
24219
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
45.3
656
3662
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
2.8
45.2
223
796
L21.0
ICD-10 Finland
Seborrhoea capitis
4.0
44.6
127
321
UJF32
NOMESCO Finland
Coloscopy
1.5
44.4
2037
15069
L17
ICPC
Foot/toe symptom/complaint
1.4
44.2
2476
18997
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.1
44.2
426
2064
M01CB03
ATC
auranofin; oral
5.4
44.1
87
163
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
4.9
43.4
95
195
L28.0
ICD-10 Finland
Lichen simplex chronicus
4.0
42.1
119
299
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
3.6
42.0
137
381
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
42.0
783
4707
R06.0
ICD-10 Finland
Dyspnoea
1.4
41.9
2101
15772
D07XB05
ATC
dexamethasone; topical
2.7
41.5
225
844
L73.2
ICD-10 Finland
Hidradenitis suppurativa
3.9
41.5
120
307
A10BJ06
ATC
semaglutide; parenteral
2.0
41.2
496
2603
C08CA01
ATC
amlodipine; oral
1.4
40.8
2974
23780
WQ031, ,
NOMESCO Finland
110.6
40.7
44
*
EBA00
NOMESCO Finland
Extraction of tooth
1.4
40.2
2980
23878
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.6
40.2
1001
6483
M01CB01
ATC
sodium aurothiomalate; parenteral
3.8
39.9
123
329
3005
Kela drug reimbursment
Tofacitinib
7.8
39.9
55
71
J02AC01
ATC
fluconazole; systemic
1.4
39.9
2892
23084
TQW99
NOMESCO Finland
Other minor procedure on skin
2.1
39.9
409
2028
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.5
39.9
1256
8586
SPAT1262
SPAT
Handing over of treatment supplies
1.5
39.6
1342
9316
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
3.0
39.2
176
597
C07AB07
ATC
bisoprolol; oral
1.3
39.1
3710
30850
S02CA02
ATC
flumetasone and antiinfectives; otic
2.0
39.1
427
2167
M45
ICD-10 Finland
Ankylosing spondylitis
2.8
39.0
203
746
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
38.6
5602
49578
J01CF05
ATC
flucloxacillin; systemic
1.8
38.4
614
3527
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
38.3
1949
14634
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
3.2
38.2
152
480
L04AA29
ATC
[U] tofacitinib
7.5
38.1
54
72
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
38.0
1748
12882
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
38.0
6022
53944
K05.31
ICD-10 Finland
Periodontitis pronounced
1.6
38.0
909
5827
J01AA02
ATC
doxycycline; systemic
1.4
37.9
6412
58020
J01CE08
ATC
benzathine benzylpenicillin; parenteral
3.6
37.8
123
342
D06AX01
ATC
fusidic acid; topical
1.7
37.7
722
4368
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
37.2
1818
13543
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
4.3
37.2
97
230
D01BA02
ATC
terbinafine; oral
1.4
37.1
2062
15714
K02.1
ICD-10 Finland
Caries of dentine
1.3
36.9
4921
42863
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
3.5
36.9
125
357
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
36.7
6023
54069
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
3.2
36.0
146
467
M01AH01
ATC
celecoxib; oral
1.5
35.9
1324
9337
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
35.9
2217
17179
P01AB01
ATC
metronidazole; oral, rectal
1.3
35.9
3075
25084
R02
ICPC
Shortness of breath/dyspnoea
1.6
35.9
1042
6985
T82
ICPC
Obesity
2.1
35.8
371
1847
NG1DA
NOMESCO Finland
X-ray of knees
2.9
35.5
167
581
205
Kela drug reimbursment
Chronic hypertension
1.4
35.5
1852
13940
H02AB04
ATC
methylprednisolone; systemic
1.5
35.5
1089
7388
XX9XE
NOMESCO Finland
Other ultrasound examination
4.1
35.5
96
234
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.8
35.5
572
3294
L40.2
ICD-10 Finland
Acrodermatitis continua
+∞
35.4
34
*
L04AA17
ATC
[U] adalimumab
7.3
35.1
51
70
M79.6
ICD-10 Finland
Pain in limb
1.3
35.0
3539
29545
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.5
34.9
1045
7050
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.2
34.8
290
1326
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
34.8
3530
29476
L30.4
ICD-10 Finland
Erythema intertrigo
3.1
34.8
148
487
D07AC09
ATC
budesonide; topical
9.4
34.4
41
44
M09.0*L40.5
ICD-10 Finland
Juvenile arthritis in psoriasis
+∞
34.4
33
*
M073, L400,
ICD-10 Finland
+∞
34.4
33
*
L28
ICPC
Limited function/disability (L)
1.5
34.4
1368
9789
J01MA02
ATC
ciprofloxacin; systemic
1.3
34.2
3018
24677
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
34.0
945
6266
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
33.5
606
3607
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
33.4
848
5507
R5140
NOMESCO Finland
Monitoring the use of the aid
1.6
33.3
929
6167
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
3.7
33.2
104
282
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
3.1
33.1
138
449
M10.9
ICD-10 Finland
Gout, unspecified
1.8
33.1
565
3308
WZA10
NOMESCO Finland
Extensive medical or dental certificate
3.2
33.0
134
429
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
32.8
844
5498
R60.0
ICD-10 Finland
Localized oedema
1.6
32.7
957
6418
WQ053, ,
NOMESCO Finland
117.1
32.7
35
*
L85.9
ICD-10 Finland
Epidermal thickening, unspecified
6.6
32.7
52
79
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.1
32.6
315
1528
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.7
32.4
578
3424
R03BB04
ATC
tiotropium bromide; inhalant
1.6
32.4
735
4641
R4180
NOMESCO Finland
Podiatric therapy
3.2
32.4
128
403
M01AE02
ATC
naproxen; oral, rectal
1.3
32.4
4493
39030
A10BH01
ATC
sitagliptin; oral
1.6
32.3
728
4589
M07.1*L40.5
ICD-10 Finland
Arthritis mutilans
+∞
32.3
31
*
A10AE04
ATC
insulin glargine; parenteral
1.6
32.1
761
4859
R05
ICPC
Cough
1.4
31.9
1924
14805
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.7
31.2
644
3968
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.1
31.1
312
1535
J01DA09
ATC
[U] cefadroxil
1.4
31.0
2009
15626
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.9
30.6
385
2051
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
30.5
3500
29558
Z71.8
ICD-10 Finland
Other specified counselling
1.3
30.5
2675
21769
A10BJ02
ATC
liraglutide; parenteral
2.2
30.4
254
1163
M01AB05
ATC
diclofenac; systemic, rectal
1.3
30.3
5391
48200
L28.1
ICD-10 Finland
Prurigo nodularis
4.0
30.2
84
209
L04AF07
ATC
deucravacitinib; oral
+∞
30.2
29
*
A03
ICPC
Fever
1.4
30.2
1345
9811
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
30.0
980
6724
K50.1
ICD-10 Finland
Crohn disease of large intestine
3.2
30.0
121
386
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.9
29.8
382
2046
J02AC02
ATC
itraconazole; systemic
1.4
29.3
1301
9477
J01FA06
ATC
roxithromycin; oral
1.3
29.1
2977
24713
D06BX01
ATC
metronidazole; topical
1.6
29.1
788
5189
SPAT1254
SPAT
Administration of medicine
1.5
28.9
1025
7149
SFA30
NOMESCO Finland
Three-surface restoration
1.3
28.9
3432
29047
R50.9
ICD-10 Finland
Fever, unspecified
1.5
28.9
1165
8335
J45.9
ICD-10 Finland
Asthma, unspecified
1.4
28.9
1430
10623
J01MA12
ATC
levofloxacin; systemic
1.4
28.7
1363
10049
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.6
28.6
822
5482
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.9
28.4
388
2122
WW200
NOMESCO Finland
Immunization
2.2
28.3
237
1086
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
28.3
5478
49282
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
1.9
28.3
374
2025
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.5
28.0
177
717
N05CF01
ATC
zopiclone; oral
1.3
28.0
2337
18833
N07BA03
ATC
varenicline; oral
1.8
28.0
411
2299
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
28.0
2164
17249
4AB02, ,
NOMESCO Finland
6.1
27.9
48
79
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.3
27.9
2161
17229
R06AX27
ATC
desloratadine; oral
1.3
27.9
2200
17587
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
5.9
27.7
49
83
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
27.7
882
6016
RS340, ,
NOMESCO Finland
6.6
27.6
44
67
N06AX21
ATC
duloxetine; oral
1.5
27.5
900
6172
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.5
27.5
169
676
4AA12, ,
NOMESCO Finland
5.8
27.5
50
87
A07EA06
ATC
budesonide; oral, local oral
2.0
27.4
297
1502
R06AE09
ATC
levocetirizine; oral
1.5
27.4
1057
7493
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.0
27.4
307
1572
3029
Kela drug reimbursment
Upadacitinib
6.2
27.4
46
74
P01BA02
ATC
hydroxychloroquine; oral
1.7
27.2
569
3517
Z2221
NOMESCO Finland
Medical doctor
1.3
27.2
1996
15778
WQ054, ,
NOMESCO Finland
+∞
27.1
26
*
N06AX11
ATC
mirtazapine; oral
1.3
27.0
2601
21365
WZA90
NOMESCO Finland
Other medical or dental certificate
1.4
26.9
1779
13839
E66.9
ICD-10 Finland
Obesity, unspecified
2.0
26.9
291
1472
QCA99
NOMESCO Finland
Other local destruction of skin of upper limb
6.4
26.8
44
69
SFA10
NOMESCO Finland
One-surface restoration
1.3
26.8
4451
39161
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
26.7
3042
25532
UJF30
NOMESCO Finland
Ileoscopy through colon
1.5
26.7
820
5547
EBA15
NOMESCO Finland
Extraction of multiple teeth
1.9
26.6
320
1679
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
3.7
26.5
82
221
B35.3
ICD-10 Finland
Tinea pedis
1.8
26.4
379
2105
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
26.4
4183
36562
J20
ICD-10 Finland
Acute bronchitis
1.5
26.4
785
5273
A07EC02
ATC
mesalazine; oral, rectal
1.8
26.3
416
2380
L85.89
ICD-10 Finland
Other specified epidermal thickening
7.6
26.3
37
49
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.7
26.2
448
2622
SPAT1301
SPAT
No procedures
1.3
26.2
2210
17810
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
26.1
2805
23354
3088, ,
Kela drug reimbursment
+∞
26.0
25
*
Z2446
NOMESCO Finland
Social worker
1.7
26.0
477
2846
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
26.0
737
4899
WZC30
NOMESCO Finland
Teaching
1.4
25.9
1282
9508
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic
2.2
25.9
216
990
A10BK01
ATC
dapagliflozin; oral
1.6
25.8
627
4020
ZXC50
NOMESCO Finland
Cryotherapy
2.2
25.7
225
1051
298, ,
Kela drug reimbursment
6.3
25.7
43
69
L71.9
ICD-10 Finland
Rosacea, unspecified
2.2
25.6
220
1020
ZX120
NOMESCO Finland
Intravenous
1.6
25.5
683
4480
L71.8
ICD-10 Finland
Other rosacea
2.5
25.5
155
617
L04AA44
ATC
[U] upadacitinib
7.8
25.5
35
45
S99
ICPC
Skin disease other
2.4
25.5
183
787
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
2.2
25.4
205
926
J01AA07
ATC
tetracycline; systemic
1.4
25.4
1059
7611
A07AA02
ATC
nystatin; oral
1.8
25.4
391
2220
K50.9
ICD-10 Finland
Crohn disease, unspecified
2.7
25.3
138
521
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.1
25.2
252
1238
E0001A1, ,
ATC
2.5
25.2
161
657
K50.8
ICD-10 Finland
Other Crohn disease
2.7
25.1
137
517
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
7.6
25.0
35
46
WQ032, ,
NOMESCO Finland
+∞
25.0
24
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
25.0
1324
9928
N06AB04
ATC
citalopram; systemic
1.4
25.0
1494
11426
R4110
NOMESCO Finland
Physiotherapy
1.3
24.8
2093
16845
Z3226
NOMESCO Finland
Physiotherapist
1.4
24.8
1298
9713
ZX112
NOMESCO Finland
Subcutaneous
2.4
24.5
174
744
H60.3
ICD-10 Finland
Other infective otitis externa
2.2
24.5
200
909
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
2.9
24.4
111
380
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
3.6
24.4
80
224
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.8
24.4
352
1959
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
24.4
2844
23871
J01CA04
ATC
amoxicillin; systemic
1.3
24.3
6753
62890
R4120
NOMESCO Finland
Occupational therapy
1.7
24.3
497
3052
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.7
24.2
443
2643
D07AC04
ATC
fluocinolone acetonide; topical
9.7
24.1
28
29
C03DA01
ATC
spironolactone; oral
1.5
24.1
850
5914
SFA20
NOMESCO Finland
Two-surface restoration
1.3
24.0
4749
42415
A10BB12
ATC
glimepiride; oral
1.7
23.9
433
2575
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
23.8
3645
31586
-1, ,
NOMESCO Finland
1.3
23.8
2481
20520
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
23.8
866
6063
N03AX16
ATC
[U] pregabalin
1.3
23.7
1677
13144
256, ,
Kela drug reimbursment
6.1
23.7
41
68
D05AD01
ATC
trioxysalen; topical
87.0
23.6
26
*
M03BX02
ATC
tizanidine; oral
1.3
23.5
4992
44895
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
23.5
2298
18843
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
23.5
1836
14603
M10.0
ICD-10 Finland
Idiopathic gout
2.0
23.4
269
1390
D11
ICPC
Diarrhoea
1.5
23.4
891
6292
A02BC01
ATC
omeprazole; systemic
1.3
23.3
1938
15543
M79.7
ICD-10 Finland
Fibromyalgia
2.0
23.3
255
1296
RS221, ,
NOMESCO Finland
2.7
23.3
121
446
A02BC03
ATC
lansoprazole; oral
1.3
23.2
2029
16385
WX290
NOMESCO Finland
Other blockage of nerve
1.3
23.2
3814
33295
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
4.9
23.1
50
102
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
23.1
2992
25394
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
23.0
1685
13272
D01AC03
ATC
econazole; topical
1.7
22.8
431
2594
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
22.7
937
6718
L41.9
ICD-10 Finland
Parapsoriasis, unspecified
230.6
22.6
23
*
J01FA10
ATC
azithromycin; systemic
1.2
22.6
4472
39817
M01AH02
ATC
rofecoxib; oral
1.5
22.4
838
5894
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
22.4
855
6038
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
2.0
22.4
261
1356
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.6
22.2
563
3646
D64.9
ICD-10 Finland
Anaemia, unspecified
1.5
22.1
744
5126
A10BK03
ATC
empagliflozin; oral
1.5
22.1
777
5401
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.2
22.0
3959
34835
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
22.0
3064
26192
N05BA04
ATC
oxazepam; oral
1.3
22.0
1877
15091
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.2
22.0
194
910
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
22.0
2666
22420
L60.0
ICD-10 Finland
Ingrowing nail
1.8
21.9
359
2075
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
21.8
1768
14113
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
21.7
1357
10428
WXQ10
NOMESCO Finland
Psoralen - Ultraviolet A therapy with systemic sensitivisation
25.1
21.7
30
12
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.8
21.7
319
1787
XQ899
NOMESCO Finland
Other assessment of skin
4.4
21.7
53
120
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
3.2
21.5
82
254
N03AX12
ATC
[U] gabapentin; oral
1.4
21.4
1150
8627
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
2.3
21.3
159
696
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.2
21.2
175
799
K50.0
ICD-10 Finland
Crohn disease of small intestine
2.5
21.2
132
533
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
1.9
21.1
268
1433
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
21.0
910
6574
L08.0
ICD-10 Finland
Pyoderma
3.1
20.9
88
289
M01AC06
ATC
meloxicam; systemic, rectal
1.3
20.9
2637
22251
M07.2
ICD-10 Finland
Psoriatic spondylitis
+∞
20.8
20
*
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
4.9
20.8
45
92
A10AB05
ATC
insulin aspart; parenteral
1.6
20.8
555
3636
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
2.9
20.8
95
327
SPAT1312
SPAT
General health counselling
1.3
20.8
2228
18430
C09AA02
ATC
enalapril; systemic
1.4
20.7
1275
9766
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
20.7
881
6343
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
2.8
20.7
102
366
S10
ICPC
Boil/carbuncle
1.6
20.6
446
2781
L44.0
ICD-10 Finland
Pityriasis rubra pilaris
110.3
20.6
22
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.8
20.5
327
1876
N06AB10
ATC
escitalopram; oral
1.3
20.5
1480
11613
SPAT1283
SPAT
Restricted health certificate
1.4
20.4
1189
9029
N05BA01
ATC
diazepam; systemic, rectal
1.4
20.4
893
6463
H04.10
ICD-10 Finland
Dry eye syndrome
1.4
20.4
852
6114
N05CD07
ATC
temazepam; oral
1.5
20.3
726
5060
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.5
20.3
597
3998
R74
ICPC
Upper respiratory infection acute
1.3
20.2
2480
20835
M54.4
ICD-10 Finland
Lumbago with sciatica
1.3
20.2
1360
10557
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
1.6
20.2
449
2817
K08.3
ICD-10 Finland
Retained dental root
1.5
20.2
594
3976
L57.0
ICD-10 Finland
Actinic keratosis
1.5
20.1
681
4693
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
1.9
20.1
253
1349
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.6
20.1
532
3479
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
20.0
1375
10707
L23.9
ICD-10 Finland
Allergic contact dermatitis, unspecified cause
3.0
20.0
85
281
D07CB01
ATC
triamcinolone and antibiotics; topical
2.3
19.9
144
622
C10AA05
ATC
atorvastatin; oral
1.2
19.9
3142
27155
H62.0*A46
ICD-10 Finland
Otitis externa in erysipelas
3.0
19.8
87
293
D06BB04
ATC
podophyllotoxin; topical
1.7
19.7
355
2108
L23.3
ICD-10 Finland
Allergic contact dermatitis due to drugs in contact with skin
3.6
19.7
63
174
ZX140
NOMESCO Finland
Intra articular
3.3
19.7
75
232
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.9
19.7
245
1302
WZA00
NOMESCO Finland
Concise certificate
1.6
19.6
471
3011
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.7
19.6
349
2067
M09.0
ICD-10 Finland
Juvenile arthritis in psoriasis
200.4
19.6
20
*
R03BA05
ATC
fluticasone; inhalant
1.3
19.5
1271
9814
T36
ICD-10 Finland
Poisoning by systemic antibiotics
1.8
19.5
313
1800
NA6CG
NOMESCO Finland
Sacro-iliac joint extensive MRI examination with high intensity magnet
4.6
19.3
45
98
P03
ICPC
Feeling depressed
1.5
19.2
705
4936
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.1
19.2
171
806
J01AA04
ATC
lymecycline; systemic
1.4
19.1
918
6749
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.6
19.1
473
3046
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.9
19.0
259
1417
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
2.2
19.0
155
705
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
2.6
19.0
106
406
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.3
19.0
1195
9179
SPAT1260
SPAT
Consultation of another employee
1.3
18.9
1191
9147
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
18.9
471
3039
L99
ICPC
Musculoskeletal disease other
2.1
18.8
171
812
H60.8
ICD-10 Finland
Other otitis externa
1.9
18.8
243
1308
L405, L400,
ICD-10 Finland
+∞
18.8
18
*
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
3.8
18.7
56
148
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.4
18.6
881
6460
A10AC01
ATC
insulin (human); parenteral
1.6
18.6
495
3241
S06
ICPC
Rash localized
1.7
18.5
384
2367
K05.30
ICD-10 Finland
Periodontitis complex
1.4
18.5
1125
8591
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.8
18.5
295
1693
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.5
18.4
622
4283
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
1.9
18.2
234
1257
J01FA01
ATC
erythromycin; systemic
1.4
18.2
938
6979
KMAK, ,
NOMESCO Finland
1.2
18.1
3915
34852
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
18.1
2079
17289
160
Kela drug reimbursment
exenatide
2.2
18.1
150
687
R03AK07
ATC
formoterol and budesonide; inhalant
1.3
18.1
1572
12629
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
1.9
18.0
233
1254
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
2.8
18.0
87
309
M79.0
ICD-10 Finland
Rheumatism, unspecified
1.9
18.0
218
1149
6929X
ICD-9 Finland
Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]
6.3
18.0
30
48
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.1
18.0
179
881
N06AA09
ATC
amitriptyline; systemic
1.5
17.9
616
4258
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
17.9
1439
11440
RS121, ,
NOMESCO Finland
3.6
17.9
58
162
B01AB05
ATC
enoxaparin; parenteral
1.3
17.9
2231
18732
L15
ICPC
Knee symptom/complaint
1.3
17.8
1830
15011
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
17.8
1935
15985
A01
ICPC
Pain general/multiple sites
1.4
17.7
699
4963
L03
ICPC
Low back symptom/complaint
1.3
17.7
2161
18099
C10AA01
ATC
simvastatin; oral
1.2
17.6
2812
24254
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.1
17.5
160
763
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.7
17.3
357
2198
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.3
17.3
2045
17054
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.7
17.3
332
2008
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
2.7
17.2
88
323
H60.1
ICD-10 Finland
Cellulitis of external ear
2.5
17.2
108
439
A06AD11
ATC
lactulose; oral
1.4
17.1
924
6924
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
2.2
17.0
145
672
H02AB08
ATC
triamcinolone; systemic
4.6
17.0
40
88
N05AH04
ATC
quetiapine; oral
1.3
16.9
1261
9912
N06AX16
ATC
venlafaxine; oral
1.4
16.9
1008
7668
SPAT1310
SPAT
Counselling related to known health issue
1.2
16.9
2194
18480
S01
ICPC
Pain/tenderness of skin
1.7
16.9
331
2012
P15
ICPC
Chronic alcohol abuse
1.8
16.9
247
1383
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.4
16.9
851
6305
OAB50, ,
SPAT
1.5
16.9
601
4183
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
1.9
16.8
204
1077
J01FA09
ATC
clarithromycin; systemic
1.2
16.7
2272
19230
M48.0
ICD-10 Finland
Spinal stenosis
1.4
16.7
798
5857
L04AF03
ATC
upadacitinib; oral
5.2
16.7
34
66
ZXD05
NOMESCO Finland
Urgent procedure
1.2
16.7
2118
17793
A02BA02
ATC
ranitidine; systemic
1.3
16.7
1250
9835
L23.8
ICD-10 Finland
Allergic contact dermatitis due to other agents
3.3
16.6
60
180
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
2.4
16.6
108
446
B35.4
ICD-10 Finland
Tinea corporis
2.4
16.5
114
484
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
1.9
16.5
193
1007
A41.9
ICD-10 Finland
Sepsis, unspecified
1.8
16.4
238
1329
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.1
16.4
159
775
SPAT1229
SPAT
Assessment of need for aid
1.5
16.4
466
3096
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.4
16.4
846
6292
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
4.9
16.4
35
71
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.5
16.3
538
3688
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.7
16.2
279
1638
R95
ICPC
Chron obstructive pulmonary disease
1.9
16.2
211
1140
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
1.9
16.2
192
1006
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
16.2
1192
9353
M08.9
ICD-10 Finland
Juvenile arthritis, unspecified
6.8
16.1
25
37
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
16.1
1250
9877
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
2.4
16.1
113
483
SGB10
NOMESCO Finland
Root filling of tooth with one root canal
1.4
16.1
890
6691
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.3
16.1
1062
8203
SPAT1153
SPAT
Removal of sutures
1.2
16.0
2191
18546
WXQ26
NOMESCO Finland
UVB broad spectrum light therapy
47.6
16.0
19
*
N06AB03
ATC
fluoxetine; oral
1.4
16.0
821
6099
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.9
16.0
192
1010
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
2.9
15.9
74
258
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
15.9
914
6913
EB1HA, ,
SPAT
1.9
15.9
192
1012
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.0
15.8
163
813
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.3
15.7
1267
10060
H01
ICPC
Ear pain/earache
1.4
15.7
819
6098
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
1.4
15.6
697
5055
L04AA21
ATC
[U] efalizumab
+∞
15.6
15
*
M07
ICD-10 Finland
Psoriatic and enteropathic arthropathies
+∞
15.6
15
*
WQ068, ,
NOMESCO Finland
+∞
15.6
15
*
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.6
15.6
379
2431
L41.1
ICD-10 Finland
Pityriasis lichenoides chronica
85.2
15.6
17
*
SGA01
NOMESCO Finland
Emergency treatment
1.3
15.5
1227
9715
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
15.5
2787
24252
M01AB55
ATC
diclofenac, combinations; oral
1.6
15.5
409
2674
A28
ICPC
Limited function/disability NOS
1.3
15.5
1099
8576
R60.9
ICD-10 Finland
Oedema, unspecified
1.6
15.4
386
2492
K04.0
ICD-10 Finland
Pulpitis
1.4
15.4
665
4795
R96
ICPC
Asthma
1.4
15.4
674
4874
M17.5
ICD-10 Finland
Other secondary gonarthrosis
2.3
15.3
111
482
162
Kela drug reimbursment
liraglutide
2.6
15.3
90
355
SGA02
NOMESCO Finland
Opening and preparing the root canals
1.3
15.3
928
7078
A10AE05
ATC
insulin detemir; parenteral
1.6
15.2
355
2257
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.6
15.2
398
2599
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.3
15.1
941
7202
A10BX07
ATC
[U] liraglutide
2.4
15.1
98
405
D11AH01
ATC
tacrolimus; topical
2.7
15.1
79
294
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
2.0
15.0
168
863
R05
ICD-10 Finland
Cough
1.3
15.0
1535
12555
W19
ICD-10 Finland
Unspecified fall
1.4
15.0
678
4930
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.6
15.0
320
1990
NF1AA
NOMESCO Finland
Hip X-ray examination
1.4
14.9
585
4145
ZXA05
NOMESCO Finland
Left side
1.3
14.9
1623
13373
M01AB01
ATC
indometacin; systemic, rectal
1.5
14.9
475
3234
B35.6
ICD-10 Finland
Tinea inguinalis [Tinea cruris]
1.9
14.9
170
880
N07BB01
ATC
disulfiram; oral
1.6
14.9
327
2048
R21
ICPC
Throat symptom/complaint
1.3
14.9
1474
12010
EBA30
NOMESCO Finland
Extraction of root of tooth
1.5
14.8
422
2805
M19.2
ICD-10 Finland
Other secondary arthrosis
2.4
14.8
101
427
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
3.3
14.7
53
159
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
1.7
14.7
279
1684
XCK10
NOMESCO Finland
Photography of fundus of eye
1.4
14.7
611
4379
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.1
14.6
128
601
A08
ICPC
Swelling
1.6
14.6
372
2413
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.4
14.6
735
5443
K59.1
ICD-10 Finland
Functional diarrhoea
1.6
14.5
374
2431
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.5
14.5
450
3045
RS222, ,
NOMESCO Finland
2.6
14.5
85
335
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.3
14.5
1174
9323
C09CA01
ATC
losartan; oral
1.2
14.4
1806
15113
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
2.0
14.4
164
848
L29.9
ICD-10 Finland
Pruritus, unspecified
1.8
14.3
193
1055
XF400
NOMESCO Finland
ECG with 12 standard connections
1.3
14.3
1008
7852
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.3
14.3
951
7347
RD210, ,
NOMESCO Finland
2.1
14.3
126
594
TND10
NOMESCO Finland
Joint puncture, wrist or finger joint
4.9
14.2
31
64
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.5
14.2
496
3441
J01CR50
ATC
combinations of penicillins; systemic
5.3
14.2
28
53
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
1.6
14.1
300
1865
L08
ICPC
Shoulder symptom/complaint
1.2
14.1
1687
14044
K07
ICPC
Swollen ankles/oedema
1.6
14.1
299
1858
H03AA01
ATC
levothyroxine sodium; systemic
1.3
14.1
1491
12240
A06AC01
ATC
ispaghula (psylla seeds); oral
1.2
13.9
1787
14986
ZXE00
NOMESCO Finland
One hour or less
1.2
13.9
2735
23949
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
13.9
1835
15440
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
1.8
13.9
206
1161
L41.3
ICD-10 Finland
Small plaque parapsoriasis
53.4
13.8
16
*
L12
ICPC
Hand/finger symptom/complaint
1.3
13.8
1223
9821
J01MA14
ATC
moxifloxacin; systemic
1.4
13.7
607
4395
SPAT1216
SPAT
Assessment of functional ability
1.3
13.7
926
7167
M13.0
ICD-10 Finland
Polyarthritis, unspecified
2.4
13.7
94
399
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.3
13.7
934
7243
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
1.7
13.7
228
1329
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
2.3
13.6
100
438
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.3
13.5
924
7164
A02BC05
ATC
esomeprazole; systemic
1.2
13.5
2958
26142
F29
ICPC
Eye symptom/complaint other
1.4
13.4
734
5504
F10.20
ICD-10 Finland
Alcohol dependence currently independent
1.9
13.4
156
813
A99
ICPC
Disease/condition unspecnature/site
1.4
13.4
714
5334
K51.5
ICD-10 Finland
Left sided colitis
1.8
13.4
195
1093
SDA03
NOMESCO Finland
Periodontal treatment
1.2
13.3
3119
27717
P06
ICPC
Sleep disturbance
1.3
13.3
925
7193
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
1.7
13.2
230
1356
B37.2
ICD-10 Finland
Candidiasis of skin and nail
2.7
13.2
71
268
K02.2
ICD-10 Finland
Caries of cementum
1.6
13.2
313
1997
E87.6
ICD-10 Finland
Hypokalaemia
1.7
13.2
224
1312
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.5
13.2
395
2655
E66
ICD-10 Finland
Obesity
1.5
13.2
389
2607
SDA04
NOMESCO Finland
Demanding periodontal treatment
1.2
13.2
2204
18981
WVA20
NOMESCO Finland
Medicine administration
1.8
13.2
202
1150
C08CA13
ATC
lercanidipine; oral
1.3
13.1
947
7399
NF2AT
NOMESCO Finland
Injection to hip joint with ultrasound guidance
3.3
13.1
48
146
EB1WA, ,
NOMESCO Finland
3.0
13.1
56
187
XX9XT
NOMESCO Finland
Other radiological intervention
15.0
13.1
21
14
F10.24
ICD-10 Finland
Alcohol depence active use
2.1
13.0
122
589
P17
ICPC
Tobacco abuse
2.2
13.0
107
491
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
2.4
12.9
84
348
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
2.9
12.9
58
199
L23.5
ICD-10 Finland
Allergic contact dermatitis due to other chemical products
2.7
12.9
67
249
A10BJ05
ATC
dulaglutide; parenteral
1.9
12.9
147
762
Z01.2
ICD-10 Finland
Dental examination
1.2
12.8
3549
31971
J05AB01
ATC
aciclovir; systemic
1.2
12.8
1476
12220
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.3
12.8
915
7138
JN3AD
NOMESCO Finland
Abdominal CT examination
1.3
12.8
933
7300
L50.3
ICD-10 Finland
Dermatographic urticaria
2.1
12.8
117
560
P74
ICPC
Anxiety disorder/anxiety state
1.6
12.8
294
1864
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.4
12.8
609
4468
AA1AD
NOMESCO Finland
CT of head and brain
1.2
12.7
1986
16976
UDC00
NOMESCO Finland
Ear microscopy
1.4
12.7
488
3445
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.2
12.7
1618
13546
ND1AE
NOMESCO Finland
Wrist ultrasound examination
3.8
12.7
38
101
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
12.7
1383
11379
Z02.7
ICD-10 Finland
Issue of medical certificate
1.4
12.6
503
3575
N06AA12
ATC
doxepin; systemic
1.6
12.6
308
1979
C09AA05
ATC
ramipril; oral
1.2
12.6
1645
13801
A97
ICPC
No disease
1.3
12.6
1406
11594
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
4.3
12.6
32
75
WX110, ,
SPAT
1.5
12.6
385
2599
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.4
12.6
664
4950
R03AK03
ATC
[U] fenoterol and ipratropium bromide
1.6
12.6
284
1791
H02AB09
ATC
hydrocortisone; systemic
1.9
12.6
164
888
N07.3
ICD-10 Finland
Hereditary nephropathy, not elsewhere classified, diffuse mesangial proliferative glomerulonephritis
70.0
12.6
14
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.4
12.6
474
3336
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
1.6
12.5
267
1661
F10.25
ICD-10 Finland
Alcohol dependence continuous use
2.0
12.5
136
693
M070, L400,
ICD-10 Finland
+∞
12.5
12
*
B01AC04
ATC
clopidogrel; oral
1.3
12.5
1041
8288
A04
ICPC
Weakness/tiredness general
1.3
12.5
1030
8191
R51.80
ICD-10 Finland
Headache
1.3
12.4
1065
8508
P76
ICPC
Depressive disorder
1.5
12.4
443
3085
R4190
NOMESCO Finland
Nutritional therapy
1.6
12.4
272
1704
TNF11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in hip joint
5.6
12.4
23
41
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.5
12.4
419
2888
I50.0
ICD-10 Finland
Congestive heart failure
1.5
12.4
400
2733
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
1.7
12.3
217
1285
M17.4
ICD-10 Finland
Other secondary gonarthrosis, bilateral
3.5
12.3
42
122
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.4
12.3
659
4926
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
1.8
12.3
168
924
F10.09
ICD-10 Finland
Alcohol intoxication UNS
1.9
12.3
151
803
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
2.0
12.2
126
631
T78.4
ICD-10 Finland
Allergy, unspecified
1.6
12.2
286
1822
SPE90
NOMESCO Finland
Other partial denture
2.0
12.2
136
700
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
1.9
12.2
143
749
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
1.7
12.2
206
1207
M02AA07
ATC
piroxicam; topical
1.2
12.2
2413
21090
L23.1
ICD-10 Finland
Allergic contact dermatitis due to adhesives
3.8
12.1
36
95
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
12.1
3165
28329
P29
ICPC
Psychological sympt/compl other
1.4
12.1
499
3570
K70.1
ICD-10 Finland
Alcoholic hepatitis
3.1
12.1
50
164
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.4
12.0
555
4048
ZXE10
NOMESCO Finland
More than one and less than three hours
1.2
12.0
2477
21716
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.6
12.0
283
1804
QDH05
NOMESCO Finland
Correction of deformity of toe nail
4.1
12.0
32
78
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
1.8
12.0
181
1026
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
2.2
12.0
98
449
R05FB02
ATC
cough suppressants and expectorants; systemic
1.2
12.0
2515
22090
N06AX12
ATC
bupropion; oral
1.4
12.0
490
3502
M10
ICD-10 Finland
Gout
1.6
11.9
307
1998
J01XC01
ATC
fusidic acid; systemic
2.3
11.9
90
399
D01AA02
ATC
natamycin; topical
2.0
11.9
133
685
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.2
11.9
1549
12987
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
1.7
11.9
224
1351
TNC11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in elbow joint
4.5
11.9
28
62
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.0
11.8
132
680
M46.8
ICD-10 Finland
Other specified inflammatory spondylopathies
5.8
11.8
21
36
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.4
11.8
474
3377
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.2
11.8
2143
18573
NH3AE
NOMESCO Finland
Feet ultrasound examination
4.1
11.8
31
75
J37.0
ICD-10 Finland
Chronic laryngitis
1.7
11.8
220
1325
7140B
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]
3.9
11.7
33
84
L04AB02
ATC
infliximab; parenteral
3.1
11.7
48
157
WXQ24
NOMESCO Finland
UVB/UVA light therapy
16.4
11.6
18
11
R06.2
ICD-10 Finland
Wheezing
1.6
11.6
291
1882
SGC00
NOMESCO Finland
Medication, disinfection of root canals
1.3
11.6
750
5765
M40.5
ICD-10 Finland
Lordosis, unspecified
30.0
11.6
15
5
349
Kela drug reimbursment
Febuxostat
4.0
11.6
32
80
SPAT1240
SPAT
Therapeutic discussion
1.4
11.6
665
5022
Z72.0
ICD-10 Finland
Tobacco use
1.7
11.6
186
1073
J04BA02
ATC
dapsone; oral
3.2
11.6
45
142
H70
ICPC
Otitis externa
1.9
11.6
147
790
ZYC01
NOMESCO Finland
Remote contact by phone
1.5
11.6
420
2935
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.3
11.6
670
5069
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
11.6
7549
72837
M03BC51
ATC
orphenadrine, combinations; systemic
1.2
11.5
1896
16268
D11AH02
ATC
pimecrolimus; topical
3.5
11.5
38
108
R52.9
ICD-10 Finland
Pain, unspecified
1.3
11.5
704
5369
H29
ICPC
Ear symptom/complaint other
1.3
11.5
808
6285
S82.8
ICD-10 Finland
Fractures of other parts of lower leg
1.6
11.5
242
1502
Z50.1
ICD-10 Finland
Other physical therapy
1.5
11.5
330
2201
C07AB02
ATC
metoprolol; systemic
1.3
11.5
1192
9744
E66.0
ICD-10 Finland
Obesity due to excess calories
2.5
11.5
72
294
M073L, ,
ICD-10 Finland
+∞
11.5
11
*
L405M, ,
ICD-10 Finland
+∞
11.5
11
*
RS211, ,
NOMESCO Finland
4.0
11.4
32
81
M01AX01
ATC
nabumetone; oral
1.6
11.4
253
1590
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
2.3
11.4
83
362
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
1.8
11.4
162
902
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.0
11.4
124
633
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.2
11.4
1854
15894
R53
ICD-10 Finland
Malaise and fatigue
1.2
11.3
1734
14771
Z01.7
ICD-10 Finland
Laboratory examination
1.3
11.3
1174
9593
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.6
11.3
264
1680
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
1.7
11.3
191
1119
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.6
11.3
250
1571
ZXA00
NOMESCO Finland
Right side
1.2
11.3
1720
14646
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.3
11.2
713
5467
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
3.5
11.2
38
110
TPH07
NOMESCO Finland
Cathetrisation of artery
1.3
11.2
753
5823
ZYC06
NOMESCO Finland
Real-time text-based remote transaction
4.0
11.2
31
78
6929B
ICD-9 Finland
Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]
4.4
11.2
27
61
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.2
11.2
1421
11878
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
2.1
11.1
105
509
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic
1.9
11.1
145
787
J45.1
ICD-10 Finland
Nonallergic asthma
1.4
11.1
446
3178
A10BB01
ATC
glibenclamide; oral
1.7
11.0
188
1105
SCA01
NOMESCO Finland
Preventive oral health care, short
1.2
11.0
1988
17199
H57.1
ICD-10 Finland
Ocular pain
1.6
11.0
261
1668
M04AA03
ATC
febuxostat; oral
3.8
11.0
33
88
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.5
11.0
351
2395
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.2
10.9
1223
10079
NF1DA
NOMESCO Finland
X-ray of hips
1.9
10.9
135
720
N05CF02
ATC
zolpidem; oral
1.3
10.9
1163
9531
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
1.9
10.9
124
643
S22.3
ICD-10 Finland
Fracture of rib
1.4
10.9
495
3602
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.2
10.9
1238
10222
L50.0
ICD-10 Finland
Allergic urticaria
1.8
10.8
168
961
L16
ICPC
Ankle symptom/complaint
1.3
10.8
805
6312
H13
ICPC
Plugged feeling ear
1.2
10.8
1312
10909
M13.8
ICD-10 Finland
Other specified arthritis
2.3
10.8
75
321
L43.3
ICD-10 Finland
Subacute (active) lichen planus
11.9
10.8
19
16
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
1.8
10.8
147
809
Z01.9
ICD-10 Finland
Special examination, unspecified
1.4
10.8
393
2750
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.2
10.8
1774
15215
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
1.9
10.7
132
704
WX722
NOMESCO Finland
PEEP
1.5
10.7
304
2024
L88
ICD-10 Finland
Pyoderma gangrenosum
4.6
10.7
25
55
S19
ICPC
Skin injury other
1.6
10.6
252
1611
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
1.5
10.6
337
2296
B03BA03
ATC
hydroxocobalamin; parenteral
1.5
10.6
329
2231
R07.3
ICD-10 Finland
Other chest pain
1.3
10.6
690
5312
QBA10
NOMESCO Finland
Incision of skin of trunk
2.2
10.6
84
381
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.3
10.6
661
5058
L50.9
ICD-10 Finland
Urticaria, unspecified
1.6
10.5
235
1481
SPAT1255
SPAT
Intravenous administration of medicine
1.4
10.5
430
3073
C10AB05
ATC
fenofibrate; oral
1.9
10.5
126
666
W10
ICD-10 Finland
Fall on and from stairs and steps
1.5
10.5
340
2326
EBA10
NOMESCO Finland
Operative extraction of tooth
1.3
10.5
867
6892
WX723
NOMESCO Finland
CPAP therapy
1.5
10.4
320
2165
R31
ICD-10 Finland
Unspecified haematuria
1.3
10.4
660
5060
L04AC12
ATC
brodalumab; systemic
+∞
10.4
10
*
J96.1
ICD-10 Finland
Chronic respiratory failure
1.9
10.4
124
654
H60
ICD-10 Finland
Otitis externa
1.5
10.4
360
2495
S20
ICPC
Corn/callosity
1.8
10.4
138
754
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.3
10.4
1110
9099
RT271, ,
NOMESCO Finland
5.4
10.4
20
37
D01AC08
ATC
ketoconazole; topical
2.1
10.4
93
443
L84
ICD-10 Finland
Corns and callosities
1.6
10.4
224
1401
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
1.9
10.4
135
733
UKC02
NOMESCO Finland
Cystoscopy
1.3
10.4
1031
8382
R03BA02
ATC
budesonide; inhalant
1.2
10.4
1186
9797
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
2.8
10.3
49
174
358
Kela drug reimbursment
liraglutide
3.1
10.3
42
137
K04.08
ICD-10 Finland
Other specified pulpit
1.4
10.3
543
4052
S87
ICPC
Dermatitis/atopic eczema
1.8
10.2
157
896
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
2.6
10.2
58
226
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.0
10.2
114
588
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.5
10.2
343
2363
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
2.0
10.2
108
547
R06AX22
ATC
ebastine; oral
1.2
10.2
1128
9281
R42
ICD-10 Finland
Dizziness and giddiness
1.2
10.2
1506
12772
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.7
10.2
195
1183
RT272, ,
NOMESCO Finland
3.8
10.2
30
79
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
1.7
10.2
177
1047
J02AB02
ATC
ketoconazole; oral
1.7
10.2
177
1047
-69
ICPC
Other reason for encounter NEC
1.6
10.2
225
1416
S01.0
ICD-10 Finland
Open wound of scalp
1.4
10.1
521
3871
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.6
10.1
221
1386
R5110, ,
SPAT
1.4
10.1
534
3984
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.4
10.1
542
4055
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.3
10.1
1075
8809
S74
ICPC
Dermatophytosis
1.8
10.1
133
726
C07AG02
ATC
carvedilol; oral
1.5
10.0
342
2363
RS230, ,
NOMESCO Finland
3.0
10.0
42
139
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
1.9
10.0
126
677
SGC10
NOMESCO Finland
Pulp capping
1.3
10.0
580
4390
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
10.0
1668
14312
L14
ICPC
Leg/thigh symptom/complaint
1.4
10.0
526
3924
G44.2
ICD-10 Finland
Tension-type headache
1.3
10.0
891
7151
S86
ICPC
Dermatitis seborrhoeic
3.3
10.0
37
114
R20.2
ICD-10 Finland
Paraesthesia of skin
1.4
9.9
473
3471
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
1.9
9.9
127
686
J01DA06
ATC
[U] cefuroxime
1.3
9.9
928
7489
K51.8
ICD-10 Finland
Other ulcerative colitis
2.0
9.9
101
505
C03AA03
ATC
hydrochlorothiazide; oral
1.4
9.9
512
3807
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prosthodontic work
1.6
9.9
254
1655
S24
ICPC
Hair/scalp symptom/complaint other
2.3
9.9
74
328
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.3
9.9
628
4818
SAA04
NOMESCO Finland
Special examination of mouth
1.5
9.9
322
2207
N19
ICD-10 Finland
Unspecified kidney failure
1.6
9.9
217
1364
D07AB09
ATC
triamcinolone; topical
2.9
9.8
45
157
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.3
9.8
1007
8218
T74.1
ICD-10 Finland
Physical abuse
1.9
9.8
121
647
K02.9
ICD-10 Finland
Dental caries, unspecified
1.9
9.8
112
584
A29
ICPC
General symptom/complaint other
1.3
9.8
883
7097
NG1EA
NOMESCO Finland
Knee X-ray examination with wrench
2.0
9.7
95
468
K04.1
ICD-10 Finland
Necrosis of pulp
1.3
9.7
772
6107
R01AD09
ATC
mometasone; nasal
1.2
9.7
3327
30280
C84.0
ICD-10 Finland
Mycosis fungoides
7.3
9.7
22
30
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.3
9.7
796
6323
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.4
9.7
440
3205
TGC00
NOMESCO Finland
Bronchial lavation
1.7
9.7
157
912
EG1CG
NOMESCO Finland
Extensive MRI examination of mandibular joint with high intensity magnet
3.8
9.6
28
73
H01.0
ICD-10 Finland
Blepharitis
1.4
9.6
457
3351
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.5
9.6
262
1730
A10BX04
ATC
[U] exenatide
2.2
9.6
74
332
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
2.1
9.6
82
384
C01DA14
ATC
isosorbide mononitrate; oral
1.3
9.6
846
6779
ND2CG
NOMESCO Finland
Extensive MRI of hand
3.7
9.6
29
78
R52.2
ICD-10 Finland
Other chronic pain
1.6
9.6
241
1564
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.5
9.6
292
1975
288
Kela drug reimbursment
Febuxostat
3.3
9.6
34
102
J45.8
ICD-10 Finland
Mixed asthma
1.6
9.5
188
1150
A07DA03
ATC
loperamide; oral
1.6
9.5
195
1204
F32.1
ICD-10 Finland
Moderate depressive episode
1.4
9.5
377
2681
C08CA02
ATC
felodipine; oral
1.3
9.5
545
4118
S06.0
ICD-10 Finland
Concussion
1.3
9.5
702
5498
SPAT1281
SPAT
Other administrative function
1.4
9.5
470
3471
J31.0
ICD-10 Finland
Chronic rhinitis
1.3
9.5
571
4346
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.2
9.5
1541
13182
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.4
9.5
429
3123
SPAT1151
SPAT
Treatment of major wounds
2.2
9.5
80
373
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.3
9.5
627
4839
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
2.3
9.5
66
284
M76.6
ICD-10 Finland
Achilles tendinitis
1.4
9.4
349
2451
EB1VA, ,
NOMESCO Finland
1.2
9.4
1300
10944
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
1.7
9.4
154
896
QXA05
NOMESCO Finland
Skin division, unspecified location
3.4
9.4
33
98
XF600
NOMESCO Finland
Bloodpressure measurement
1.4
9.4
386
2762
56510
ICD-8 Finland
Anal fissure and fistula, Anal fistula
3.7
9.4
29
79
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.4
9.4
446
3272
SPAT1202
SPAT
Intra-articular injection
1.7
9.4
169
1010
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.3
9.4
602
4625
M70.6
ICD-10 Finland
Trochanteric bursitis
1.3
9.4
806
6437
L400, L405,
ICD-10 Finland
+∞
9.4
9
*
WYA10
NOMESCO Finland
Emergency care or similar visit
1.4
9.4
451
3316
EJ2S1
NOMESCO Finland
Photography of oral mucosa
2.3
9.4
69
304
A10BH05
ATC
linagliptin; oral
1.5
9.3
305
2091
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.5
9.3
316
2182
WX408
NOMESCO Finland
General anesthesy, balanced
1.2
9.3
1768
15338
SPAT1211
SPAT
Application of soft bandage
1.3
9.3
523
3944
SBA00
NOMESCO Finland
Microbiological examinations
1.7
9.2
152
887
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.6
9.2
234
1523
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.5
9.2
306
2107
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
1.8
9.2
126
697
L71.0
ICD-10 Finland
Perioral dermatitis
2.0
9.2
99
506
M01AX17
ATC
nimesulide; oral
1.2
9.1
1518
13007
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.4
9.1
419
3058
L01
ICPC
Neck symptom/complaint
1.2
9.1
1095
9088
S02
ICPC
Pruritus
1.6
9.1
216
1384
NK4AT
NOMESCO Finland
Puncture of joint with ultrasound guidance not elsewher classified
2.3
9.1
65
283
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
1.7
9.1
168
1012
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.2
9.1
1032
8515
R03AC12
ATC
salmeterol; inhalant
1.5
9.0
247
1633
ZXA10
NOMESCO Finland
Bilateral
1.2
9.0
1133
9444
L50.8
ICD-10 Finland
Other urticaria
1.9
9.0
113
607
F41.09
ICD-10 Finland
UNS Panic Syndrome
1.6
9.0
178
1090
WQ022, ,
NOMESCO Finland
36.7
9.0
11
*
WXQ27, ,
SPAT
36.7
9.0
11
*
C02AC05
ATC
moxonidine; oral
1.5
9.0
282
1919
K85
ICD-10 Finland
Acute pancreatitis
2.0
9.0
99
510
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.6
9.0
188
1169
M47.82
ICD-10 Finland
Other spondylosis, cervical region
1.5
9.0
249
1652
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
1.6
8.9
198
1248
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.3
8.9
539
4105
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
1.8
8.9
129
725
C10AC01
ATC
colestyramine; oral
1.7
8.9
168
1017
L04AA24
ATC
abatacept; parenteral
2.9
8.9
39
133
N05BA12
ATC
alprazolam; oral
1.3
8.9
623
4846
K07.60
ICD-10 Finland
Snapping jaw
1.5
8.9
309
2146
P01
ICPC
Feeling anxious/nervous/tense
1.3
8.9
787
6309
L13.0
ICD-10 Finland
Dermatitis herpetiformis
3.2
8.9
33
102
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
1.6
8.9
188
1173
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
3.0
8.9
38
128
SGA04
NOMESCO Finland
Opening and preparing the root canals, extremely complicated
1.3
8.8
758
6051
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
2.4
8.8
57
237
L01
ICD-10 Finland
Impetigo
2.0
8.8
90
451
TQW11
NOMESCO Finland
Vacuum treatment of wound
1.8
8.8
136
779
NG4AA
NOMESCO Finland
Lower leg X-ray examination
1.6
8.8
206
1315
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
1.5
8.8
308
2141
N02BF02
ATC
pregabalin; oral
1.4
8.8
454
3378
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
8.8
1821
15911
F03
ICPC
Eye discharge
1.4
8.7
435
3217
L01.1
ICD-10 Finland
Impetiginization of other dermatoses
2.7
8.7
44
162
SPAT1059
SPAT
Spirometry at the office
1.5
8.7
305
2121
R04.0
ICD-10 Finland
Epistaxis
1.4
8.7
462
3451
SPAT1157
SPAT
Guidance concerning treatment of mouth and mucous membranes
2.1
8.7
78
373
K61.0
ICD-10 Finland
Anal abscess
1.8
8.7
117
644
L30
ICD-10 Finland
Other dermatitis
1.7
8.7
156
933
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
3.0
8.7
36
119
F34.1
ICD-10 Finland
Dysthymia
1.5
8.7
223
1456
N05AA02
ATC
levomepromazine; systemic
1.5
8.6
252
1690
TNH10
NOMESCO Finland
Joint puncture, ankle joint or foot joint
4.2
8.6
22
52
C09BA02
ATC
enalapril and diuretics; systemic
1.4
8.6
464
3473
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
1.6
8.6
186
1165
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.5
8.6
297
2059
E000005, ,
ATC
7.6
8.6
19
25
L86
ICPC
Back syndrome with radiating pain
1.4
8.6
393
2866
R03BA01
ATC
beclometasone; inhalant
1.3
8.6
870
7083
L01.0
ICD-10 Finland
Impetigo [any organism] [any site]
1.9
8.6
102
539
H60.5
ICD-10 Finland
Acute otitis externa, noninfective
2.2
8.6
67
303
SPAT1325
SPAT
Vaccination
1.2
8.6
2097
18561
L02
ICPC
Back symptom/complaint
1.3
8.6
673
5314
K04.7
ICD-10 Finland
Periapical abscess without sinus
1.4
8.6
395
2886
WQ020, ,
NOMESCO Finland
8.2
8.6
18
22
EB1AA, ,
SPAT
1.4
8.5
417
3076
WX320
NOMESCO Finland
Spinalanesthesy
1.2
8.5
1639
14224
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
1.8
8.5
120
670
RJ190, ,
NOMESCO Finland
4.0
8.5
23
57
NHQ40
NOMESCO Finland
Amputation of toe
1.9
8.5
95
492
A01AB09
ATC
miconazole; local oral
1.3
8.5
479
3612
B07.9
ICD-10 Finland
Verruca simplex
1.5
8.5
238
1583
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.2
8.5
1460
12544
J46
ICD-10 Finland
Status asthmaticus
1.6
8.5
170
1046
C09CA06
ATC
candesartan; oral
1.2
8.5
1670
14521
L03.2
ICD-10 Finland
Cellulitis of face
2.3
8.5
58
248
A63.0
ICD-10 Finland
Anogenital (venereal) warts
1.6
8.5
211
1368
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.3
8.4
551
4244
A60
ICPC
General and Unspecified, Result test/procedure
1.5
8.4
258
1749
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.4
8.4
387
2827
RJ511, ,
NOMESCO Finland
4.3
8.4
21
49
ZXX06
NOMESCO Finland
Extent of procedure, 6 units
4.5
8.3
20
45
O99.7
ICD-10 Finland
Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium
4.9
8.3
18
37
L41.8
ICD-10 Finland
Other parapsoriasis
+∞
8.3
8
*
L04AC17
ATC
tildrakizumab; parenteral
+∞
8.3
8
*
A01AB04
ATC
amphotericin B; local oral
1.5
8.3
238
1590
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
2.7
8.3
42
155
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
1.7
8.3
145
861
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
1.9
8.3
106
574
WX002
NOMESCO Finland
Sedation and analgesia
1.2
8.3
1227
10394
ZX114
NOMESCO Finland
Intramuscular
2.0
8.3
89
455
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.2
8.3
937
7724
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.3
8.3
661
5231
RS311, ,
NOMESCO Finland
3.6
8.3
26
72
K04.09
ICD-10 Finland
Pulpit UNS
1.4
8.2
300
2103
N02AA05
ATC
oxycodone; systemic
1.2
8.2
1134
9541
Z71.9
ICD-10 Finland
Counselling, unspecified
1.3
8.2
525
4033
SGA03
NOMESCO Finland
Opening and preparing the root canals, complicated
1.3
8.2
651
5148
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.5
8.2
255
1735
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
1.7
8.1
157
957
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
1.9
8.1
101
542
M02.3
ICD-10 Finland
Reiter disease
4.4
8.1
20
46
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
1.8
8.1
106
578
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
2.0
8.1
82
410
SPAT1147
SPAT
Destruction of skin lesion with external methods
1.9
8.1
104
564
C10AX09
ATC
ezetimibe; oral
1.2
8.1
1162
9814
ND1BG
NOMESCO Finland
Wrist and hand MRI examination with high intensity magnet
1.9
8.1
89
459
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.2
8.1
1567
13601
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
2.6
8.1
44
169
A10BG03
ATC
pioglitazone; oral
1.7
8.0
152
922
D69.0
ICD-10 Finland
Allergic purpura
2.5
8.0
47
187
R03AC03
ATC
terbutaline; inhalant
1.2
8.0
863
7075
SPAT1252
SPAT
Overall medication plan or its review
1.4
8.0
369
2696
RS224, ,
NOMESCO Finland
3.0
8.0
34
114
L70.0
ICD-10 Finland
Acne vulgaris
1.7
8.0
147
885
C09DA01
ATC
losartan and diuretics; oral
1.3
8.0
672
5352
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
2.2
8.0
62
280
S81.9
ICD-10 Finland
Open wound of lower leg, part unspecified
2.2
8.0
64
293
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.2
8.0
1545
13408
UJF92
NOMESCO Finland
Capsular endoscopy
1.7
8.0
143
856
F32
ICD-10 Finland
Depressive episode
1.4
8.0
324
2318
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.5
8.0
264
1819
K10.3
ICD-10 Finland
Alveolitis of jaws
1.4
7.9
304
2151
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
1.8
7.9
110
612
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.3
7.9
505
3879
ECA20
NOMESCO Finland
Biopsy of gingiva
2.1
7.9
69
327
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
2.4
7.9
53
225
SFA00
NOMESCO Finland
Small restoration
1.2
7.9
951
7892
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.3
7.9
712
5722
Z72.1
ICD-10 Finland
Alcohol use
1.9
7.8
89
464
M25.4
ICD-10 Finland
Effusion of joint
1.9
7.8
91
478
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.4
7.8
407
3032
J45
ICD-10 Finland
Asthma
1.3
7.8
663
5286
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.3
7.8
530
4105
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
1.7
7.8
140
838
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
1.9
7.8
89
465
K60.3
ICD-10 Finland
Anal fistula
1.8
7.8
118
674
B35.2
ICD-10 Finland
Tinea manuum
3.4
7.8
27
80
R06AX18
ATC
acrivastine; oral
1.6
7.8
158
977
K02.0
ICD-10 Finland
Caries limited to enamel
1.2
7.8
1357
11669
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
2.2
7.8
65
303
SXB00
NOMESCO Finland
Removal of sutures from oral mucosa
1.4
7.7
404
3012
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
1.6
7.7
189
1222
WQ055, ,
NOMESCO Finland
45.0
7.7
9
*
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
1.7
7.7
143
864
I50
ICD-10 Finland
Heart failure
1.7
7.7
146
887
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
1.8
7.7
117
669
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
1.8
7.7
111
625
K92.1
ICD-10 Finland
Melaena
1.4
7.7
317
2274
D19
ICPC
Teeth/gum symptom/complaint
1.2
7.7
2215
19831
GD1AD
NOMESCO Finland
Thorax CT examination
1.4
7.7
405
3026
B35.0
ICD-10 Finland
Tinea barbae and tinea capitis
7.4
7.7
17
23
SPAT1058
SPAT
PEF monitoring instruction
1.3
7.6
471
3601
212
Kela drug reimbursment
Gout
1.8
7.6
109
612
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.4
7.6
329
2379
H25.8
ICD-10 Finland
Other senile cataract
1.3
7.6
585
4608
S01BA01
ATC
dexamethasone; ophthalmic
1.5
7.6
195
1274
F51.0
ICD-10 Finland
Nonorganic insomnia
1.2
7.6
1130
9574
SPF30
NOMESCO Finland
Relining of denture
1.9
7.6
96
519
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
1.9
7.6
94
505
D06
ICPC
Abdominal pain localized other
1.3
7.6
568
4459
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
2.2
7.6
63
293
M77.9
ICD-10 Finland
Enthesopathy, unspecified
1.5
7.6
195
1275
R06AX13
ATC
loratadine; oral
1.2
7.6
933
7759
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
2.6
7.6
43
169
QDA10
NOMESCO Finland
Incision of skin of lower limb
2.4
7.6
49
205
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
2.0
7.5
80
408
K12.18
ICD-10 Finland
Other forms of stomatitis
2.3
7.5
52
224
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.3
7.5
469
3593
M79.1
ICD-10 Finland
Myalgia
1.2
7.5
982
8218
TNH33
NOMESCO Finland
Custom moulded brace, ankle or foot
1.9
7.5
92
493
K29.7
ICD-10 Finland
Gastritis, unspecified
1.5
7.5
208
1383
R1250
NOMESCO Finland
Evaluation of functional capability
1.6
7.5
154
956
E86
ICD-10 Finland
Volume depletion
1.7
7.5
136
818
M25.9
ICD-10 Finland
Joint disorder, unspecified
2.1
7.5
68
328
F43.1
ICD-10 Finland
Post-traumatic stress disorder
1.6
7.5
145
887
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.2
7.5
1222
10446
L20.8
ICD-10 Finland
Other atopic dermatitis
2.0
7.5
77
389
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.3
7.4
693
5589
R18
ICD-10 Finland
Ascites
1.7
7.4
119
691
Z00.8
ICD-10 Finland
Other general examinations
1.3
7.4
500
3870
EC1VA, ,
NOMESCO Finland
1.4
7.4
312
2246
N06AB06
ATC
sertraline; oral
1.3
7.4
716
5798
RJ412, ,
NOMESCO Finland
3.9
7.4
21
54
R10.0
ICD-10 Finland
Acute abdomen
1.5
7.4
202
1338
XG466
NOMESCO Finland
Sleep oxymetry
1.5
7.4
187
1218
D01
ICPC
Abdominal pain/cramps general
1.2
7.4
786
6435
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
1.7
7.4
124
730
-31
ICPC
Medical examin/health eval partial
1.4
7.4
372
2760
D50.8
ICD-10 Finland
Other iron deficiency anaemias
1.8
7.4
95
517
K85
ICPC
Elevated blood pressure
1.2
7.4
1050
8859
A07AA09
ATC
vancomycin; oral
1.9
7.3
86
454
C07AA05
ATC
propranolol; systemic
1.2
7.3
1300
11195
N01
ICPC
Headache
1.3
7.3
683
5512
6961D
ICD-9 Finland
Psoriasis and similar disorders, Other psoriasis[PUSTULOSIS PALMOPLANTARIS]
+∞
7.3
7
*
M073, L409,
ICD-10 Finland
+∞
7.3
7
*
H05AA02
ATC
teriparatide; parenteral
3.0
7.3
30
99
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
1.8
7.3
106
599
L85.3
ICD-10 Finland
Xerosis cutis
2.0
7.3
73
365
A03FA01
ATC
metoclopramide; systemic, rectal
1.2
7.3
1417
12296
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
1.6
7.3
149
924
S22
ICPC
Nail symptom/complaint
1.3
7.3
422
3199
L28.2
ICD-10 Finland
Other prurigo
3.1
7.3
29
94
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
1.5
7.3
182
1184
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.4
7.3
282
2003
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
1.6
7.2
142
871
U02
ICPC
Urinary frequency/urgency
1.2
7.2
886
7364
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.4
7.2
270
1904
K05.38
ICD-10 Finland
Other chronic periodontitis
1.5
7.2
194
1282
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
1.3
7.2
634
5080
N06AB08
ATC
fluvoxamine; oral
1.6
7.2
157
989
I21.19
ICD-10 Finland
Acute transmural myocardial infarction of inferior wall
1.9
7.2
80
415
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
1.9
7.2
83
436
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
1.6
7.2
165
1052
NH1AD
NOMESCO Finland
Ankle and foot CT
1.6
7.2
149
927
H25.1
ICD-10 Finland
Senile nuclear cataract
1.2
7.2
1505
13138
S07
ICPC
Rash generalized
2.6
7.2
39
150
H22.1*M45
ICD-10 Finland
Iridocyclitis in ankylosing spondylitis
4.5
7.2
17
38
ED1AA
NOMESCO Finland
Mandibular X-ray examination
2.4
7.2
48
204
R11
ICD-10 Finland
Nausea and vomiting
1.3
7.2
524
4102
N05AN01
ATC
lithium; oral
1.6
7.1
146
905
B81
ICPC
Anaemia vit B12/folate deficiency
1.5
7.1
212
1430
C10AB02
ATC
bezafibrate; oral
2.0
7.1
68
334
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
7.1
169
1086
NHJ10
NOMESCO Finland
Internal fixation of fracture of ankle using wire, rod, cerclage or pin
1.4
7.1
283
2020
S04
ICPC
Lump/swelling localized
1.2
7.1
711
5785
R03DA04
ATC
theophylline; systemic, rectal
1.4
7.1
255
1787
K92.0
ICD-10 Finland
Haematemesis
1.6
7.1
139
854
NA6BM
NOMESCO Finland
Sacro-iliac joint MRI examination with 3 Tesla magnet
8.8
7.0
14
16
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
1.5
7.0
233
1607
SDA02
NOMESCO Finland
Periodontal treatment, brief
1.1
7.0
2514
22821
ACC51
NOMESCO Finland
Release of median nerve
1.3
7.0
464
3583
Z08
ICPC
Social welfare problem
1.9
7.0
86
461
M07.4
ICD-10 Finland
Arthropathy in Crohn disease [regional enteritis]
10.0
7.0
13
13
A02BA04
ATC
nizatidine; systemic
1.3
7.0
412
3129
C09CA03
ATC
valsartan; oral
1.3
7.0
575
4568
A10BX01
ATC
guar gum; oral
1.5
7.0
180
1178
R03DC03
ATC
montelukast; oral
1.2
7.0
1070
9088
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
2.5
7.0
40
158
N05AX12
ATC
aripiprazole; systemic
1.4
7.0
242
1684
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
2.5
7.0
42
170
SPAT1104
SPAT
Monitoring of emergency patient
1.3
7.0
377
2829
QDB10, ,
SPAT
1.6
7.0
160
1021
WX203
NOMESCO Finland
Infraclavicular plexus blockade
1.6
6.9
150
943
R06.5
ICD-10 Finland
Mouth breathing
1.3
6.9
622
4994
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
2.9
6.9
30
102
N05BA02
ATC
chlordiazepoxide; systemic
1.6
6.9
140
866
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.2
6.9
1606
14131
M13.1
ICD-10 Finland
Monoarthritis, not elsewhere classified
2.0
6.9
68
338
M05BA04
ATC
alendronic acid; oral
1.3
6.9
431
3302
SGA05
NOMESCO Finland
Opening and preparing the root canals, extremely complicated And time consuming
1.3
6.9
387
2921
WXQ20
NOMESCO Finland
UVA broad spectrum light therapy
13.8
6.9
11
8
L05
ICPC
Flank/axilla symptom/complaint
1.3
6.9
401
3043
L04AC07
ATC
tocilizumab; parenteral
2.9
6.9
31
108
B86
ICD-10 Finland
Scabies
1.6
6.9
161
1032
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
1.9
6.9
78
408
X14
ICPC
Vaginal discharge
1.7
6.9
114
670
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.3
6.9
617
4957
M16.7
ICD-10 Finland
Other secondary coxarthrosis
2.3
6.8
50
221
ZXE20
NOMESCO Finland
More than three and less than five hours
1.2
6.8
818
6782
M06.4
ICD-10 Finland
Inflammatory polyarthropathy
2.9
6.8
30
103
7200A
ICD-9 Finland
Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis
3.2
6.8
26
82
L13
ICPC
Hip symptom/complaint
1.2
6.8
1220
10511
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.3
6.8
489
3822
H10.2
ICD-10 Finland
Other acute conjunctivitis
1.8
6.8
88
481
5551A
ICD-9 Finland
Regional enteritis, Large intestine
9.3
6.8
13
14
ZYC03
NOMESCO Finland
Remote contact, text-based
2.4
6.7
44
185
ZQZ00
NOMESCO Finland
Treatment of several skin areas
2.7
6.7
34
126
K70.4
ICD-10 Finland
Alcoholic hepatic failure
2.7
6.7
34
126
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.3
6.7
443
3420
WX780
NOMESCO Finland
Remote monitoring CPAP
1.4
6.7
307
2243
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
1.6
6.7
156
998
ZXD10
NOMESCO Finland
Scheduled procedure
1.1
6.7
2522
22953
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.1
6.7
2091
18793
318
Kela drug reimbursment
Teriparatide
2.8
6.7
32
115
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.2
6.7
1326
11516
R03AK08
ATC
formoterol and beclometasone; inhalant
1.4
6.7
269
1923
SPAT1251
SPAT
Organisation of medication
1.5
6.7
174
1142
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
1.4
6.7
301
2194
G56.2
ICD-10 Finland
Lesion of ulnar nerve
1.5
6.7
220
1516
SPF10
NOMESCO Finland
Demanding reparation of dental prosthesis
1.8
6.7
92
512
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
2.2
6.7
54
249
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
1.7
6.7
124
751
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
1.7
6.7
103
593
H20.1
ICD-10 Finland
Chronic iridocyclitis
2.0
6.7
66
329
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
2.2
6.6
50
224
S02CA06
ATC
dexamethasone and antiinfectives; otic
2.2
6.6
52
237
M00.0
ICD-10 Finland
Staphylococcal arthritis and polyarthritis
3.7
6.6
20
54
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.2
6.6
652
5297
WX290, ,
SPAT
1.5
6.6
206
1406
L30.1
ICD-10 Finland
Dyshidrosis [pompholyx]
2.6
6.6
37
145
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.4
6.6
320
2363
XQ801
NOMESCO Finland
Intracutantest
2.5
6.6
38
151
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
1.7
6.6
115
686
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
1.4
6.6
258
1838
OAB72
NOMESCO Finland
Weight control and weight loss guidance
2.0
6.6
62
304
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
1.5
6.6
179
1188
SCA02
NOMESCO Finland
Preventive oral health care
1.3
6.6
618
4993
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
1.5
6.6
164
1068
M05BA07
ATC
risedronic acid; oral
1.6
6.6
131
809
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.4
6.5
230
1606
ZXX05
NOMESCO Finland
Extent of procedure, 5 units
3.2
6.5
24
74
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.4
6.5
310
2280
K73.80
ICD-10 Finland
Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)
2.6
6.5
35
134
9311
FHL
Knee cleansing surgery (synovectomy, debridement)
3.8
6.5
19
50
K86.1
ICD-10 Finland
Other chronic pancreatitis
2.1
6.5
59
285
Z22.30
ICD-10 Finland
Latent tuberculosis
6.8
6.5
15
22
N03AX09
ATC
lamotrigine; oral
1.4
6.5
290
2112
OAA67, ,
SPAT
0.8
6.5
886
10486
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.2
6.5
777
6443
L12.0
ICD-10 Finland
Bullous pemphigoid
2.5
6.5
39
158
K59.09
ICD-10 Finland
Constipation, unspecified
1.3
6.5
397
3035
X58
ICD-10 Finland
Exposure to other specified factors
1.2
6.5
1019
8676
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.3
6.5
405
3106
R81
ICPC
Pneumonia
1.4
6.5
222
1543
K42.0
ICD-10 Finland
Umbilical hernia with obstruction, without gangrene
1.9
6.5
79
424
WZC00, ,
SPAT
1.2
6.5
993
8437
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.3
6.5
349
2620
SGB30
NOMESCO Finland
Other complicated root filling
1.2
6.5
779
6465
B02.9
ICD-10 Finland
Zoster without complication
1.3
6.5
406
3116
A10BD07
ATC
metformin and sitagliptin; systemic
1.4
6.5
255
1819
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
1.4
6.4
225
1569
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
2.1
6.4
54
253
RJ422, ,
NOMESCO Finland
5.3
6.4
18
34
L60.3
ICD-10 Finland
Nail dystrophy
2.6
6.4
35
135
C09DA07
ATC
telmisartan and diuretics; oral
1.4
6.4
248
1762
XQ820
NOMESCO Finland
Exposure to medicinal substance
2.7
6.4
32
118
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.1
6.4
3647
34021
K50
ICD-10 Finland
Crohn disease [regional enteritis]
2.9
6.4
28
96
E16.0
ICD-10 Finland
Drug-induced hypoglycaemia without coma
2.9
6.4
28
96
N05BE01
ATC
buspirone; oral
1.5
6.4
174
1154
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
1.9
6.4
80
433
H81
ICPC
Excessive ear wax
1.2
6.4
1122
9649
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
1.8
6.4
83
455
SDA05
NOMESCO Finland
Very demanding periodontal treatment
1.3
6.4
485
3820
M54.2
ICD-10 Finland
Cervicalgia
1.3
6.3
517
4107
D11AX14
ATC
[U] tacrolimus
2.5
6.3
38
154
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
2.0
6.3
65
329
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
1.9
6.3
77
413
N05AF03
ATC
chlorprothixene; systemic
1.6
6.3
152
982
3051, ,
Kela drug reimbursment
1.9
6.3
70
364
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.5
6.3
190
1288
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
3.6
6.3
20
56
C07BB07
ATC
bisoprolol and thiazides; systemic
1.5
6.3
205
1411
L04
ICPC
Chest symptom/complaint
1.3
6.3
391
2996
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
1.4
6.3
246
1752
L04AF01
ATC
tofacitinib; oral
5.9
6.3
16
27
N02BF01
ATC
gabapentin; oral
1.2
6.3
674
5525
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.2
6.3
618
5018
D05BA02
ATC
methoxsalen; oral
18.0
6.3
9
5
WX892
NOMESCO Finland
Monitored bed care
1.3
6.3
455
3562
M073, L403,
ICD-10 Finland
+∞
6.2
6
*
M073, M405,
ICD-10 Finland
+∞
6.2
6
*
M074, L405,
ICD-10 Finland
+∞
6.2
6
*
6960A, ,
ICD-10 Finland
+∞
6.2
6
*
L41.4
ICD-10 Finland
Large plaque parapsoriasis
+∞
6.2
6
*
SPAT1361
SPAT
Collection of tissue sample
2.8
6.2
29
103
L43.2
ICD-10 Finland
Lichenoid drug reaction
26.7
6.2
8
*
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
1.6
6.2
152
986
K05.18
ICD-10 Finland
Chronic gingivitis
1.3
6.2
473
3726
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
1.5
6.2
156
1019
F01
ICPC
Eye pain
1.5
6.2
174
1164
SPAT1097
SPAT
Recording of ECG
1.2
6.2
849
7141
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
1.6
6.1
135
854
I40.0
ICD-10 Finland
Infective myocarditis
5.3
6.1
17
32
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
2.7
6.1
32
121
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
3.3
6.1
22
67
D12
ICPC
Constipation
1.5
6.1
207
1436
J04AB02
ATC
rifampicin; systemic
1.8
6.1
79
432
OAB72, ,
SPAT
1.7
6.1
99
579
L34
ICPC
Musculoskeletal, Blood test
7.7
6.1
13
17
CL2S4, ,
SPAT
1.6
6.1
147
950
A62
ICPC
General and Unspecified, Administrative procedure
1.6
6.1
140
895
L60.9
ICD-10 Finland
Nail disorder, unspecified
1.7
6.1
100
587
L27.1
ICD-10 Finland
Localized skin eruption due to drugs and medicaments
2.5
6.1
36
145
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.3
6.1
439
3434
L18
ICPC
Muscle pain
1.4
6.1
250
1797
K06.1
ICD-10 Finland
Gingival enlargement
4.1
6.1
16
39
R04
ICPC
Breathing problem other
1.4
6.1
240
1713
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
2.1
6.1
55
266
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
1.3
6.1
359
2733
R2110
NOMESCO Finland
Giving the first information
1.3
6.1
377
2891
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
1.5
6.0
155
1016
C08DB01
ATC
diltiazem; oral
1.4
6.0
241
1723
R13
ICD-10 Finland
Dysphagia
1.3
6.0
417
3243
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.3
6.0
412
3199
C09CA07
ATC
telmisartan; oral
1.3
6.0
448
3517
R01AD58
ATC
fluticasone, combinations; nasal
1.1
6.0
1718
15334
A10AD05
ATC
insulin aspart; parenteral
1.8
6.0
86
485
Y94.8
ICD-10 Finland
Other leisure activity accident
1.5
6.0
162
1073
J01DB05
ATC
cefadroxil; oral
1.4
6.0
252
1817
J02.0
ICD-10 Finland
Streptococcal pharyngitis
1.6
6.0
139
890
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
1.8
6.0
88
500
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
2.2
6.0
48
221
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.2
6.0
700
5790

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
1.1e+00
2.2e+00
3.3e+00
3.6e+01
4.9e+00
4.3e+00
2.8e+00
cases:14.46%
controls:5.21%
cases:16.93%
controls:2.20%
cases:8.11%
controls:0.34%
cases:86.82%
controls:0.01%
cases:31.16%
controls:0.35%
cases:60.90%
controls:2.05%
cases:49.22%
controls:5.76%
1271
4568
7519
83174
1488
1929
7303
85818
713
294
8078
87453
7632
6
1159
87741
2737
305
6046
87303
5251
1764
3372
84111
3826
4440
3947
72681
acitretin; oral
D05BB02 [21602051]
4.6e+00
5.0e+00
5.0e+00
1.0e+50
6.6e+00
6.0e+00
5.2e+00
cases:3.98%
controls:0.04%
cases:3.66%
controls:0.03%
cases:1.22%
controls:0.01%
cases:1.25%
controls:0.00%
cases:4.98%
controls:0.01%
cases:9.90%
controls:0.03%
cases:10.88%
controls:0.06%
350
37
8440
87705
322
22
8469
87725
107
7
8684
87740
110
0
8681
87747
437
6
8346
87602
854
24
7769
85851
846
50
6927
77071
Psoriasis vulgaris
L40.0 [45543370]
4.9e+00
5.6e+00
—
1.0e+50
1.0e+50
9.4e+00
7.2e+00
cases:3.20%
controls:0.02%
cases:4.32%
controls:0.02%
—
—
cases:95.37%
controls:0.00%
cases:29.74%
controls:0.00%
cases:58.47%
controls:0.01%
cases:46.91%
controls:0.07%
281
21
8509
87721
380
15
8411
87732
—
8384
0
407
87747
2612
0
6171
87608
5042
10
3581
85865
3646
51
4127
77070
combinations of corticosteroids
D07AB30 [21602118]
2.1e+00
3.1e+00
3.5e+00
7.4e+00
4.3e+00
3.0e+00
2.5e+00
cases:45.18%
controls:9.32%
cases:41.36%
controls:2.99%
cases:10.59%
controls:0.36%
cases:12.49%
controls:0.01%
cases:20.74%
controls:0.36%
cases:40.29%
controls:3.10%
cases:57.02%
controls:9.68%
3971
8174
4819
79568
3636
2621
5155
85126
931
315
7860
87432
1098
8
7693
87739
1822
313
6961
87295
3474
2664
5149
83211
4432
7464
3341
69657
combinations of corticosteroids
D07XB30 [21602188]
2.1e+00
3.1e+00
3.5e+00
7.4e+00
4.3e+00
3.0e+00
2.5e+00
cases:45.18%
controls:9.32%
cases:41.36%
controls:2.99%
cases:10.59%
controls:0.36%
cases:12.49%
controls:0.01%
cases:20.74%
controls:0.36%
cases:40.29%
controls:3.10%
cases:57.02%
controls:9.68%
3971
8174
4819
79568
3636
2621
5155
85126
931
315
7860
87432
1098
8
7693
87739
1822
313
6961
87295
3474
2664
5149
83211
4432
7464
3341
69657
betamethasone
S02BA07 [21605169]
2.3e+00
3.1e+00
3.4e+00
7.0e+00
4.1e+00
3.0e+00
2.5e+00
cases:34.43%
controls:5.10%
cases:30.28%
controls:1.92%
cases:6.76%
controls:0.25%
cases:8.21%
controls:0.01%
cases:14.18%
controls:0.27%
cases:28.61%
controls:2.03%
cases:42.53%
controls:5.93%
3026
4475
5764
83267
2662
1682
6129
86065
594
222
8197
87525
722
7
8069
87740
1245
240
7538
87368
2467
1740
6156
84135
3306
4572
4467
72549
betamethasone
A07EA04 [21600656]
2.3e+00
3.1e+00
3.4e+00
7.0e+00
4.1e+00
3.0e+00
2.5e+00
cases:34.43%
controls:5.10%
cases:30.28%
controls:1.92%
cases:6.76%
controls:0.25%
cases:8.21%
controls:0.01%
cases:14.18%
controls:0.27%
cases:28.61%
controls:2.03%
cases:42.53%
controls:5.93%
3026
4475
5764
83267
2662
1682
6129
86065
594
222
8197
87525
722
7
8069
87740
1245
240
7538
87368
2467
1740
6156
84135
3306
4572
4467
72549
betamethasone
D07AC01 [21602120]
2.3e+00
3.1e+00
3.4e+00
7.0e+00
4.1e+00
3.0e+00
2.5e+00
cases:34.43%
controls:5.10%
cases:30.28%
controls:1.92%
cases:6.76%
controls:0.25%
cases:8.21%
controls:0.01%
cases:14.18%
controls:0.27%
cases:28.61%
controls:2.03%
cases:42.53%
controls:5.93%
3026
4475
5764
83267
2662
1682
6129
86065
594
222
8197
87525
722
7
8069
87740
1245
240
7538
87368
2467
1740
6156
84135
3306
4572
4467
72549
betamethasone
C05AA05 [21601610]
2.3e+00
3.1e+00
3.4e+00
7.0e+00
4.1e+00
3.0e+00
2.5e+00
cases:34.43%
controls:5.10%
cases:30.28%
controls:1.92%
cases:6.76%
controls:0.25%
cases:8.21%
controls:0.01%
cases:14.18%
controls:0.27%
cases:28.61%
controls:2.03%
cases:42.53%
controls:5.93%
3026
4475
5764
83267
2662
1682
6129
86065
594
222
8197
87525
722
7
8069
87740
1245
240
7538
87368
2467
1740
6156
84135
3306
4572
4467
72549
calcipotriol; ointment
D05AX02 [21602039]
4.7e+00
5.5e+00
—
1.0e+50
—
5.9e+00
5.4e+00
cases:12.71%
controls:0.14%
cases:9.05%
controls:0.04%
—
—
cases:2.63%
controls:0.00%
—
—
cases:11.83%
controls:0.04%
cases:16.08%
controls:0.09%
1117
121
7673
87621
796
36
7995
87711
—
231
0
8560
87747
—
1020
32
7603
85843
1250
68
6523
77053
calcitriol; ointment
D05AX03 [21602040]
4.8e+00
4.8e+00
—
1.0e+50
—
5.7e+00
5.9e+00
cases:2.39%
controls:0.02%
cases:1.81%
controls:0.01%
—
—
cases:0.84%
controls:0.00%
—
—
cases:3.46%
controls:0.01%
cases:6.02%
controls:0.02%
210
18
8580
87724
159
13
8632
87734
—
74
0
8717
87747
—
298
10
8325
85865
468
14
7305
77107
betamethasone
S03BA03 [21605203]
2.8e+00
3.5e+00
3.8e+00
—
4.5e+00
3.4e+00
3.0e+00
cases:20.96%
controls:1.59%
cases:16.63%
controls:0.62%
cases:3.61%
controls:0.08%
—
—
cases:7.66%
controls:0.09%
cases:16.89%
controls:0.66%
cases:27.22%
controls:1.76%
1842
1394
6948
86348
1462
542
7329
87205
317
73
8474
87674
—
673
81
8110
87527
1456
570
7167
85305
2116
1358
5657
75763
Psoriasis
L40 [45577035]
4.5e+00
5.7e+00
—
1.0e+50
—
5.1e+00
5.1e+00
cases:3.08%
controls:0.04%
cases:3.97%
controls:0.01%
—
—
cases:0.27%
controls:0.00%
—
—
cases:2.35%
controls:0.02%
cases:8.26%
controls:0.06%
271
32
8519
87710
349
12
8442
87735
—
24
0
8767
87747
—
203
13
8420
85862
642
44
7131
77077
clobetasol
D07AD01 [21602141]
2.4e+00
3.2e+00
3.6e+00
—
4.3e+00
3.2e+00
2.7e+00
cases:15.01%
controls:1.59%
cases:14.04%
controls:0.64%
cases:3.06%
controls:0.08%
—
—
cases:5.53%
controls:0.08%
cases:14.11%
controls:0.65%
cases:21.78%
controls:1.91%
1319
1398
7471
86344
1234
559
7557
87188
269
73
8522
87674
—
486
73
8297
87535
1217
562
7406
85313
1693
1472
6080
75649
methotrexate; oral, parenteral
L04AX03 [21603929]
1.9e+00
2.1e+00
1.8e+00
4.6e+00
2.7e+00
2.8e+00
3.0e+00
cases:8.44%
controls:1.32%
cases:7.46%
controls:1.02%
cases:2.23%
controls:0.38%
cases:1.05%
controls:0.01%
cases:4.99%
controls:0.36%
cases:15.06%
controls:1.04%
cases:22.27%
controls:1.41%
742
1162
8048
86580
656
897
8135
86850
196
335
8595
87412
92
9
8699
87738
438
312
8345
87296
1299
891
7324
84984
1731
1087
6042
76034
methotrexate
L01BA01 [21601423]
1.9e+00
2.1e+00
1.8e+00
4.6e+00
2.7e+00
2.8e+00
3.0e+00
cases:8.44%
controls:1.32%
cases:7.46%
controls:1.02%
cases:2.23%
controls:0.38%
cases:1.05%
controls:0.01%
cases:4.99%
controls:0.36%
cases:15.06%
controls:1.04%
cases:22.27%
controls:1.41%
742
1162
8048
86580
656
897
8135
86850
196
335
8595
87412
92
9
8699
87738
438
312
8345
87296
1299
891
7324
84984
1731
1087
6042
76034
other preparations, combinations; ointment
C05AX03 [21601631]
2.1e+00
2.9e+00
3.4e+00
—
4.3e+00
3.0e+00
2.6e+00
cases:15.47%
controls:2.13%
cases:11.60%
controls:0.69%
cases:2.49%
controls:0.09%
—
—
cases:6.00%
controls:0.08%
cases:13.31%
controls:0.73%
cases:22.30%
controls:2.04%
1360
1869
7430
85873
1020
603
7771
87144
219
76
8572
87671
—
527
73
8256
87535
1148
624
7475
85251
1733
1570
6040
75551
Pustulosis palmaris et plantaris
L40.3 [45591634]
3.7e+00
5.5e+00
—
1.0e+50
—
5.3e+00
3.8e+00
cases:1.05%
controls:0.03%
cases:1.60%
controls:0.01%
—
—
cases:0.58%
controls:0.00%
—
—
cases:1.76%
controls:0.01%
cases:1.93%
controls:0.04%
92
22
8698
87720
141
6
8650
87741
—
51
0
8740
87747
—
152
8
8471
85867
150
33
7623
77088
hydrocortisone aceponate
D07AC16 [21602135]
1.4e+00
2.2e+00
2.4e+00
5.8e+00
3.3e+00
1.8e+00
1.4e+00
cases:20.91%
controls:6.23%
cases:15.03%
controls:1.98%
cases:2.72%
controls:0.25%
cases:3.24%
controls:0.01%
cases:5.49%
controls:0.21%
cases:11.70%
controls:2.11%
cases:21.88%
controls:6.27%
1838
5467
6952
82275
1321
1741
7470
86006
239
219
8552
87528
285
9
8506
87738
482
186
8301
87422
1009
1811
7614
84064
1701
4834
6072
72287
hydrocortisone butyrate
D07AB02 [21602106]
1.4e+00
2.2e+00
2.4e+00
5.8e+00
3.3e+00
1.8e+00
1.4e+00
cases:20.91%
controls:6.23%
cases:15.03%
controls:1.98%
cases:2.72%
controls:0.25%
cases:3.24%
controls:0.01%
cases:5.49%
controls:0.21%
cases:11.70%
controls:2.11%
cases:21.88%
controls:6.27%
1838
5467
6952
82275
1321
1741
7470
86006
239
219
8552
87528
285
9
8506
87738
482
186
8301
87422
1009
1811
7614
84064
1701
4834
6072
72287
hydrocortisone buteprate
D07AB11 [21602115]
1.4e+00
2.2e+00
2.4e+00
5.8e+00
3.3e+00
1.8e+00
1.4e+00
cases:20.91%
controls:6.23%
cases:15.03%
controls:1.98%
cases:2.72%
controls:0.25%
cases:3.24%
controls:0.01%
cases:5.49%
controls:0.21%
cases:11.70%
controls:2.11%
cases:21.88%
controls:6.27%
1838
5467
6952
82275
1321
1741
7470
86006
239
219
8552
87528
285
9
8506
87738
482
186
8301
87422
1009
1811
7614
84064
1701
4834
6072
72287
hydrocortisone
D07AA02 [21602102]
1.4e+00
2.2e+00
2.4e+00
5.8e+00
3.3e+00
1.8e+00
1.4e+00
cases:20.91%
controls:6.23%
cases:15.03%
controls:1.98%
cases:2.72%
controls:0.25%
cases:3.24%
controls:0.01%
cases:5.49%
controls:0.21%
cases:11.70%
controls:2.11%
cases:21.88%
controls:6.27%
1838
5467
6952
82275
1321
1741
7470
86006
239
219
8552
87528
285
9
8506
87738
482
186
8301
87422
1009
1811
7614
84064
1701
4834
6072
72287
Rheumatology
66 [38004491]
1.4e+00
1.8e+00
2.4e+00
5.8e+00
2.4e+00
2.4e+00
2.1e+00
cases:8.59%
controls:2.35%
cases:7.75%
controls:1.43%
cases:2.73%
controls:0.25%
cases:3.19%
controls:0.01%
cases:3.21%
controls:0.29%
cases:12.97%
controls:1.35%
cases:18.02%
controls:2.58%
755
2059
8035
85683
681
1259
8110
86488
240
215
8551
87532
280
9
8511
87738
282
253
8501
87355
1118
1159
7505
84716
1401
1986
6372
75135
hydrocortisone
A07EA02 [21600654]
1.4e+00
2.2e+00
2.4e+00
5.8e+00
3.3e+00
1.8e+00
1.4e+00
cases:21.13%
controls:6.35%
cases:15.09%
controls:2.01%
cases:2.72%
controls:0.26%
cases:3.24%
controls:0.01%
cases:5.49%
controls:0.21%
cases:11.74%
controls:2.13%
cases:21.96%
controls:6.32%
1857
5570
6933
82172
1327
1765
7464
85982
239
224
8552
87523
285
9
8506
87738
482
187
8301
87421
1012
1833
7611
84042
1707
4874
6066
72247
hydrocortisone
C05AA01 [21601608]
1.4e+00
2.2e+00
2.4e+00
5.8e+00
3.3e+00
1.8e+00
1.4e+00
cases:21.13%
controls:6.35%
cases:15.09%
controls:2.01%
cases:2.72%
controls:0.26%
cases:3.24%
controls:0.01%
cases:5.49%
controls:0.21%
cases:11.74%
controls:2.13%
cases:21.96%
controls:6.32%
1857
5570
6933
82172
1327
1765
7464
85982
239
224
8552
87523
285
9
8506
87738
482
187
8301
87421
1012
1833
7611
84042
1707
4874
6066
72247
imidazoles/triazoles in combination with corticosteroids
D01AC20 [21601936]
2.0e+00
2.9e+00
3.4e+00
—
4.4e+00
3.0e+00
2.5e+00
cases:20.66%
controls:3.25%
cases:15.54%
controls:1.00%
cases:3.48%
controls:0.12%
—
—
cases:8.77%
controls:0.12%
cases:18.00%
controls:1.11%
cases:29.23%
controls:3.36%
1816
2850
6974
84892
1366
880
7425
86867
306
104
8485
87643
—
770
104
8013
87504
1552
953
7071
84922
2272
2590
5501
74531
hydrocortisone
S02BA01 [21605166]
1.3e+00
2.0e+00
2.4e+00
5.6e+00
3.1e+00
1.6e+00
1.3e+00
cases:16.91%
controls:5.50%
cases:11.63%
controls:1.69%
cases:2.22%
controls:0.21%
cases:2.41%
controls:0.01%
cases:3.68%
controls:0.18%
cases:8.48%
controls:1.81%
cases:17.03%
controls:5.45%
1486
4825
7304
82917
1022
1480
7769
86267
195
183
8596
87564
212
8
8579
87739
323
156
8460
87452
731
1557
7892
84318
1324
4200
6449
72921
Psoriasis, unspecified
L40.9 [45533641]
4.8e+00
6.3e+00
—
1.0e+50
—
—
5.1e+00
cases:1.98%
controls:0.02%
cases:3.12%
controls:0.01%
—
—
cases:0.40%
controls:0.00%
—
—
—
—
cases:4.18%
controls:0.03%
174
15
8616
87727
274
5
8517
87742
—
35
0
8756
87747
—
—
325
20
7448
77101
Connective tissue diseases, rheumatoid arthritis and comparable disease
202 [2001600200]
1.7e+00
2.4e+00
2.8e+00
—
4.1e+00
3.0e+00
2.1e+00
cases:3.13%
controls:0.61%
cases:1.46%
controls:0.14%
cases:0.33%
controls:0.02%
—
—
cases:0.50%
controls:0.01%
cases:2.13%
controls:0.10%
cases:4.03%
controls:0.50%
275
539
8515
87203
128
121
8663
87626
29
17
8762
87730
—
44
7
8739
87601
184
89
8439
85786
313
387
7460
76734
Infective dermatitis
L30.3 [45577034]
1.5e+00
2.8e+00
3.9e+00
—
3.7e+00
2.6e+00
1.4e+00
cases:1.00%
controls:0.22%
cases:1.21%
controls:0.08%
cases:0.41%
controls:0.01%
—
—
cases:0.46%
controls:0.01%
cases:1.06%
controls:0.08%
cases:1.02%
controls:0.26%
88
195
8702
87547
106
68
8685
87679
36
7
8755
87740
—
40
10
8743
87598
91
70
8532
85805
79
203
7694
76918
glycerol
A06AX01 [21600597]
1.4e+00
2.3e+00
2.7e+00
1.0e+50
3.9e+00
3.0e+00
2.5e+00
cases:0.97%
controls:0.23%
cases:0.68%
controls:0.07%
cases:0.23%
controls:0.02%
cases:0.25%
controls:0.00%
cases:0.52%
controls:0.01%
cases:1.22%
controls:0.06%
cases:2.28%
controls:0.19%
85
203
8705
87539
60
62
8731
87685
20
14
8771
87733
22
0
8769
87747
46
9
8737
87599
105
51
8518
85824
177
150
7596
76971
glycerol; rectal
A06AG04 [21600587]
1.4e+00
2.3e+00
2.7e+00
1.0e+50
3.9e+00
3.0e+00
2.5e+00
cases:0.97%
controls:0.23%
cases:0.68%
controls:0.07%
cases:0.23%
controls:0.02%
cases:0.25%
controls:0.00%
cases:0.52%
controls:0.01%
cases:1.22%
controls:0.06%
cases:2.28%
controls:0.19%
85
203
8705
87539
60
62
8731
87685
20
14
8771
87733
22
0
8769
87747
46
9
8737
87599
105
51
8518
85824
177
150
7596
76971
carbamide
D02AE01 [21601975]
1.5e+00
2.2e+00
2.4e+00
—
3.8e+00
3.0e+00
2.7e+00
cases:1.65%
controls:0.39%
cases:1.42%
controls:0.16%
cases:0.28%
controls:0.03%
—
—
cases:1.04%
controls:0.02%
cases:2.84%
controls:0.14%
cases:4.48%
controls:0.31%
145
343
8645
87399
125
144
8666
87603
25
23
8766
87724
—
91
21
8692
87587
245
120
8378
85755
348
236
7425
76885
Local dermatologic skincare
TQW80 [2001310149]
1.7e+00
3.0e+00
4.0e+00
1.0e+50
—
3.9e+00
2.9e+00
cases:0.65%
controls:0.12%
cases:0.97%
controls:0.05%
cases:0.30%
controls:0.01%
cases:1.97%
controls:0.00%
—
—
cases:2.16%
controls:0.04%
cases:2.47%
controls:0.14%
57
107
8733
87635
85
42
8706
87705
26
5
8765
87742
173
0
8618
87747
—
186
37
8437
85838
192
107
7581
77014
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
1.3e+00
2.7e+00
4.3e+00
—
2.6e+00
2.6e+00
1.8e+00
cases:2.13%
controls:0.58%
cases:2.86%
controls:0.19%
cases:0.94%
controls:0.01%
—
—
cases:0.27%
controls:0.02%
cases:2.41%
controls:0.18%
cases:3.43%
controls:0.60%
187
510
8603
87232
251
167
8540
87580
83
11
8708
87736
—
24
18
8759
87590
208
154
8415
85721
267
463
7506
76658
dithranol, combinations
D05AC51 [21602033]
3.4e+00
4.2e+00
—
1.0e+50
1.0e+50
4.0e+00
3.6e+00
cases:0.53%
controls:0.02%
cases:0.46%
controls:0.01%
—
—
cases:0.09%
controls:0.00%
cases:0.23%
controls:0.00%
cases:0.52%
controls:0.01%
cases:0.87%
controls:0.02%
47
16
8743
87726
40
6
8751
87741
—
8
0
8783
87747
20
0
8763
87608
45
8
8578
85867
68
19
7705
77102
mometasone
D07AC13 [21602132]
1.7e+00
2.5e+00
3.0e+00
—
3.7e+00
2.2e+00
1.8e+00
cases:17.90%
controls:3.72%
cases:13.40%
controls:1.21%
cases:2.65%
controls:0.13%
—
—
cases:4.82%
controls:0.12%
cases:10.52%
controls:1.23%
cases:18.50%
controls:3.62%
1573
3266
7217
84476
1178
1060
7613
86687
233
117
8558
87630
—
423
106
8360
87502
907
1058
7716
84817
1438
2789
6335
74332
desonide
D07AB08 [21602112]
1.4e+00
2.3e+00
3.0e+00
1.0e+50
3.8e+00
2.4e+00
1.9e+00
cases:4.44%
controls:1.19%
cases:3.77%
controls:0.40%
cases:0.88%
controls:0.05%
cases:1.04%
controls:0.00%
cases:1.99%
controls:0.04%
cases:4.35%
controls:0.43%
cases:7.46%
controls:1.19%
390
1041
8400
86701
331
348
8460
87399
77
40
8714
87707
91
0
8700
87747
175
39
8608
87569
375
370
8248
85505
580
914
7193
76207
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
88518-6 [36304997]
1.2e+00
1.6e+00
3.1e+00
—
3.9e+00
2.6e+00
2.1e+00
cases:1.14%
controls:0.33%
cases:0.53%
controls:0.11%
cases:0.27%
controls:0.01%
—
—
cases:0.35%
controls:0.01%
cases:1.23%
controls:0.09%
cases:3.23%
controls:0.39%
100
293
8690
87449
47
94
8744
87653
24
11
8767
87736
—
31
6
8752
87602
106
76
8517
85799
251
303
7522
76818
UVB narrow spectrum light therapy
WXQ27 [2001310161]
1.8e+00
3.1e+00
—
1.0e+50
—
5.7e+00
4.1e+00
cases:0.28%
controls:0.05%
cases:0.36%
controls:0.02%
—
—
cases:0.92%
controls:0.00%
—
—
cases:4.04%
controls:0.01%
cases:3.11%
controls:0.06%
25
42
8765
87700
32
15
8759
87732
—
81
0
8710
87747
—
348
12
8275
85863
242
43
7531
77078
Dermatological photography
XQ848 [2001310110]
9.5e-01
2.4e+00
3.2e+00
1.0e+50
2.8e+00
3.0e+00
2.2e+00
cases:0.36%
controls:0.14%
cases:0.61%
controls:0.06%
cases:0.19%
controls:0.01%
cases:1.54%
controls:0.00%
cases:0.11%
controls:0.01%
cases:1.03%
controls:0.05%
cases:1.79%
controls:0.21%
32
124
8758
87618
54
49
8737
87698
17
7
8774
87740
135
0
8656
87747
10
6
8773
87602
89
45
8534
85830
139
161
7634
76960
Skin Pathology biopsy report
65754-4 [40768443]
1.6e+00
2.7e+00
4.0e+00
1.0e+50
2.8e+00
2.2e+00
1.2e+00
cases:2.09%
controls:0.43%
cases:2.63%
controls:0.18%
cases:0.65%
controls:0.01%
cases:1.79%
controls:0.00%
cases:0.20%
controls:0.01%
cases:1.12%
controls:0.13%
cases:2.03%
controls:0.59%
184
381
8606
87361
231
156
8560
87591
57
11
8734
87736
157
0
8634
87747
18
11
8765
87597
97
113
8526
85762
158
457
7615
76664
hydrocortisone; oral, parenteral
H02AB09 [21602737]
1.1e+00
1.8e+00
1.7e+00
4.5e+00
2.5e+00
1.6e+00
1.3e+00
cases:3.65%
controls:1.28%
cases:2.86%
controls:0.48%
cases:0.44%
controls:0.08%
cases:0.60%
controls:0.01%
cases:0.90%
controls:0.08%
cases:2.49%
controls:0.50%
cases:4.46%
controls:1.30%
321
1124
8469
86618
251
420
8540
87327
39
70
8752
87677
53
6
8738
87741
79
68
8704
87540
215
432
8408
85443
347
1000
7426
76121
Other specified dermatitis
L30.8 [45581941]
1.2e+00
2.9e+00
3.6e+00
1.0e+50
3.1e+00
2.2e+00
1.4e+00
cases:0.39%
controls:0.11%
cases:0.69%
controls:0.04%
cases:0.20%
controls:0.01%
cases:0.24%
controls:0.00%
cases:0.15%
controls:0.01%
cases:0.53%
controls:0.06%
cases:0.80%
controls:0.21%
34
100
8756
87642
61
35
8730
87712
18
5
8773
87742
21
0
8770
87747
13
6
8770
87602
46
49
8577
85826
62
159
7711
76962
Nummular dermatitis
L30.0 [45562535]
1.8e+00
2.9e+00
3.2e+00
1.0e+50
3.3e+00
2.0e+00
8.4e-01
cases:1.13%
controls:0.19%
cases:1.35%
controls:0.07%
cases:0.31%
controls:0.01%
cases:0.18%
controls:0.00%
cases:0.28%
controls:0.01%
cases:0.61%
controls:0.08%
cases:0.77%
controls:0.33%
99
170
8691
87572
119
65
8672
87682
27
11
8764
87736
16
0
8775
87747
25
9
8758
87599
53
70
8570
85805
60
258
7713
76863
Arthrocentesis, unspecified region, unspecified region
TNX10 [2001308560]
1.5e+00
2.3e+00
2.6e+00
—
2.7e+00
2.6e+00
2.2e+00
cases:2.33%
controls:0.55%
cases:1.44%
controls:0.15%
cases:0.25%
controls:0.02%
—
—
cases:0.28%
controls:0.02%
cases:2.03%
controls:0.15%
cases:4.08%
controls:0.48%
205
480
8585
87262
127
132
8664
87615
22
16
8769
87731
—
25
16
8758
87592
175
127
8448
85748
317
367
7456
76754
adalimumab; parenteral
L04AB04 [21603911]
1.9e+00
2.3e+00
2.3e+00
—
2.1e+00
2.5e+00
2.8e+00
cases:1.21%
controls:0.18%
cases:1.29%
controls:0.14%
cases:0.57%
controls:0.05%
—
—
cases:0.54%
controls:0.07%
cases:1.67%
controls:0.14%
cases:3.05%
controls:0.20%
106
154
8684
87588
113
119
8678
87628
50
48
8741
87699
—
47
59
8736
87549
144
120
8479
85755
237
154
7536
76967
Dermatitis, unspecified
L30.9 [45572271]
1.4e+00
2.7e+00
3.6e+00
—
3.1e+00
2.0e+00
8.5e-01
cases:6.12%
controls:1.63%
cases:8.90%
controls:0.65%
cases:3.16%
controls:0.09%
—
—
cases:1.88%
controls:0.08%
cases:4.81%
controls:0.69%
cases:5.69%
controls:2.51%
538
1434
8252
86308
782
569
8009
87178
278
75
8513
87672
—
165
73
8618
87535
415
589
8208
85286
442
1938
7331
75183
zinc bandage without supplements
D09AB01 [21602278]
2.2e+00
2.6e+00
—
1.0e+50
3.8e+00
2.6e+00
2.4e+00
cases:0.73%
controls:0.08%
cases:0.51%
controls:0.04%
—
—
cases:0.14%
controls:0.00%
cases:0.31%
controls:0.01%
cases:0.56%
controls:0.04%
cases:1.33%
controls:0.13%
64
74
8726
87668
45
34
8746
87713
—
12
0
8779
87747
27
6
8756
87602
48
34
8575
85841
103
98
7670
77023
zinc preparations; ointment
C05AX04 [21601632]
2.2e+00
2.6e+00
—
1.0e+50
3.8e+00
2.6e+00
2.4e+00
cases:0.73%
controls:0.08%
cases:0.51%
controls:0.04%
—
—
cases:0.14%
controls:0.00%
cases:0.31%
controls:0.01%
cases:0.56%
controls:0.04%
cases:1.33%
controls:0.13%
64
74
8726
87668
45
34
8746
87713
—
12
0
8779
87747
27
6
8756
87602
48
34
8575
85841
103
98
7670
77023
tacrolimus
D11AH01 [21602338]
1.5e+00
2.2e+00
2.1e+00
1.0e+50
3.5e+00
2.4e+00
1.9e+00
cases:2.20%
controls:0.49%
cases:2.01%
controls:0.23%
cases:0.31%
controls:0.04%
cases:0.69%
controls:0.00%
cases:0.97%
controls:0.03%
cases:2.44%
controls:0.23%
cases:4.53%
controls:0.73%
193
428
8597
87314
177
199
8614
87548
27
32
8764
87715
61
0
8730
87747
85
27
8698
87581
210
201
8413
85674
352
564
7421
76557
ustekinumab; parenteral
L04AC05 [21603919]
2.4e+00
2.0e+00
2.1e+00
—
2.1e+00
3.2e+00
3.6e+00
cases:0.13%
controls:0.01%
cases:0.13%
controls:0.02%
cases:0.08%
controls:0.01%
—
—
cases:0.06%
controls:0.01%
cases:0.63%
controls:0.03%
cases:1.30%
controls:0.04%
11
10
8779
87732
11
15
8780
87732
7
9
8784
87738
—
5
6
8778
87602
54
22
8569
85853
101
27
7672
77094
infliximab; parenteral
L04AB02 [21603909]
2.0e+00
2.4e+00
1.9e+00
—
2.3e+00
2.2e+00
2.3e+00
cases:0.90%
controls:0.12%
cases:0.77%
controls:0.07%
cases:0.19%
controls:0.03%
—
—
cases:0.18%
controls:0.02%
cases:0.63%
controls:0.07%
cases:0.93%
controls:0.09%
79
106
8711
87636
68
60
8723
87687
17
26
8774
87721
—
16
16
8767
87592
54
59
8569
85816
72
72
7701
77049
sulfasalazine; oral, rectal
A07EC01 [21600663]
1.6e+00
1.6e+00
1.6e+00
2.9e+00
1.8e+00
1.8e+00
1.8e+00
cases:4.49%
controls:0.98%
cases:3.15%
controls:0.67%
cases:1.02%
controls:0.20%
cases:0.17%
controls:0.01%
cases:1.21%
controls:0.20%
cases:3.75%
controls:0.66%
cases:5.53%
controls:0.97%
395
863
8395
86879
277
591
8514
87156
90
179
8701
87568
15
8
8776
87739
106
177
8677
87431
323
569
8300
85306
430
745
7343
76376
Arthropathic psoriasis
L40.5 [45557703]
5.9e+00
—
—
1.0e+50
1.0e+50
—
6.9e+00
cases:3.71%
controls:0.01%
—
—
—
—
cases:1.04%
controls:0.00%
cases:1.29%
controls:0.00%
—
—
cases:10.36%
controls:0.01%
326
9
8464
87733
—
—
91
0
8700
87747
113
0
8670
87608
—
805
9
6968
77112
Erysipelas
A46 [45561706]
7.9e-01
1.4e+00
2.2e+00
4.0e+00
2.1e+00
1.3e+00
9.5e-01
cases:2.96%
controls:1.37%
cases:1.81%
controls:0.44%
cases:0.64%
controls:0.07%
cases:0.38%
controls:0.01%
cases:0.44%
controls:0.06%
cases:1.70%
controls:0.47%
cases:4.67%
controls:1.85%
260
1202
8530
86540
159
388
8632
87359
56
61
8735
87686
33
6
8758
87741
39
50
8744
87558
147
404
8476
85471
363
1430
7410
75691
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
281 [2001600213]
1.8e+00
2.6e+00
2.3e+00
—
2.8e+00
2.7e+00
2.7e+00
cases:1.32%
controls:0.22%
cases:0.50%
controls:0.04%
cases:0.06%
controls:0.01%
—
—
cases:0.09%
controls:0.01%
cases:0.78%
controls:0.05%
cases:2.34%
controls:0.16%
116
192
8674
87550
44
34
8747
87713
5
5
8786
87742
—
8
5
8775
87603
67
45
8556
85830
182
120
7591
77001
leflunomide; oral
L04AK01 [955035]
2.0e+00
2.2e+00
1.9e+00
—
1.8e+00
2.2e+00
2.4e+00
cases:1.27%
controls:0.17%
cases:1.00%
controls:0.11%
cases:0.18%
controls:0.03%
—
—
cases:0.22%
controls:0.03%
cases:0.93%
controls:0.11%
cases:1.92%
controls:0.18%
112
147
8678
87595
88
94
8703
87653
16
25
8775
87722
—
19
30
8764
87578
80
93
8543
85782
149
135
7624
76986
Outpatient Visit
OP [9202]
3.8e-01
5.9e-01
9.2e-01
6.3e+00
1.7e+00
1.6e+00
1.0e+00
cases:70.06%
controls:61.45%
cases:56.17%
controls:41.65%
cases:19.83%
controls:8.98%
cases:65.59%
controls:0.37%
cases:36.15%
controls:9.04%
cases:78.14%
controls:42.04%
cases:87.13%
controls:70.72%
6158
53921
2632
33821
4938
36548
3853
51199
1743
7884
7048
79863
5766
321
3025
87426
3175
7916
5608
79692
6738
36103
1885
49772
6773
54542
1000
22579
Juvenile polyarthritis (seronegative)
M08.3 [45596450]
1.6e+00
2.0e+00
2.4e+00
—
2.3e+00
2.0e+00
2.0e+00
cases:0.27%
controls:0.05%
cases:0.31%
controls:0.04%
cases:0.11%
controls:0.01%
—
—
cases:0.10%
controls:0.01%
cases:0.26%
controls:0.04%
cases:0.31%
controls:0.04%
24
48
8766
87694
27
35
8764
87712
10
9
8781
87738
—
9
9
8774
87599
22
31
8601
85844
24
32
7749
77089
Joint ultrasound examination not elsewhere classified
NK4XE [2001308469]
1.3e+00
1.7e+00
2.3e+00
1.0e+50
2.3e+00
2.5e+00
2.2e+00
cases:2.22%
controls:0.61%
cases:1.49%
controls:0.27%
cases:0.33%
controls:0.03%
cases:0.63%
controls:0.00%
cases:0.28%
controls:0.03%
cases:2.57%
controls:0.22%
cases:4.94%
controls:0.59%
195
535
8595
87207
131
237
8660
87510
29
30
8762
87717
55
0
8736
87747
25
24
8758
87584
222
191
8401
85684
384
457
7389
76664
Hypersensitivity skin testing
268377001 [4147813]
5.9e-01
1.4e+00
3.3e+00
1.0e+50
3.7e+00
2.2e+00
1.1e+00
cases:1.33%
controls:0.74%
cases:0.89%
controls:0.21%
cases:0.57%
controls:0.02%
cases:1.01%
controls:0.00%
cases:0.76%
controls:0.02%
cases:1.50%
controls:0.17%
cases:1.93%
controls:0.68%
117
650
8673
87092
78
187
8713
87560
50
19
8741
87728
89
0
8702
87747
67
17
8716
87591
129
146
8494
85729
150
521
7623
76600
Besnier prurigo
L20.0 [45562534]
1.1e+00
1.8e+00
2.9e+00
1.0e+50
3.4e+00
1.9e+00
9.9e-01
cases:1.79%
controls:0.61%
cases:1.48%
controls:0.24%
cases:0.77%
controls:0.04%
cases:0.88%
controls:0.00%
cases:0.82%
controls:0.03%
cases:1.64%
controls:0.25%
cases:1.94%
controls:0.73%
157
535
8633
87207
130
209
8661
87538
68
36
8723
87711
77
0
8714
87747
72
24
8711
87584
141
212
8482
85663
151
563
7622
76558
Atopic dermatitis, unspecified
L20.9 [45548191]
1.1e+00
1.8e+00
3.4e+00
1.0e+50
3.1e+00
1.8e+00
8.8e-01
cases:0.65%
controls:0.22%
cases:0.48%
controls:0.08%
cases:0.23%
controls:0.01%
cases:0.41%
controls:0.00%
cases:0.18%
controls:0.01%
cases:0.55%
controls:0.09%
cases:0.67%
controls:0.28%
57
189
8733
87553
42
70
8749
87677
20
7
8771
87740
36
0
8755
87747
16
7
8767
87601
47
74
8576
85801
52
214
7721
76907
Medical doctor
Z2221 [2001311556]
5.4e-01
9.6e-01
1.5e+00
5.5e+00
1.2e+00
1.3e+00
1.0e+00
cases:6.01%
controls:3.60%
cases:2.90%
controls:1.13%
cases:0.59%
controls:0.13%
cases:1.41%
controls:0.01%
cases:0.46%
controls:0.14%
cases:3.39%
controls:0.95%
cases:6.92%
controls:2.63%
528
3162
8262
84580
255
992
8536
86755
52
118
8739
87629
124
5
8667
87742
40
122
8743
87486
292
813
8331
85062
538
2031
7235
75090
Exfoliative dermatitis
L26 [45581939]
2.5e+00
2.9e+00
—
1.0e+50
1.0e+50
3.2e+00
3.3e+00
cases:0.11%
controls:0.01%
cases:0.13%
controls:0.01%
—
—
cases:0.13%
controls:0.00%
cases:0.13%
controls:0.00%
cases:0.17%
controls:0.01%
cases:0.28%
controls:0.01%
10
8
8780
87734
11
6
8780
87741
—
11
0
8780
87747
11
0
8772
87608
15
6
8608
85869
22
8
7751
77113
hydrocortisone; local oral
A01AC03 [21600036]
1.2e+00
2.1e+00
2.2e+00
—
3.3e+00
1.8e+00
1.3e+00
cases:3.28%
controls:1.04%
cases:2.60%
controls:0.32%
cases:0.39%
controls:0.04%
—
—
cases:0.80%
controls:0.03%
cases:2.11%
controls:0.34%
cases:3.87%
controls:1.08%
288
909
8502
86833
229
284
8562
87463
34
36
8757
87711
—
70
27
8713
87581
182
296
8441
85579
301
834
7472
76287
Hidradenitis suppurativa
L73.2 [45557711]
1.1e+00
1.8e+00
2.3e+00
—
2.4e+00
2.5e+00
1.7e+00
cases:0.19%
controls:0.06%
cases:0.19%
controls:0.03%
cases:0.08%
controls:0.01%
—
—
cases:0.10%
controls:0.01%
cases:0.42%
controls:0.03%
cases:0.46%
controls:0.08%
17
54
8773
87688
17
28
8774
87719
7
7
8784
87740
—
9
8
8774
87600
36
30
8587
85845
36
65
7737
77056
Sacroiliitis, not elsewhere classified
M46.1 [45577263]
1.2e+00
2.0e+00
2.4e+00
—
2.5e+00
2.0e+00
1.7e+00
cases:0.24%
controls:0.08%
cases:0.26%
controls:0.04%
cases:0.09%
controls:0.01%
—
—
cases:0.08%
controls:0.01%
cases:0.26%
controls:0.03%
cases:0.42%
controls:0.08%
21
66
8769
87676
23
31
8768
87716
8
7
8783
87740
—
7
6
8776
87602
22
30
8601
85845
33
59
7740
77062
Lichen planus, unspecified
L43.9 [45591635]
2.6e+00
3.8e+00
1.0e+50
1.0e+50
—
3.4e+00
1.9e+00
cases:0.30%
controls:0.02%
cases:0.25%
controls:0.01%
cases:0.06%
controls:0.00%
cases:0.08%
controls:0.00%
—
—
cases:0.21%
controls:0.01%
cases:0.32%
controls:0.05%
26
19
8764
87723
22
5
8769
87742
5
0
8786
87747
7
0
8784
87747
—
18
6
8605
85869
25
37
7748
77084
Crohn disease of large intestine
K50.1 [45601173]
1.6e+00
2.0e+00
2.1e+00
1.0e+50
2.1e+00
1.8e+00
1.7e+00
cases:0.53%
controls:0.11%
cases:0.41%
controls:0.06%
cases:0.14%
controls:0.02%
cases:0.07%
controls:0.00%
cases:0.11%
controls:0.01%
cases:0.38%
controls:0.06%
cases:0.57%
controls:0.10%
47
94
8743
87648
36
51
8755
87696
12
14
8779
87733
6
0
8785
87747
10
12
8773
87596
33
52
8590
85823
44
78
7729
77043
Other psoriatic arthropathies
M07.3 [45591706]
5.4e+00
—
—
1.0e+50
1.0e+50
—
6.0e+00
cases:1.25%
controls:0.01%
—
—
—
—
cases:0.15%
controls:0.00%
cases:0.30%
controls:0.00%
—
—
cases:3.06%
controls:0.01%
110
5
8680
87737
—
—
13
0
8778
87747
26
0
8757
87608
—
238
6
7535
77115
Basophils/Leukocytes in Blood
30180-4 [3022096]
4.9e-01
8.7e-01
1.9e+00
3.7e+00
1.9e+00
1.4e+00
1.2e+00
cases:10.76%
controls:6.85%
cases:9.35%
controls:4.14%
cases:5.20%
controls:0.83%
cases:1.13%
controls:0.03%
cases:4.65%
controls:0.74%
cases:14.70%
controls:4.10%
cases:25.31%
controls:9.46%
946
6014
7844
81728
822
3633
7969
84114
457
729
8334
87018
99
25
8692
87722
408
651
8375
86957
1268
3522
7355
82353
1967
7297
5806
69824
Differential panel, method unspecified - Blood
69738-3 [42870588]
5.3e-01
8.2e-01
1.8e+00
3.7e+00
1.8e+00
1.4e+00
1.2e+00
cases:7.62%
controls:4.63%
cases:6.29%
controls:2.87%
cases:3.57%
controls:0.58%
cases:0.78%
controls:0.02%
cases:3.35%
controls:0.56%
cases:10.45%
controls:2.86%
cases:18.32%
controls:6.07%
670
4066
8120
83676
553
2517
8238
85230
314
511
8477
87236
69
17
8722
87730
294
488
8489
87120
901
2459
7722
83416
1424
4683
6349
72438
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
5.0e-01
8.7e-01
1.9e+00
3.6e+00
1.9e+00
1.4e+00
1.2e+00
cases:10.81%
controls:6.87%
cases:9.36%
controls:4.15%
cases:5.18%
controls:0.83%
cases:1.13%
controls:0.03%
cases:4.65%
controls:0.74%
cases:14.80%
controls:4.11%
cases:25.34%
controls:9.45%
950
6030
7840
81712
823
3644
7968
84103
455
732
8336
87015
99
26
8692
87721
408
652
8375
86956
1276
3529
7347
82346
1970
7288
5803
69833
Monocytes/Leukocytes in Blood
26485-3 [3019069]
4.9e-01
8.7e-01
1.9e+00
3.6e+00
1.9e+00
1.4e+00
1.2e+00
cases:10.80%
controls:6.89%
cases:9.37%
controls:4.15%
cases:5.19%
controls:0.84%
cases:1.13%
controls:0.03%
cases:4.63%
controls:0.75%
cases:14.84%
controls:4.12%
cases:25.32%
controls:9.43%
949
6049
7841
81693
824
3641
7967
84106
456
734
8335
87013
99
26
8692
87721
407
657
8376
86951
1280
3539
7343
82336
1968
7274
5805
69847
hydrocortisone and antiseptics
D07BA04 [21602146]
1.1e+00
2.0e+00
2.2e+00
—
3.1e+00
1.6e+00
1.2e+00
cases:5.24%
controls:1.80%
cases:3.88%
controls:0.52%
cases:0.58%
controls:0.06%
—
—
cases:1.17%
controls:0.05%
cases:2.83%
controls:0.57%
cases:5.65%
controls:1.76%
461
1576
8329
86166
341
456
8450
87291
51
54
8740
87693
—
103
48
8680
87560
244
487
8379
85388
439
1354
7334
75767
hydrocortisone
D07XA01 [21602180]
1.1e+00
2.0e+00
2.2e+00
—
3.1e+00
1.6e+00
1.2e+00
cases:5.24%
controls:1.80%
cases:3.88%
controls:0.52%
cases:0.58%
controls:0.06%
—
—
cases:1.17%
controls:0.05%
cases:2.83%
controls:0.57%
cases:5.65%
controls:1.76%
461
1576
8329
86166
341
456
8450
87291
51
54
8740
87693
—
103
48
8680
87560
244
487
8379
85388
439
1354
7334
75767
chlorhexidine
S03AA04 [21605193]
1.1e+00
2.0e+00
2.2e+00
—
3.1e+00
1.6e+00
1.2e+00
cases:5.21%
controls:1.80%
cases:3.86%
controls:0.52%
cases:0.57%
controls:0.06%
—
—
cases:1.17%
controls:0.05%
cases:2.83%
controls:0.56%
cases:5.65%
controls:1.75%
458
1575
8332
86167
339
454
8452
87293
50
54
8741
87693
—
103
48
8680
87560
244
484
8379
85391
439
1353
7334
75768
chlorhexidine
D09AA12 [21602275]
1.1e+00
2.0e+00
2.2e+00
—
3.1e+00
1.6e+00
1.2e+00
cases:5.21%
controls:1.80%
cases:3.86%
controls:0.52%
cases:0.57%
controls:0.06%
—
—
cases:1.17%
controls:0.05%
cases:2.83%
controls:0.56%
cases:5.65%
controls:1.75%
458
1575
8332
86167
339
454
8452
87293
50
54
8741
87693
—
103
48
8680
87560
244
484
8379
85391
439
1353
7334
75768
chlorhexidine, combinations
D08AC52 [21602208]
1.1e+00
2.0e+00
2.2e+00
—
3.1e+00
1.6e+00
1.2e+00
cases:5.21%
controls:1.80%
cases:3.86%
controls:0.52%
cases:0.57%
controls:0.06%
—
—
cases:1.17%
controls:0.05%
cases:2.83%
controls:0.56%
cases:5.65%
controls:1.75%
458
1575
8332
86167
339
454
8452
87293
50
54
8741
87693
—
103
48
8680
87560
244
484
8379
85391
439
1353
7334
75768
chlorhexidine
S02AA09 [21605155]
1.1e+00
2.0e+00
2.2e+00
—
3.1e+00
1.6e+00
1.2e+00
cases:5.21%
controls:1.80%
cases:3.86%
controls:0.52%
cases:0.57%
controls:0.06%
—
—
cases:1.17%
controls:0.05%
cases:2.83%
controls:0.56%
cases:5.65%
controls:1.75%
458
1575
8332
86167
339
454
8452
87293
50
54
8741
87693
—
103
48
8680
87560
244
484
8379
85391
439
1353
7334
75768
other antifungals for topical use - combinations; ointment
D01AE20 [21601959]
1.1e+00
2.0e+00
2.2e+00
—
3.1e+00
1.6e+00
1.2e+00
cases:5.21%
controls:1.80%
cases:3.86%
controls:0.52%
cases:0.57%
controls:0.06%
—
—
cases:1.17%
controls:0.05%
cases:2.83%
controls:0.56%
cases:5.65%
controls:1.75%
458
1575
8332
86167
339
454
8452
87293
50
54
8741
87693
—
103
48
8680
87560
244
484
8379
85391
439
1353
7334
75768
Monocytes [#/volume] in Blood
26484-6 [3001604]
4.6e-01
8.4e-01
1.9e+00
3.7e+00
1.8e+00
1.4e+00
1.2e+00
cases:11.14%
controls:7.34%
cases:9.93%
controls:4.56%
cases:5.62%
controls:0.90%
cases:1.19%
controls:0.03%
cases:4.91%
controls:0.82%
cases:16.21%
controls:4.45%
cases:27.44%
controls:10.40%
979
6440
7811
81302
873
4000
7918
83747
494
794
8297
86953
105
27
8686
87720
431
717
8352
86891
1398
3819
7225
82056
2133
8022
5640
69099
triamcinolone and antiseptics
D07BB03 [21602150]
1.1e+00
2.0e+00
2.2e+00
—
3.1e+00
1.6e+00
1.2e+00
cases:5.32%
controls:1.85%
cases:3.88%
controls:0.53%
cases:0.58%
controls:0.06%
—
—
cases:1.20%
controls:0.06%
cases:2.85%
controls:0.58%
cases:5.71%
controls:1.80%
468
1622
8322
86120
341
461
8450
87286
51
54
8740
87693
—
105
50
8678
87558
246
496
8377
85379
444
1386
7329
75735
Basophils [#/volume] in Blood
26444-0 [3006315]
4.6e-01
8.4e-01
1.9e+00
3.6e+00
1.8e+00
1.4e+00
1.2e+00
cases:11.17%
controls:7.35%
cases:9.96%
controls:4.57%
cases:5.62%
controls:0.91%
cases:1.19%
controls:0.03%
cases:4.92%
controls:0.82%
cases:16.22%
controls:4.46%
cases:27.49%
controls:10.46%
982
6445
7808
81297
876
4013
7915
83734
494
795
8297
86952
105
28
8686
87719
432
717
8351
86891
1399
3831
7224
82044
2137
8066
5636
69055
ciclosporin; oral, parenteral
L04AD01 [21603924]
1.5e+00
1.7e+00
1.2e+00
—
2.1e+00
2.2e+00
2.5e+00
cases:1.05%
controls:0.23%
cases:0.92%
controls:0.17%
cases:0.25%
controls:0.08%
—
—
cases:0.38%
controls:0.04%
cases:1.38%
controls:0.16%
cases:2.44%
controls:0.21%
92
202
8698
87540
81
148
8710
87599
22
66
8769
87681
—
33
39
8750
87569
119
136
8504
85739
190
162
7583
76959
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
4.6e-01
8.3e-01
1.8e+00
3.7e+00
1.8e+00
1.4e+00
1.1e+00
cases:10.88%
controls:7.12%
cases:9.34%
controls:4.29%
cases:5.19%
controls:0.86%
cases:1.11%
controls:0.03%
cases:4.66%
controls:0.76%
cases:14.86%
controls:4.26%
cases:25.41%
controls:9.86%
956
6250
7834
81492
821
3767
7970
83980
456
754
8335
86993
98
25
8693
87722
409
670
8374
86938
1281
3662
7342
82213
1975
7605
5798
69516
Other psoriasis
L40.8 [45567355]
5.3e+00
—
1.0e+50
1.0e+50
1.0e+50
—
5.9e+00
cases:1.08%
controls:0.01%
—
—
cases:0.58%
controls:0.00%
cases:0.43%
controls:0.00%
cases:0.51%
controls:0.00%
—
—
cases:2.33%
controls:0.01%
95
5
8695
87737
—
51
0
8740
87747
38
0
8753
87747
45
0
8738
87608
—
181
5
7592
77116
Prick test
37968009 [4242723]
4.3e-01
1.4e+00
2.7e+00
1.0e+50
3.7e+00
1.8e+00
1.1e+00
cases:0.84%
controls:0.55%
cases:0.52%
controls:0.13%
cases:0.15%
controls:0.01%
cases:0.53%
controls:0.00%
cases:0.28%
controls:0.01%
cases:0.74%
controls:0.12%
cases:1.31%
controls:0.44%
74
484
8716
87258
46
116
8745
87631
13
9
8778
87738
47
0
8744
87747
25
6
8758
87602
64
102
8559
85773
102
338
7671
76783
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
4.7e-01
8.4e-01
1.9e+00
3.6e+00
1.8e+00
1.4e+00
1.1e+00
cases:10.59%
controls:6.92%
cases:9.12%
controls:4.17%
cases:5.05%
controls:0.82%
cases:1.07%
controls:0.03%
cases:4.52%
controls:0.74%
cases:14.64%
controls:4.18%
cases:24.86%
controls:9.63%
931
6071
7859
81671
802
3660
7989
84087
444
723
8347
87024
94
25
8697
87722
397
652
8386
86956
1262
3593
7361
82282
1932
7423
5841
69698
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
4.5e-01
8.2e-01
1.8e+00
3.6e+00
1.8e+00
1.4e+00
1.1e+00
cases:11.52%
controls:7.66%
cases:10.09%
controls:4.73%
cases:5.62%
controls:0.93%
cases:1.19%
controls:0.03%
cases:4.93%
controls:0.84%
cases:16.26%
controls:4.61%
cases:27.65%
controls:10.85%
1013
6721
7777
81021
887
4148
7904
83599
494
816
8297
86931
105
28
8686
87719
433
734
8350
86874
1402
3956
7221
81919
2149
8369
5624
68752
HLA-B27 [Presence]
4821-5 [3008898]
1.0e+00
1.8e+00
2.7e+00
—
2.6e+00
1.7e+00
1.1e+00
cases:1.24%
controls:0.44%
cases:0.74%
controls:0.12%
cases:0.23%
controls:0.01%
—
—
cases:0.16%
controls:0.01%
cases:0.70%
controls:0.13%
cases:1.39%
controls:0.44%
109
388
8681
87354
65
108
8726
87639
20
13
8771
87734
—
14
10
8769
87598
60
108
8563
85767
108
343
7665
76778
carbamide, combinations
D02AE51 [21601976]
1.3e+00
2.3e+00
1.9e+00
1.0e+50
3.7e+00
2.2e+00
1.5e+00
cases:0.71%
controls:0.19%
cases:0.52%
controls:0.05%
cases:0.07%
controls:0.01%
cases:0.09%
controls:0.00%
cases:0.24%
controls:0.01%
cases:0.46%
controls:0.05%
cases:0.77%
controls:0.18%
62
163
8728
87579
46
46
8745
87701
6
9
8785
87738
8
0
8783
87747
21
5
8762
87603
40
44
8583
85831
60
137
7713
76984
Eosinophils [#/volume] in Blood
26449-9 [3013115]
4.5e-01
8.3e-01
1.8e+00
3.6e+00
1.8e+00
1.4e+00
1.2e+00
cases:11.62%
controls:7.73%
cases:10.26%
controls:4.76%
cases:5.73%
controls:0.96%
cases:1.23%
controls:0.04%
cases:4.99%
controls:0.88%
cases:16.37%
controls:4.64%
cases:27.96%
controls:10.83%
1021
6786
7769
80956
902
4178
7889
83569
504
839
8287
86908
108
31
8683
87716
438
772
8345
86836
1412
3987
7211
81888
2173
8354
5600
68767
Blasts/Leukocytes in Blood
26446-5 [3025159]
8.8e-01
1.0e+00
2.0e+00
2.6e+00
1.7e+00
1.4e+00
1.3e+00
cases:1.29%
controls:0.54%
cases:1.42%
controls:0.52%
cases:0.77%
controls:0.11%
cases:0.09%
controls:0.01%
cases:0.54%
controls:0.10%
cases:2.30%
controls:0.57%
cases:5.04%
controls:1.46%
113
470
8677
87272
125
455
8666
87292
68
95
8723
87652
8
6
8783
87741
47
85
8736
87523
198
491
8425
85384
392
1129
7381
75992
antibiotics in combination with corticosteroids
D01AA20 [21601918]
1.0e+00
2.0e+00
2.3e+00
—
2.8e+00
1.6e+00
1.2e+00
cases:3.46%
controls:1.24%
cases:2.15%
controls:0.31%
cases:0.31%
controls:0.03%
—
—
cases:0.67%
controls:0.04%
cases:1.61%
controls:0.35%
cases:3.77%
controls:1.14%
304
1089
8486
86653
189
273
8602
87474
27
28
8764
87719
—
59
36
8724
87572
139
297
8484
85578
293
879
7480
76242
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
8.8e-01
1.0e+00
2.0e+00
2.5e+00
1.7e+00
1.4e+00
1.3e+00
cases:1.33%
controls:0.55%
cases:1.33%
controls:0.49%
cases:0.71%
controls:0.10%
cases:0.08%
controls:0.01%
cases:0.46%
controls:0.08%
cases:2.12%
controls:0.53%
cases:4.95%
controls:1.38%
117
486
8673
87256
117
427
8674
87320
62
84
8729
87663
7
6
8784
87741
40
70
8743
87538
183
454
8440
85421
385
1068
7388
76053
Hospital outpatient
ZY010 [2001311599]
3.9e-01
9.5e-01
1.2e+00
3.9e+00
1.6e+00
1.5e+00
1.6e+00
cases:0.71%
controls:0.48%
cases:0.48%
controls:0.19%
cases:0.18%
controls:0.06%
cases:0.35%
controls:0.01%
cases:0.31%
controls:0.06%
cases:0.70%
controls:0.16%
cases:1.63%
controls:0.34%
62
421
8728
87321
42
163
8749
87584
16
50
8775
87697
31
6
8760
87741
27
54
8756
87554
60
135
8563
85740
127
265
7646
76856
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
8.5e-01
9.9e-01
1.9e+00
2.5e+00
1.7e+00
1.4e+00
1.3e+00
cases:1.43%
controls:0.62%
cases:1.41%
controls:0.53%
cases:0.78%
controls:0.11%
cases:0.08%
controls:0.01%
cases:0.52%
controls:0.09%
cases:2.28%
controls:0.56%
cases:5.08%
controls:1.44%
126
540
8664
87202
124
464
8667
87283
69
99
8722
87648
7
6
8784
87741
46
83
8737
87525
197
481
8426
85394
395
1114
7378
76007
Other Crohn disease
K50.8 [45533599]
1.5e+00
1.7e+00
2.0e+00
—
2.0e+00
1.7e+00
1.8e+00
cases:0.88%
controls:0.20%
cases:0.78%
controls:0.14%
cases:0.35%
controls:0.05%
—
—
cases:0.38%
controls:0.05%
cases:0.77%
controls:0.15%
cases:1.07%
controls:0.18%
77
173
8713
87569
69
125
8722
87622
31
44
8760
87703
—
33
46
8750
87562
66
126
8557
85749
83
138
7690
76983
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
8.2e-01
9.8e-01
1.9e+00
2.5e+00
1.7e+00
1.4e+00
1.3e+00
cases:1.46%
controls:0.65%
cases:1.43%
controls:0.54%
cases:0.80%
controls:0.12%
cases:0.08%
controls:0.01%
cases:0.52%
controls:0.10%
cases:2.37%
controls:0.58%
cases:5.25%
controls:1.51%
128
566
8662
87176
126
478
8665
87269
70
102
8721
87645
7
6
8784
87741
46
86
8737
87522
204
500
8419
85375
408
1164
7365
75957
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
6.8e-01
1.4e+00
1.7e+00
—
3.0e+00
2.1e+00
1.6e+00
cases:1.02%
controls:0.52%
cases:0.65%
controls:0.16%
cases:0.14%
controls:0.02%
—
—
cases:0.32%
controls:0.02%
cases:1.17%
controls:0.14%
cases:2.06%
controls:0.41%
90
459
8700
87283
57
141
8734
87606
12
21
8779
87726
—
28
14
8755
87594
101
124
8522
85751
160
313
7613
76808
Epidermal thickening, unspecified
L85.9 [45606000]
2.2e+00
3.2e+00
—
—
—
3.0e+00
2.2e+00
cases:0.16%
controls:0.02%
cases:0.17%
controls:0.01%
—
—
—
—
—
—
cases:0.14%
controls:0.01%
cases:0.10%
controls:0.01%
14
16
8776
87726
15
6
8776
87741
—
—
—
12
6
8611
85869
8
9
7765
77112
golimumab; parenteral
L04AB06 [21603913]
1.6e+00
1.8e+00
1.6e+00
—
1.7e+00
1.5e+00
2.3e+00
cases:0.31%
controls:0.06%
cases:0.30%
controls:0.05%
cases:0.16%
controls:0.03%
—
—
cases:0.18%
controls:0.03%
cases:0.27%
controls:0.06%
cases:0.75%
controls:0.08%
27
56
8763
87686
26
41
8765
87706
14
27
8777
87720
—
16
30
8767
87578
23
50
8600
85825
58
59
7715
77062
Thorax X-ray examination
GD1AA [2001303617]
4.4e-01
6.3e-01
1.1e+00
4.7e+00
1.5e+00
1.2e+00
9.6e-01
cases:8.61%
controls:5.73%
cases:4.13%
controls:2.24%
cases:0.88%
controls:0.28%
cases:1.66%
controls:0.02%
cases:0.97%
controls:0.23%
cases:6.62%
controls:2.06%
cases:15.64%
controls:6.62%
757
5026
8033
82716
363
1969
8428
85778
77
245
8714
87502
146
14
8645
87733
85
198
8698
87410
571
1766
8052
84109
1216
5107
6557
72014
auranofin; oral
M01CB03 [21604027]
2.2e+00
2.6e+00
—
—
—
2.4e+00
3.1e+00
cases:0.22%
controls:0.03%
cases:0.14%
controls:0.01%
—
—
—
—
—
—
cases:0.13%
controls:0.01%
cases:0.22%
controls:0.01%
19
22
8771
87720
12
9
8779
87738
—
—
—
11
10
8612
85865
17
8
7756
77113
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
313 [2001600274]
1.9e+00
2.7e+00
2.0e+00
—
—
2.9e+00
2.7e+00
cases:1.62%
controls:0.25%
cases:0.55%
controls:0.04%
cases:0.06%
controls:0.01%
—
—
—
—
cases:0.93%
controls:0.05%
cases:2.52%
controls:0.17%
142
217
8648
87525
48
34
8743
87713
5
7
8786
87740
—
—
80
44
8543
85831
196
130
7577
76991
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
5.4e-01
8.3e-01
1.9e+00
3.1e+00
1.5e+00
1.3e+00
9.7e-01
cases:4.99%
controls:2.98%
cases:3.91%
controls:1.74%
cases:2.14%
controls:0.32%
cases:0.30%
controls:0.01%
cases:1.39%
controls:0.31%
cases:5.95%
controls:1.68%
cases:11.17%
controls:4.55%
439
2613
8351
85129
344
1528
8447
86219
188
280
8603
87467
26
12
8765
87735
122
270
8661
87338
513
1446
8110
84429
868
3507
6905
73614
DNA double strand Ab [Units/volume] in Serum
5130-0 [3023420]
8.5e-01
1.4e+00
1.9e+00
1.0e+50
2.5e+00
1.9e+00
1.4e+00
cases:1.05%
controls:0.45%
cases:0.78%
controls:0.19%
cases:0.18%
controls:0.03%
cases:0.09%
controls:0.00%
cases:0.28%
controls:0.02%
cases:1.03%
controls:0.16%
cases:2.42%
controls:0.58%
92
393
8698
87349
69
163
8722
87584
16
23
8775
87724
8
0
8783
87747
25
20
8758
87588
89
137
8534
85738
188
449
7585
76672
Smith extractable nuclear Ab [Units/volume] in Serum
11090-8 [3016921]
7.2e-01
1.4e+00
2.3e+00
1.0e+50
2.9e+00
1.8e+00
9.4e-01
cases:0.53%
controls:0.26%
cases:0.42%
controls:0.11%
cases:0.11%
controls:0.01%
cases:0.06%
controls:0.00%
cases:0.18%
controls:0.01%
cases:0.57%
controls:0.10%
cases:1.09%
controls:0.43%
47
228
8743
87514
37
94
8754
87653
10
10
8781
87737
5
0
8786
87747
16
9
8767
87599
49
82
8574
85793
85
332
7688
76789
Pharmacy visit
OMOP4822462 [581458]
6.1e-01
1.3e+00
9.1e-01
2.9e+00
1.4e+00
1.5e+00
1.4e+00
cases:94.31%
controls:89.97%
cases:93.16%
controls:78.17%
cases:61.37%
controls:39.03%
cases:26.68%
controls:1.92%
cases:71.43%
controls:39.06%
cases:94.31%
controls:79.47%
cases:98.28%
controls:93.42%
8290
78943
500
8799
8190
68588
601
19159
5395
34248
3396
53499
2345
1682
6446
86065
6274
34217
2509
53391
8132
68242
491
17633
7639
72047
134
5074
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
29374-6 [3006999]
7.2e-01
1.4e+00
2.3e+00
1.0e+50
2.9e+00
1.8e+00
9.3e-01
cases:0.53%
controls:0.26%
cases:0.43%
controls:0.11%
cases:0.11%
controls:0.01%
cases:0.06%
controls:0.00%
cases:0.18%
controls:0.01%
cases:0.57%
controls:0.10%
cases:1.09%
controls:0.43%
47
229
8743
87513
38
96
8753
87651
10
10
8781
87737
5
0
8786
87747
16
9
8767
87599
49
83
8574
85792
85
334
7688
76787
etanercept; parenteral
L04AB01 [21603908]
1.7e+00
1.8e+00
1.3e+00
—
1.8e+00
2.1e+00
2.5e+00
cases:0.72%
controls:0.13%
cases:0.50%
controls:0.08%
cases:0.10%
controls:0.03%
—
—
cases:0.16%
controls:0.03%
cases:0.65%
controls:0.08%
cases:1.52%
controls:0.12%
63
110
8727
87632
44
70
8747
87677
9
24
8782
87723
—
14
24
8769
87584
56
70
8567
85805
118
93
7655
77028
Arthritis, unspecified
M13.9 [45567463]
1.2e+00
1.8e+00
2.4e+00
—
1.9e+00
1.5e+00
1.1e+00
cases:1.87%
controls:0.56%
cases:1.46%
controls:0.23%
cases:0.48%
controls:0.04%
—
—
cases:0.39%
controls:0.06%
cases:1.14%
controls:0.25%
cases:2.02%
controls:0.72%
164
492
8626
87250
128
204
8663
87543
42
38
8749
87709
—
34
49
8749
87559
98
217
8525
85658
157
552
7616
76569
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
17792-3 [3023939]
8.3e-01
1.2e+00
2.6e+00
—
2.9e+00
1.5e+00
9.2e-01
cases:0.46%
controls:0.20%
cases:0.30%
controls:0.09%
cases:0.09%
controls:0.01%
—
—
cases:0.10%
controls:0.01%
cases:0.34%
controls:0.08%
cases:0.86%
controls:0.34%
40
174
8750
87568
26
76
8765
87671
8
6
8783
87741
—
9
5
8774
87603
29
65
8594
85810
67
266
7706
76855
hydrocortisone and antiinfectives
S01CA03 [21603654]
9.4e-01
1.8e+00
2.4e+00
—
2.6e+00
1.2e+00
9.5e-01
cases:2.46%
controls:0.98%
cases:1.49%
controls:0.24%
cases:0.24%
controls:0.02%
—
—
cases:0.39%
controls:0.03%
cases:0.89%
controls:0.27%
cases:2.32%
controls:0.91%
216
856
8574
86886
131
210
8660
87537
21
19
8770
87728
—
34
25
8749
87583
77
235
8546
85640
180
700
7593
76421
Bilateral hand X-ray examination
ND2DA [2001307619]
1.8e+00
2.0e+00
1.0e+50
1.0e+50
1.0e+50
3.5e+00
2.6e+00
cases:0.39%
controls:0.06%
cases:0.14%
controls:0.02%
cases:0.07%
controls:0.00%
cases:0.08%
controls:0.00%
cases:0.07%
controls:0.00%
cases:0.34%
controls:0.01%
cases:0.80%
controls:0.06%
34
54
8756
87688
12
16
8779
87731
6
0
8785
87747
7
0
8784
87747
6
0
8777
87608
29
9
8594
85866
62
47
7711
77074
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
17791-5 [3027450]
7.2e-01
1.4e+00
2.2e+00
1.0e+50
2.8e+00
1.7e+00
9.6e-01
cases:0.58%
controls:0.28%
cases:0.47%
controls:0.12%
cases:0.11%
controls:0.01%
cases:0.06%
controls:0.00%
cases:0.19%
controls:0.01%
cases:0.59%
controls:0.10%
cases:1.17%
controls:0.45%
51
248
8739
87494
41
103
8750
87644
10
11
8781
87736
5
0
8786
87747
17
10
8766
87598
51
89
8572
85786
91
349
7682
76772
Extractable nuclear Ab [Units/volume] in Serum
30342-0 [3015171]
7.9e-01
1.5e+00
2.7e+00
1.0e+50
2.1e+00
1.6e+00
1.2e+00
cases:1.02%
controls:0.47%
cases:0.67%
controls:0.16%
cases:0.26%
controls:0.02%
cases:0.06%
controls:0.00%
cases:0.13%
controls:0.02%
cases:0.60%
controls:0.12%
cases:1.49%
controls:0.47%
90
409
8700
87333
59
137
8732
87610
23
15
8768
87732
5
0
8786
87747
11
14
8772
87594
52
102
8571
85773
116
363
7657
76758
Intravenous
ZX120 [2001311495]
7.5e-01
1.3e+00
9.2e-01
2.6e+00
1.7e+00
1.3e+00
1.3e+00
cases:1.63%
controls:0.77%
cases:1.09%
controls:0.31%
cases:0.20%
controls:0.08%
cases:0.09%
controls:0.01%
cases:0.31%
controls:0.06%
cases:1.02%
controls:0.27%
cases:2.35%
controls:0.66%
143
678
8647
87064
96
276
8695
87471
18
72
8773
87675
8
6
8783
87741
27
50
8756
87558
88
235
8535
85640
183
511
7590
76610
Hand and fingers X-ray examination
ND2AA [2001307607]
6.7e-01
1.2e+00
2.3e+00
—
2.2e+00
2.0e+00
1.4e+00
cases:1.38%
controls:0.71%
cases:0.69%
controls:0.22%
cases:0.17%
controls:0.02%
—
—
cases:0.19%
controls:0.02%
cases:1.29%
controls:0.18%
cases:3.20%
controls:0.79%
121
625
8669
87117
61
190
8730
87557
15
15
8776
87732
—
17
19
8766
87589
111
156
8512
85719
249
606
7524
76515
Psoriasis
S91 [2002001055]
4.8e+00
—
1.0e+50
—
—
—
4.9e+00
cases:1.11%
controls:0.01%
—
—
cases:0.36%
controls:0.00%
—
—
—
—
—
—
cases:2.77%
controls:0.02%
98
8
8692
87734
—
32
0
8759
87747
—
—
—
215
17
7558
77104
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
4.1e-01
7.4e-01
1.5e+00
3.1e+00
1.5e+00
1.3e+00
1.1e+00
cases:12.56%
controls:8.71%
cases:11.08%
controls:5.62%
cases:6.10%
controls:1.39%
cases:1.33%
controls:0.06%
cases:5.42%
controls:1.32%
cases:17.13%
controls:5.43%
cases:28.83%
controls:11.87%
1104
7645
7686
80097
974
4931
7817
82816
536
1217
8255
86530
117
54
8674
87693
476
1158
8307
86450
1477
4666
7146
81209
2241
9152
5532
67969
Other seropositive rheumatoid arthritis
M05.8 [45538634]
7.5e-01
8.1e-01
9.5e-01
4.1e+00
1.1e+00
8.9e-01
9.6e-01
cases:1.52%
controls:0.73%
cases:1.22%
controls:0.55%
cases:0.39%
controls:0.15%
cases:0.41%
controls:0.01%
cases:0.46%
controls:0.14%
cases:1.35%
controls:0.56%
cases:2.32%
controls:0.90%
134
640
8656
87102
107
480
8684
87267
34
131
8757
87616
36
6
8755
87741
40
127
8743
87481
116
480
8507
85395
180
695
7593
76426
cefalexin; oral
J01DB01 [21602870]
6.2e-01
1.0e+00
1.5e+00
3.7e+00
1.2e+00
8.2e-01
6.7e-01
cases:39.64%
controls:26.10%
cases:20.36%
controls:8.33%
cases:3.72%
controls:0.89%
cases:0.76%
controls:0.02%
cases:3.11%
controls:0.92%
cases:16.37%
controls:7.97%
cases:40.19%
controls:25.68%
3484
22901
5306
64841
1790
7312
7001
80435
327
778
8464
86969
67
17
8724
87730
273
808
8510
86800
1412
6845
7211
79030
3124
19805
4649
57316
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
7.0e-01
1.3e+00
2.2e+00
—
2.4e+00
1.7e+00
1.2e+00
cases:3.36%
controls:1.69%
cases:2.17%
controls:0.61%
cases:0.67%
controls:0.07%
—
—
cases:0.61%
controls:0.06%
cases:2.64%
controls:0.51%
cases:6.28%
controls:1.98%
295
1485
8495
86257
191
536
8600
87211
59
64
8732
87683
—
54
51
8729
87557
228
442
8395
85433
488
1525
7285
75596
Other specified counselling
Z71.8 [45581061]
2.7e-01
6.0e-01
1.1e+00
5.0e+00
1.3e+00
7.3e-01
4.0e-01
cases:3.66%
controls:2.81%
cases:2.43%
controls:1.35%
cases:0.55%
controls:0.19%
cases:0.88%
controls:0.01%
cases:0.74%
controls:0.21%
cases:3.21%
controls:1.57%
cases:7.60%
controls:5.22%
322
2469
8468
85273
214
1183
8577
86564
48
167
8743
87580
77
5
8714
87742
65
184
8718
87424
277
1346
8346
84529
591
4023
7182
73098
folic acid
V04CX02 [715877]
1.1e+00
1.2e+00
1.0e+00
—
2.3e+00
1.9e+00
1.8e+00
cases:1.87%
controls:0.62%
cases:1.72%
controls:0.51%
cases:0.34%
controls:0.13%
—
—
cases:1.15%
controls:0.11%
cases:3.92%
controls:0.59%
cases:7.63%
controls:1.39%
164
544
8626
87198
151
449
8640
87298
30
110
8761
87637
—
101
99
8682
87509
338
504
8285
85371
593
1072
7180
76049
folic acid; oral, parenteral
B03BB01 [21601129]
1.1e+00
1.2e+00
1.0e+00
—
2.3e+00
1.9e+00
1.8e+00
cases:1.87%
controls:0.62%
cases:1.72%
controls:0.51%
cases:0.34%
controls:0.13%
—
—
cases:1.15%
controls:0.11%
cases:3.92%
controls:0.59%
cases:7.63%
controls:1.39%
164
544
8626
87198
151
449
8640
87298
30
110
8761
87637
—
101
99
8682
87509
338
504
8285
85371
593
1072
7180
76049
Office Visit
OMOP4822458 [581477]
3.4e-01
5.7e-01
1.1e+00
4.2e+00
1.6e+00
9.5e-01
6.2e-01
cases:10.07%
controls:7.35%
cases:3.80%
controls:2.19%
cases:0.88%
controls:0.28%
cases:1.24%
controls:0.02%
cases:1.34%
controls:0.28%
cases:5.22%
controls:2.08%
cases:11.37%
controls:6.45%
885
6446
7905
81296
334
1925
8457
85822
77
246
8714
87501
109
17
8682
87730
118
249
8665
87359
450
1785
8173
84090
884
4975
6889
72146
pimecrolimus
D11AH02 [21602339]
1.0e+00
1.6e+00
1.9e+00
—
2.2e+00
1.5e+00
1.1e+00
cases:1.02%
controls:0.37%
cases:0.72%
controls:0.15%
cases:0.14%
controls:0.02%
—
—
cases:0.19%
controls:0.02%
cases:0.75%
controls:0.17%
cases:1.49%
controls:0.50%
90
325
8700
87417
63
133
8728
87614
12
18
8779
87729
—
17
18
8766
87590
65
143
8558
85732
116
387
7657
76734
methylprednisolone
D07AA01 [21602101]
1.6e+00
2.4e+00
2.8e+00
—
—
1.2e+00
1.2e+00
cases:0.98%
controls:0.19%
cases:0.69%
controls:0.06%
cases:0.09%
controls:0.01%
—
—
—
—
cases:0.23%
controls:0.07%
cases:0.62%
controls:0.20%
86
169
8704
87573
61
53
8730
87694
8
5
8783
87742
—
—
20
58
8603
85817
48
151
7725
76970
methylprednisolone aceponate
D07AC14 [21602133]
1.6e+00
2.4e+00
2.8e+00
—
—
1.2e+00
1.2e+00
cases:0.98%
controls:0.19%
cases:0.69%
controls:0.06%
cases:0.09%
controls:0.01%
—
—
—
—
cases:0.23%
controls:0.07%
cases:0.62%
controls:0.20%
86
169
8704
87573
61
53
8730
87694
8
5
8783
87742
—
—
20
58
8603
85817
48
151
7725
76970
Fatty (change of) liver, not elsewhere classified
K76.0 [45601189]
1.0e+00
1.4e+00
1.9e+00
1.0e+50
1.9e+00
1.7e+00
1.2e+00
cases:0.43%
controls:0.15%
cases:0.35%
controls:0.08%
cases:0.09%
controls:0.01%
cases:0.06%
controls:0.00%
cases:0.11%
controls:0.02%
cases:0.48%
controls:0.09%
cases:0.85%
controls:0.25%
38
135
8752
87607
31
74
8760
87673
8
12
8783
87735
5
0
8786
87747
10
15
8773
87593
41
74
8582
85801
66
190
7707
76931
Bilateral foot X-ray examination
NH3DA [2001308279]
1.6e+00
1.9e+00
—
1.0e+50
—
3.1e+00
2.7e+00
cases:0.35%
controls:0.07%
cases:0.17%
controls:0.03%
—
—
cases:0.08%
controls:0.00%
—
—
cases:0.28%
controls:0.01%
cases:0.90%
controls:0.06%
31
64
8759
87678
15
23
8776
87724
—
7
0
8784
87747
—
24
11
8599
85864
70
49
7703
77072
SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
26975-3 [3025245]
3.9e-01
1.5e+00
1.9e+00
1.0e+50
3.0e+00
1.9e+00
8.7e-01
cases:0.31%
controls:0.21%
cases:0.40%
controls:0.09%
cases:0.08%
controls:0.01%
cases:0.06%
controls:0.00%
cases:0.18%
controls:0.01%
cases:0.56%
controls:0.09%
cases:0.86%
controls:0.36%
27
182
8763
87560
35
80
8756
87667
7
10
8784
87737
5
0
8786
87747
16
8
8767
87600
48
74
8575
85801
67
281
7706
76840
Prurigo nodularis
L28.1 [45577033]
1.6e+00
2.4e+00
—
1.0e+50
—
2.6e+00
2.6e+00
cases:0.14%
controls:0.03%
cases:0.15%
controls:0.01%
—
—
cases:0.08%
controls:0.00%
—
—
cases:0.24%
controls:0.02%
cases:0.45%
controls:0.03%
12
25
8778
87717
13
12
8778
87735
—
7
0
8784
87747
—
21
16
8602
85859
35
26
7738
77095
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
3.9e-01
8.4e-01
1.7e+00
3.2e+00
1.3e+00
8.8e-01
7.2e-01
cases:17.34%
controls:12.47%
cases:13.57%
controls:6.36%
cases:4.72%
controls:0.88%
cases:0.65%
controls:0.03%
cases:3.24%
controls:0.86%
cases:14.14%
controls:6.41%
cases:29.63%
controls:17.06%
1524
10941
7266
76801
1193
5580
7598
82167
415
769
8376
86978
57
23
8734
87724
285
757
8498
86851
1219
5501
7404
80374
2303
13154
5470
63967
hydroxyzine; oral, parenteral
N05BB01 [21604590]
8.1e-01
1.5e+00
2.1e+00
—
2.0e+00
1.5e+00
1.1e+00
cases:3.50%
controls:1.58%
cases:2.74%
controls:0.60%
cases:0.96%
controls:0.12%
—
—
cases:0.76%
controls:0.11%
cases:2.54%
controls:0.57%
cases:4.34%
controls:1.44%
308
1389
8482
86353
241
527
8550
87220
84
105
8707
87642
—
67
92
8716
87516
219
490
8404
85385
337
1114
7436
76007
Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
35333-4 [3036086]
4.9e-01
1.4e+00
1.9e+00
—
2.7e+00
2.0e+00
9.7e-01
cases:0.36%
controls:0.22%
cases:0.39%
controls:0.09%
cases:0.08%
controls:0.01%
—
—
cases:0.17%
controls:0.01%
cases:0.61%
controls:0.09%
cases:0.94%
controls:0.36%
32
196
8758
87546
34
81
8757
87666
7
10
8784
87737
—
15
10
8768
87598
53
73
8570
85802
73
277
7700
76844
Seronegative rheumatoid arthritis
M06.0 [45577103]
1.3e+00
1.5e+00
1.8e+00
—
2.0e+00
1.3e+00
1.2e+00
cases:0.93%
controls:0.25%
cases:0.71%
controls:0.16%
cases:0.23%
controls:0.04%
—
—
cases:0.28%
controls:0.04%
cases:0.67%
controls:0.18%
cases:0.84%
controls:0.26%
82
219
8708
87523
62
144
8729
87603
20
34
8771
87713
—
25
35
8758
87573
58
153
8565
85722
65
201
7708
76920
Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
71792-6 [42869547]
9.5e-01
1.8e+00
—
1.0e+50
—
3.8e+00
3.4e+00
cases:0.08%
controls:0.03%
cases:0.08%
controls:0.01%
—
—
cases:0.09%
controls:0.00%
—
—
cases:0.46%
controls:0.01%
cases:1.13%
controls:0.04%
7
27
8783
87715
7
11
8784
87736
—
8
0
8783
87747
—
40
9
8583
85866
88
30
7685
77091
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
TNH11 [2001308401]
1.5e+00
2.5e+00
—
—
—
2.9e+00
2.1e+00
cases:0.24%
controls:0.05%
cases:0.16%
controls:0.01%
—
—
—
—
—
—
cases:0.16%
controls:0.01%
cases:0.42%
controls:0.05%
21
46
8769
87696
14
11
8777
87736
—
—
—
14
8
8609
85867
33
42
7740
77079
HIV disease resulting in (persistent) generalized lymphadenopathy
B23.1 [45532868]
1.3e+00
1.4e+00
—
—
2.5e+00
1.7e+00
2.0e+00
cases:0.16%
controls:0.04%
cases:0.15%
controls:0.04%
—
—
—
—
cases:0.13%
controls:0.01%
cases:0.20%
controls:0.04%
cases:0.30%
controls:0.04%
14
39
8776
87703
13
33
8778
87714
—
—
11
9
8772
87599
17
31
8606
85844
23
31
7750
77090
Inpatient Hospital
21 [8717]
3.1e-01
4.9e-01
9.3e-01
4.7e+00
1.1e+00
6.3e-01
5.8e-01
cases:34.80%
controls:28.18%
cases:13.84%
controls:8.93%
cases:2.89%
controls:1.16%
cases:4.77%
controls:0.05%
cases:3.30%
controls:1.09%
cases:14.54%
controls:8.32%
cases:34.44%
controls:22.75%
3059
24726
5731
63016
1217
7838
7574
79909
254
1021
8537
86726
419
40
8372
87707
290
958
8493
86650
1254
7147
7369
78728
2677
17547
5096
59574
Ankylosing spondylitis
M45 [45591841]
1.2e+00
1.5e+00
1.7e+00
—
1.5e+00
1.5e+00
1.4e+00
cases:1.02%
controls:0.32%
cases:0.83%
controls:0.18%
cases:0.18%
controls:0.03%
—
—
cases:0.22%
controls:0.05%
cases:0.85%
controls:0.19%
cases:1.18%
controls:0.30%
90
279
8700
87463
73
161
8718
87586
16
30
8775
87717
—
19
43
8764
87565
73
164
8550
85711
92
234
7681
76887
Asthma, unspecified
J45.9 [45562456]
4.1e-01
4.4e-01
6.6e-01
4.4e+00
1.3e+00
8.4e-01
5.8e-01
cases:3.32%
controls:2.23%
cases:1.73%
controls:1.12%
cases:0.36%
controls:0.19%
cases:0.81%
controls:0.01%
cases:0.64%
controls:0.18%
cases:2.46%
controls:1.07%
cases:5.34%
controls:3.05%
292
1960
8498
85782
152
986
8639
86761
32
165
8759
87582
71
9
8720
87738
56
157
8727
87451
212
922
8411
84953
415
2353
7358
74768
prednisolone; oral, parenteral
H02AB06 [21602734]
7.4e-01
1.0e+00
1.1e+00
2.7e+00
1.2e+00
9.7e-01
8.2e-01
cases:15.78%
controls:8.24%
cases:9.59%
controls:3.65%
cases:1.91%
controls:0.62%
cases:0.30%
controls:0.02%
cases:1.90%
controls:0.60%
cases:8.88%
controls:3.57%
cases:18.81%
controls:9.23%
1387
7226
7403
80516
843
3199
7948
84548
168
547
8623
87200
26
17
8765
87730
167
527
8616
87081
766
3069
7857
82806
1462
7119
6311
70002
prednisolone
A07EA01 [21600653]
7.3e-01
1.0e+00
1.1e+00
2.7e+00
1.2e+00
9.7e-01
8.3e-01
cases:15.84%
controls:8.28%
cases:9.61%
controls:3.66%
cases:1.92%
controls:0.63%
cases:0.30%
controls:0.02%
cases:1.90%
controls:0.60%
cases:8.93%
controls:3.59%
cases:18.94%
controls:9.28%
1392
7267
7398
80475
845
3213
7946
84534
169
549
8622
87198
26
17
8765
87730
167
530
8616
87078
770
3082
7853
82793
1472
7156
6301
69965
Foot and toes X-ray examination
NH3AA [2001308267]
8.2e-01
1.3e+00
1.8e+00
—
1.7e+00
1.8e+00
1.2e+00
cases:1.46%
controls:0.65%
cases:0.72%
controls:0.20%
cases:0.13%
controls:0.02%
—
—
cases:0.14%
controls:0.03%
cases:1.04%
controls:0.17%
cases:2.50%
controls:0.76%
128
570
8662
87172
63
178
8728
87569
11
19
8780
87728
—
12
22
8771
87586
90
150
8533
85725
194
587
7579
76534
Ulcerative colitis, unspecified
K51.9 [45605941]
1.2e+00
1.3e+00
1.4e+00
1.0e+50
2.1e+00
1.3e+00
1.1e+00
cases:0.81%
controls:0.26%
cases:0.49%
controls:0.13%
cases:0.13%
controls:0.03%
cases:0.13%
controls:0.00%
cases:0.16%
controls:0.02%
cases:0.50%
controls:0.13%
cases:0.91%
controls:0.30%
71
224
8719
87518
43
114
8748
87633
11
26
8780
87721
11
0
8780
87747
14
17
8769
87591
43
112
8580
85763
71
233
7702
76888
certolizumab pegol; parenteral
L04AB05 [21603912]
1.9e+00
2.2e+00
—
—
—
1.7e+00
2.6e+00
cases:0.18%
controls:0.03%
cases:0.19%
controls:0.02%
—
—
—
—
—
—
cases:0.13%
controls:0.02%
cases:0.27%
controls:0.02%
16
23
8774
87719
17
19
8774
87728
—
—
—
11
20
8612
85855
21
15
7752
77106
Lichen simplex chronicus
L28.0 [45577032]
1.9e+00
2.5e+00
—
1.0e+50
—
2.4e+00
1.6e+00
cases:0.34%
controls:0.05%
cases:0.23%
controls:0.02%
—
—
cases:0.19%
controls:0.00%
—
—
cases:0.21%
controls:0.02%
cases:0.31%
controls:0.06%
30
45
8760
87697
20
16
8771
87731
—
17
0
8774
87747
—
18
17
8605
85858
24
49
7749
77072
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]
7.6e-01
1.5e+00
2.2e+00
—
1.8e+00
1.2e+00
8.5e-01
cases:4.15%
controls:1.98%
cases:3.01%
controls:0.67%
cases:0.66%
controls:0.07%
—
—
cases:0.50%
controls:0.08%
cases:2.28%
controls:0.71%
cases:6.07%
controls:2.68%
365
1735
8425
86007
265
588
8526
87159
58
62
8733
87685
—
44
73
8739
87535
197
613
8426
85262
472
2070
7301
75051
Allergic contact dermatitis due to metals
L23.0 [45557699]
1.1e+00
1.8e+00
—
1.0e+50
—
3.5e+00
2.0e+00
cases:0.16%
controls:0.05%
cases:0.10%
controls:0.02%
—
—
cases:0.16%
controls:0.00%
—
—
cases:0.34%
controls:0.01%
cases:0.39%
controls:0.05%
14
48
8776
87694
9
15
8782
87732
—
14
0
8777
87747
—
29
9
8594
85866
30
40
7743
77081
Puncture of knee
TNG10 [2001308221]
2.0e+00
2.2e+00
—
—
—
1.9e+00
2.2e+00
cases:0.34%
controls:0.05%
cases:0.13%
controls:0.01%
—
—
—
—
—
—
cases:0.13%
controls:0.02%
cases:0.42%
controls:0.05%
30
42
8760
87700
11
12
8780
87735
—
—
—
11
16
8612
85859
33
36
7740
77085
Normoblasts [#/volume] in Blood
715-3 [3021589]
2.9e-01
5.4e-01
1.3e+00
2.8e+00
1.4e+00
9.8e-01
9.0e-01
cases:8.11%
controls:6.17%
cases:8.04%
controls:4.87%
cases:4.05%
controls:1.12%
cases:0.96%
controls:0.06%
cases:4.05%
controls:1.03%
cases:12.06%
controls:4.90%
cases:20.75%
controls:9.59%
713
5415
8077
82327
707
4270
8084
83477
356
984
8435
86763
84
50
8707
87697
356
900
8427
86708
1040
4210
7583
81665
1613
7394
6160
69727
Sacro-iliac joint MRI examination with high intensity magnet
NA6BG [2001307059]
1.1e+00
2.0e+00
—
—
—
2.8e+00
2.4e+00
cases:0.24%
controls:0.08%
cases:0.15%
controls:0.02%
—
—
—
—
—
—
cases:0.27%
controls:0.02%
cases:0.64%
controls:0.06%
21
69
8769
87673
13
18
8778
87729
—
—
—
23
14
8600
85861
50
47
7723
77074
Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
53017-0 [3041067]
2.9e-01
1.7e+00
—
—
2.9e+00
2.4e+00
1.2e+00
cases:0.14%
controls:0.10%
cases:0.24%
controls:0.04%
—
—
—
—
cases:0.10%
controls:0.01%
cases:0.32%
controls:0.03%
cases:0.40%
controls:0.12%
12
90
8778
87652
21
37
8770
87710
—
—
9
5
8774
87603
28
25
8595
85850
31
94
7742
77027
secukinumab; parenteral
L04AC10 [40253794]
3.1e+00
—
—
—
1.0e+50
—
5.2e+00
cases:0.17%
controls:0.01%
—
—
—
—
—
—
cases:0.19%
controls:0.00%
—
—
cases:1.34%
controls:0.01%
15
7
8775
87735
—
—
—
17
0
8766
87608
—
104
6
7669
77115
Rheumatoid/seropositive arthritis
L88 [2002000707]
1.4e+00
1.6e+00
1.2e+00
—
1.5e+00
2.0e+00
1.8e+00
cases:1.05%
controls:0.27%
cases:0.58%
controls:0.12%
cases:0.09%
controls:0.03%
—
—
cases:0.16%
controls:0.04%
cases:0.83%
controls:0.12%
cases:2.07%
controls:0.35%
92
238
8698
87504
51
103
8740
87644
8
25
8783
87722
—
14
31
8769
87577
72
102
8551
85773
161
270
7612
76851
Gastroenterology
10 [38004455]
5.6e-01
7.7e-01
1.1e+00
2.9e+00
1.2e+00
9.3e-01
7.4e-01
cases:6.53%
controls:3.83%
cases:3.77%
controls:1.78%
cases:1.06%
controls:0.36%
cases:0.24%
controls:0.01%
cases:1.16%
controls:0.34%
cases:4.38%
controls:1.78%
cases:9.65%
controls:4.84%
574
3358
8216
84384
331
1562
8460
86185
93
318
8698
87429
21
12
8770
87735
102
302
8681
87306
378
1528
8245
84347
750
3731
7023
73390
Internal Medicine
11 [38004456]
3.9e-01
5.8e-01
9.0e-01
3.9e+00
9.8e-01
7.2e-01
6.4e-01
cases:24.88%
controls:18.37%
cases:12.76%
controls:7.60%
cases:3.17%
controls:1.32%
cases:2.37%
controls:0.05%
cases:3.22%
controls:1.23%
cases:14.28%
controls:7.53%
cases:29.82%
controls:18.26%
2187
16119
6603
71623
1122
6669
7669
81078
279
1154
8512
86593
208
41
8583
87706
283
1077
8500
86531
1231
6463
7392
79412
2318
14086
5455
63035
Acne vulgaris
L70.0 [45581958]
5.0e-01
1.3e+00
2.4e+00
—
2.1e+00
1.5e+00
8.2e-01
cases:0.28%
controls:0.17%
cases:0.24%
controls:0.07%
cases:0.09%
controls:0.01%
—
—
cases:0.11%
controls:0.01%
cases:0.32%
controls:0.07%
cases:0.46%
controls:0.20%
25
151
8765
87591
21
59
8770
87688
8
7
8783
87740
—
10
12
8773
87596
28
63
8595
85812
36
157
7737
76964
hydrocortisone and antiinfectives
S03CA04 [21605208]
8.2e-01
1.5e+00
1.8e+00
—
2.1e+00
1.1e+00
8.2e-01
cases:3.63%
controls:1.63%
cases:2.02%
controls:0.46%
cases:0.32%
controls:0.05%
—
—
cases:0.44%
controls:0.05%
cases:1.50%
controls:0.52%
cases:3.90%
controls:1.75%
319
1427
8471
86315
178
401
8613
87346
28
46
8763
87701
—
39
47
8744
87561
129
450
8494
85425
303
1351
7470
75770
hydrocortisone and antiinfectives
S02CA03 [21605175]
8.2e-01
1.5e+00
1.8e+00
—
2.1e+00
1.1e+00
8.2e-01
cases:3.63%
controls:1.63%
cases:2.02%
controls:0.46%
cases:0.32%
controls:0.05%
—
—
cases:0.44%
controls:0.05%
cases:1.50%
controls:0.52%
cases:3.90%
controls:1.75%
319
1427
8471
86315
178
401
8613
87346
28
46
8763
87701
—
39
47
8744
87561
129
450
8494
85425
303
1351
7470
75770
Psoralen - Ultraviolet A therapy with local sensitivisation
WXQ12 [2001310156]
3.1e+00
—
—
1.0e+50
—
5.0e+00
—
cases:0.13%
controls:0.01%
—
—
—
—
cases:0.24%
controls:0.00%
—
—
cases:0.88%
controls:0.01%
—
—
11
5
8779
87737
—
—
21
0
8770
87747
—
76
5
8547
85870
—
Injection of diagnostic or therapeutic substance in joint, wrist or hand
TND11 [2001307783]
1.7e+00
2.1e+00
—
—
—
2.4e+00
2.0e+00
cases:0.34%
controls:0.06%
cases:0.17%
controls:0.02%
—
—
—
—
—
—
cases:0.22%
controls:0.02%
cases:0.50%
controls:0.07%
30
53
8760
87689
15
19
8776
87728
—
—
—
19
18
8604
85857
39
55
7734
77066
antibiotics in combination with other drugs
S01AA20 [21603571]
4.2e-01
6.7e-01
1.1e+00
3.6e+00
1.2e+00
6.8e-01
4.1e-01
cases:8.11%
controls:5.46%
cases:3.28%
controls:1.70%
cases:0.52%
controls:0.18%
cases:0.20%
controls:0.01%
cases:0.60%
controls:0.18%
cases:3.47%
controls:1.79%
cases:9.57%
controls:6.55%
713
4789
8077
82953
288
1494
8503
86253
46
154
8745
87593
18
5
8773
87742
53
158
8730
87450
299
1539
8324
84336
744
5049
7029
72072
Sleep apnoea
G47.3 [45562094]
5.4e-01
5.5e-01
8.1e-01
3.8e+00
8.1e-01
7.4e-01
7.0e-01
cases:5.95%
controls:3.56%
cases:4.04%
controls:2.37%
cases:1.06%
controls:0.48%
cases:0.92%
controls:0.02%
cases:1.10%
controls:0.49%
cases:4.92%
controls:2.41%
cases:9.33%
controls:4.88%
523
3127
8267
84615
355
2077
8436
85670
93
417
8698
87330
81
18
8710
87729
97
433
8686
87175
424
2069
8199
83806
725
3763
7048
73358
Crystals [Presence] in Synovial fluid by Light microscopy
38458-6 [3050238]
1.0e+00
1.6e+00
2.1e+00
1.0e+50
1.5e+00
2.0e+00
1.2e+00
cases:0.81%
controls:0.29%
cases:0.41%
controls:0.08%
cases:0.10%
controls:0.01%
cases:0.08%
controls:0.00%
cases:0.06%
controls:0.01%
cases:0.53%
controls:0.08%
cases:1.29%
controls:0.39%
71
255
8719
87487
36
70
8755
87677
9
11
8782
87736
7
0
8784
87747
5
11
8778
87597
46
65
8577
85810
100
299
7673
76822
Pauciarticular juvenile arthritis
M08.4 [45582020]
2.0e+00
1.9e+00
—
—
—
2.0e+00
2.0e+00
cases:0.32%
controls:0.04%
cases:0.20%
controls:0.03%
—
—
—
—
—
—
cases:0.17%
controls:0.02%
cases:0.26%
controls:0.04%
28
37
8762
87705
18
27
8773
87720
—
—
—
15
20
8608
85855
20
27
7753
77094
Tissue Pathology biopsy report
66121-5 [40768804]
2.2e-01
7.0e-01
6.9e-01
4.8e+00
7.9e-01
3.6e-01
4.2e-01
cases:7.06%
controls:5.76%
cases:4.07%
controls:2.07%
cases:0.51%
controls:0.26%
cases:0.66%
controls:0.01%
cases:0.41%
controls:0.19%
cases:2.64%
controls:1.87%
cases:9.04%
controls:6.11%
621
5052
8169
82690
358
1815
8433
85932
45
226
8746
87521
58
5
8733
87742
36
164
8747
87444
228
1604
8395
84271
703
4709
7070
72412
Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
53019-6 [3041423]
3.3e-01
1.5e+00
—
—
2.8e+00
2.4e+00
1.2e+00
cases:0.13%
controls:0.09%
cases:0.17%
controls:0.04%
—
—
—
—
cases:0.09%
controls:0.01%
cases:0.29%
controls:0.03%
cases:0.35%
controls:0.11%
11
79
8779
87663
15
33
8776
87714
—
—
8
5
8775
87603
25
23
8598
85852
27
83
7746
77038
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
6.3e-01
7.0e-01
7.6e-01
3.3e+00
1.0e+00
7.5e-01
6.8e-01
cases:1.92%
controls:1.04%
cases:1.29%
controls:0.64%
cases:0.31%
controls:0.14%
cases:0.34%
controls:0.01%
cases:0.39%
controls:0.14%
cases:1.45%
controls:0.69%
cases:3.02%
controls:1.55%
169
910
8621
86832
113
565
8678
87182
27
126
8764
87621
30
11
8761
87736
34
124
8749
87484
125
595
8498
85280
235
1197
7538
75924
Granulocytes [#/volume] in Blood
30394-1 [3035715]
6.4e-01
1.2e+00
2.5e+00
—
1.6e+00
1.8e+00
1.7e+00
cases:0.60%
controls:0.32%
cases:0.31%
controls:0.09%
cases:0.15%
controls:0.01%
—
—
cases:0.08%
controls:0.02%
cases:0.37%
controls:0.06%
cases:1.00%
controls:0.18%
53
279
8737
87463
27
82
8764
87665
13
11
8778
87736
—
7
14
8776
87594
32
53
8591
85822
78
141
7695
76980
Fungus identified in Specimen by Culture
580-1 [3000494]
7.8e-01
1.6e+00
1.7e+00
—
1.6e+00
1.2e+00
8.9e-01
cases:2.96%
controls:1.38%
cases:2.24%
controls:0.46%
cases:0.35%
controls:0.06%
—
—
cases:0.27%
controls:0.06%
cases:1.67%
controls:0.52%
cases:4.44%
controls:1.88%
260
1209
8530
86533
197
406
8594
87341
31
55
8760
87692
—
24
49
8759
87559
144
444
8479
85431
345
1449
7428
75672
Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 [3021614]
7.4e-01
1.4e+00
1.9e+00
—
1.6e+00
1.2e+00
8.2e-01
cases:4.54%
controls:2.23%
cases:3.07%
controls:0.74%
cases:0.61%
controls:0.09%
—
—
cases:0.47%
controls:0.09%
cases:2.48%
controls:0.76%
cases:6.42%
controls:2.92%
399
1953
8391
85789
270
652
8521
87095
54
80
8737
87667
—
41
80
8742
87528
214
656
8409
85219
499
2254
7274
74867
Other ultrasound examination
XX9XE [2001311056]
1.8e+00
1.8e+00
—
—
—
1.8e+00
2.3e+00
cases:0.20%
controls:0.04%
cases:0.08%
controls:0.01%
—
—
—
—
—
—
cases:0.12%
controls:0.02%
cases:0.18%
controls:0.02%
18
31
8772
87711
7
11
8784
87736
—
—
—
10
16
8613
85859
14
14
7759
77107
Short blood count panel - Blood
55429-5 [40758558]
1.8e-01
5.1e-01
9.9e-01
3.0e+00
1.3e+00
8.7e-01
8.7e-01
cases:4.63%
controls:3.89%
cases:3.44%
controls:2.09%
cases:1.23%
controls:0.46%
cases:0.53%
controls:0.03%
cases:1.49%
controls:0.42%
cases:4.38%
controls:1.89%
cases:10.95%
controls:4.89%
407
3417
8383
84325
302
1836
8489
85911
108
404
8683
87343
47
23
8744
87724
131
364
8652
87244
378
1623
8245
84252
851
3770
6922
73351
Emergency Room Visit
ER [9203]
3.6e-01
4.9e-01
9.1e-01
4.3e+00
5.6e-01
5.5e-01
5.2e-01
cases:36.06%
controls:28.23%
cases:15.02%
controls:9.74%
cases:2.88%
controls:1.18%
cases:2.59%
controls:0.04%
cases:2.11%
controls:1.21%
cases:15.16%
controls:9.34%
cases:38.90%
controls:27.50%
3170
24771
5620
62971
1320
8544
7471
79203
253
1032
8538
86715
228
31
8563
87716
185
1062
8598
86546
1307
8024
7316
77851
3024
21210
4749
55911
Pruritus, unspecified
L29.9 [45548195]
9.4e-01
1.8e+00
—
1.0e+50
2.7e+00
1.6e+00
7.1e-01
cases:0.31%
controls:0.12%
cases:0.27%
controls:0.05%
—
—
cases:0.16%
controls:0.00%
cases:0.10%
controls:0.01%
cases:0.23%
controls:0.05%
cases:0.37%
controls:0.18%
27
105
8763
87637
24
40
8767
87707
—
14
0
8777
87747
9
6
8774
87602
20
42
8603
85833
29
142
7744
76979
Other infective otitis externa
H60.3 [45576803]
1.2e+00
1.9e+00
2.1e+00
—
—
1.5e+00
1.0e+00
cases:0.35%
controls:0.11%
cases:0.24%
controls:0.04%
cases:0.07%
controls:0.01%
—
—
—
—
cases:0.22%
controls:0.05%
cases:0.45%
controls:0.16%
31
94
8759
87648
21
33
8770
87714
6
7
8785
87740
—
—
19
44
8604
85831
35
123
7738
76998
Rash and other nonspecific skin eruption
R21 [45553721]
1.0e+00
2.2e+00
2.9e+00
1.0e+50
—
8.7e-01
6.5e-01
cases:0.67%
controls:0.24%
cases:0.69%
controls:0.08%
cases:0.19%
controls:0.01%
cases:0.06%
controls:0.00%
—
—
cases:0.22%
controls:0.09%
cases:0.64%
controls:0.34%
59
209
8731
87533
61
69
8730
87678
17
9
8774
87738
5
0
8786
87747
—
19
79
8604
85796
50
259
7723
76862
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
4.3e-01
5.6e-01
6.9e-01
3.7e+00
9.6e-01
6.8e-01
5.4e-01
cases:5.51%
controls:3.64%
cases:3.47%
controls:2.02%
cases:0.71%
controls:0.35%
cases:1.19%
controls:0.03%
cases:1.04%
controls:0.40%
cases:4.19%
controls:2.16%
cases:8.90%
controls:5.41%
484
3194
8306
84548
305
1771
8486
85976
62
311
8729
87436
105
25
8686
87722
91
351
8692
87257
361
1851
8262
84024
692
4170
7081
72951
Other obesity
E66.8 [45533036]
7.6e-01
8.5e-01
6.7e-01
3.2e+00
1.0e+00
8.1e-01
9.5e-01
cases:1.10%
controls:0.52%
cases:0.63%
controls:0.27%
cases:0.13%
controls:0.06%
cases:0.14%
controls:0.01%
cases:0.18%
controls:0.06%
cases:0.65%
controls:0.29%
cases:1.75%
controls:0.68%
97
455
8693
87287
55
235
8736
87512
11
56
8780
87691
12
5
8779
87742
16
56
8767
87552
56
250
8567
85625
136
527
7637
76594
Pulmonary Disease
29 [38004472]
4.8e-01
5.3e-01
9.1e-01
3.4e+00
7.7e-01
7.5e-01
7.4e-01
cases:10.84%
controls:7.01%
cases:6.27%
controls:3.79%
cases:1.69%
controls:0.69%
cases:0.68%
controls:0.02%
cases:1.55%
controls:0.72%
cases:7.42%
controls:3.64%
cases:15.49%
controls:8.05%
953
6147
7837
81595
551
3328
8240
84419
149
605
8642
87142
60
20
8731
87727
136
633
8647
86975
640
3128
7983
82747
1204
6210
6569
70911
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
3.9e-01
6.3e-01
1.5e+00
—
2.3e+00
1.5e+00
1.3e+00
cases:1.48%
controls:1.01%
cases:0.69%
controls:0.37%
cases:0.15%
controls:0.03%
—
—
cases:0.36%
controls:0.04%
cases:1.54%
controls:0.34%
cases:3.85%
controls:1.11%
130
887
8660
86855
61
326
8730
87421
13
30
8778
87717
—
32
32
8751
87576
133
296
8490
85579
299
855
7474
76266
inFLIXimab Ab [Units/volume] in Serum by Immunoassay
90780-8 [1175556]
1.7e+00
2.0e+00
—
—
—
1.9e+00
1.9e+00
cases:0.26%
controls:0.05%
cases:0.22%
controls:0.03%
—
—
—
—
—
—
cases:0.16%
controls:0.02%
cases:0.30%
controls:0.04%
23
43
8767
87699
19
25
8772
87722
—
—
—
14
21
8609
85854
23
33
7750
77088
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
5.2e-01
9.0e-01
1.6e+00
—
2.2e+00
1.4e+00
8.8e-01
cases:0.94%
controls:0.57%
cases:0.42%
controls:0.17%
cases:0.13%
controls:0.03%
—
—
cases:0.19%
controls:0.02%
cases:0.81%
controls:0.20%
cases:1.44%
controls:0.61%
83
496
8707
87246
37
151
8754
87596
11
22
8780
87725
—
17
19
8766
87589
70
170
8553
85705
112
467
7661
76654
Other psoriatic arthropathies
M07.3*L40.5 [2000503010]
—
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
7.5e+00
—
—
—
—
cases:1.23%
controls:0.00%
cases:1.43%
controls:0.00%
cases:1.50%
controls:0.00%
cases:7.31%
controls:0.00%
cases:11.89%
controls:0.01%
—
—
108
0
8683
87747
126
0
8665
87747
132
0
8651
87608
630
0
7993
85875
924
6
6849
77115
flucloxacillin; oral, parenteral
J01CF05 [21602857]
6.6e-01
1.4e+00
1.6e+00
—
2.2e+00
9.9e-01
5.7e-01
cases:0.64%
controls:0.33%
cases:0.53%
controls:0.13%
cases:0.09%
controls:0.02%
—
—
cases:0.13%
controls:0.01%
cases:0.42%
controls:0.15%
cases:1.31%
controls:0.75%
56
289
8734
87453
47
116
8744
87631
8
16
8783
87731
—
11
12
8772
87596
36
133
8587
85742
102
575
7671
76546
Measles virus Ab [Titer] in Serum
22499-8 [3009871]
1.5e+00
—
—
—
1.0e+50
3.4e+00
2.6e+00
cases:0.16%
controls:0.04%
—
—
—
—
—
—
cases:0.15%
controls:0.00%
cases:0.30%
controls:0.01%
cases:0.48%
controls:0.04%
14
31
8776
87711
—
—
—
13
0
8770
87608
26
9
8597
85866
37
28
7736
77093
Physical Medicine And Rehabilitation
25 [38004468]
3.9e-01
6.4e-01
6.7e-01
3.4e+00
8.3e-01
8.2e-01
6.6e-01
cases:7.69%
controls:5.36%
cases:3.63%
controls:1.94%
cases:0.68%
controls:0.35%
cases:0.32%
controls:0.01%
cases:0.85%
controls:0.37%
cases:4.36%
controls:1.98%
cases:10.99%
controls:6.02%
676
4700
8114
83042
319
1706
8472
86041
60
306
8731
87441
28
9
8763
87738
75
328
8708
87280
376
1698
8247
84177
854
4642
6919
72479
Bacteria identified in Blood by Culture
600-7 [3023368]
3.6e-01
4.0e-01
9.4e-01
3.2e+00
1.1e+00
7.4e-01
6.1e-01
cases:4.04%
controls:2.84%
cases:2.01%
controls:1.36%
cases:0.49%
controls:0.19%
cases:0.20%
controls:0.01%
cases:0.49%
controls:0.17%
cases:2.69%
controls:1.30%
cases:7.63%
controls:4.31%
355
2492
8435
85250
177
1191
8614
86556
43
168
8748
87579
18
7
8773
87740
43
146
8740
87462
232
1115
8391
84760
593
3322
7180
73799
cetirizine; oral
R06AE07 [21603497]
4.4e-01
7.5e-01
1.0e+00
3.3e+00
8.0e-01
5.8e-01
5.2e-01
cases:11.18%
controls:7.47%
cases:6.90%
controls:3.39%
cases:1.46%
controls:0.53%
cases:0.36%
controls:0.01%
cases:1.16%
controls:0.53%
cases:5.94%
controls:3.41%
cases:11.42%
controls:7.15%
983
6552
7807
81190
607
2979
8184
84768
128
469
8663
87278
32
12
8759
87735
102
461
8681
87147
512
2929
8111
82946
888
5511
6885
71610
Patch test
41778007 [4218642]
8.3e-01
2.2e+00
—
1.0e+50
—
3.0e+00
1.4e+00
cases:0.56%
controls:0.25%
cases:0.58%
controls:0.07%
—
—
cases:0.55%
controls:0.00%
—
—
cases:1.00%
controls:0.05%
cases:1.02%
controls:0.25%
49
215
8741
87527
51
58
8740
87689
—
48
0
8743
87747
—
86
45
8537
85830
79
191
7694
76930
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
3.2e-01
4.7e-01
1.5e+00
3.1e+00
9.5e-01
6.5e-01
4.0e-01
cases:5.22%
controls:3.84%
cases:2.95%
controls:1.86%
cases:1.01%
controls:0.23%
cases:0.13%
controls:0.01%
cases:0.67%
controls:0.26%
cases:3.63%
controls:1.94%
cases:8.80%
controls:6.06%
459
3368
8331
84374
259
1628
8532
86119
89
202
8702
87545
11
5
8780
87742
59
228
8724
87380
313
1663
8310
84212
684
4671
7089
72450
Essential (primary) hypertension
I10 [45591453]
2.7e-01
4.2e-01
6.3e-01
4.2e+00
9.5e-01
4.9e-01
4.3e-01
cases:15.05%
controls:11.90%
cases:8.92%
controls:6.07%
cases:1.84%
controls:0.99%
cases:3.50%
controls:0.06%
cases:2.63%
controls:1.04%
cases:9.97%
controls:6.33%
cases:23.89%
controls:16.97%
1323
10438
7467
77304
784
5325
8007
82422
162
872
8629
86875
308
49
8483
87698
231
907
8552
86701
860
5438
7763
80437
1857
13090
5916
64031
Infectious Disease
44 [38004484]
4.8e-01
1.0e+00
1.9e+00
—
1.8e+00
1.2e+00
9.5e-01
cases:2.04%
controls:1.27%
cases:1.42%
controls:0.51%
cases:0.51%
controls:0.07%
—
—
cases:0.47%
controls:0.08%
cases:1.57%
controls:0.50%
cases:3.47%
controls:1.37%
179
1115
8611
86627
125
444
8666
87303
45
65
8746
87682
—
41
70
8742
87538
135
426
8488
85449
270
1057
7503
76064
Atopic dermatitis
L20 [45557698]
1.1e+00
1.6e+00
2.1e+00
—
2.5e+00
4.2e-01
3.9e-01
cases:0.63%
controls:0.21%
cases:0.47%
controls:0.09%
cases:0.07%
controls:0.01%
—
—
cases:0.08%
controls:0.01%
cases:0.15%
controls:0.10%
cases:0.44%
controls:0.30%
55
183
8735
87559
41
82
8750
87665
6
7
8785
87740
—
7
6
8776
87602
13
85
8610
85790
34
229
7739
76892
terbinafine; ointment
D01AE15 [21601954]
7.5e-01
1.7e+00
1.1e+00
1.0e+50
2.7e+00
1.5e+00
6.4e-01
cases:1.41%
controls:0.67%
cases:0.86%
controls:0.16%
cases:0.07%
controls:0.02%
cases:0.08%
controls:0.00%
cases:0.27%
controls:0.02%
cases:0.74%
controls:0.17%
cases:1.29%
controls:0.68%
124
591
8666
87151
76
137
8715
87610
6
20
8785
87727
7
0
8784
87747
24
16
8759
87592
64
147
8559
85728
100
527
7673
76594
U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
59026-5 [40762119]
1.8e-01
1.5e+00
—
—
3.0e+00
1.7e+00
1.0e+00
cases:0.17%
controls:0.14%
cases:0.22%
controls:0.05%
—
—
—
—
cases:0.14%
controls:0.01%
cases:0.31%
controls:0.05%
cases:0.57%
controls:0.20%
15
125
8775
87617
19
43
8772
87704
—
—
12
6
8771
87602
27
47
8596
85828
44
156
7729
76965
Tinea pedis
B35.3 [45581158]
5.3e-01
1.6e+00
—
1.0e+50
3.4e+00
1.6e+00
5.6e-01
cases:0.49%
controls:0.29%
cases:0.47%
controls:0.09%
—
—
cases:0.35%
controls:0.00%
cases:0.17%
controls:0.01%
cases:0.51%
controls:0.10%
cases:0.69%
controls:0.40%
43
253
8747
87489
41
80
8750
87667
—
31
0
8760
87747
15
5
8768
87603
44
86
8579
85789
54
306
7719
76815
inFLIXimab [Mass/volume] in Serum or Plasma
39803-2 [3042299]
1.6e+00
2.0e+00
—
—
—
1.8e+00
1.8e+00
cases:0.28%
controls:0.06%
cases:0.27%
controls:0.04%
—
—
—
—
—
—
cases:0.20%
controls:0.03%
cases:0.36%
controls:0.06%
25
52
8765
87690
24
32
8767
87715
—
—
—
17
27
8606
85848
28
48
7745
77073
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
4.6e-01
9.4e-01
1.7e+00
—
2.0e+00
1.2e+00
8.2e-01
cases:0.75%
controls:0.47%
cases:0.38%
controls:0.15%
cases:0.10%
controls:0.02%
—
—
cases:0.08%
controls:0.01%
cases:0.36%
controls:0.11%
cases:0.94%
controls:0.42%
66
415
8724
87327
33
129
8758
87618
9
16
8782
87731
—
7
9
8776
87599
31
95
8592
85780
73
322
7700
76799
Seborrhoeic dermatitis, unspecified
L21.9 [45572264]
1.7e+00
2.4e+00
—
1.0e+50
2.0e+00
2.2e+00
8.6e-01
cases:0.50%
controls:0.09%
cases:0.49%
controls:0.05%
—
—
cases:0.19%
controls:0.00%
cases:0.06%
controls:0.01%
cases:0.32%
controls:0.03%
cases:0.35%
controls:0.15%
44
78
8746
87664
43
41
8748
87706
—
17
0
8774
87747
5
7
8778
87601
28
30
8595
85845
27
114
7746
77007
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
326 [2001600287]
1.4e+00
2.3e+00
—
—
—
1.7e+00
1.8e+00
cases:0.25%
controls:0.06%
cases:0.18%
controls:0.02%
—
—
—
—
—
—
cases:0.14%
controls:0.02%
cases:0.40%
controls:0.07%
22
56
8768
87686
16
16
8775
87731
—
—
—
12
21
8611
85854
31
53
7742
77068
Discoid lupus erythematosus
L93.0 [45601250]
1.6e+00
1.7e+00
—
1.0e+50
—
2.1e+00
1.8e+00
cases:0.10%
controls:0.02%
cases:0.11%
controls:0.02%
—
—
cases:0.07%
controls:0.00%
—
—
cases:0.12%
controls:0.01%
cases:0.15%
controls:0.03%
9
19
8781
87723
10
18
8781
87729
—
6
0
8785
87747
—
10
12
8613
85863
12
20
7761
77101
Leukocytes [#/volume] in Synovial fluid
26469-7 [3000475]
1.0e+00
1.5e+00
1.8e+00
1.0e+50
1.7e+00
1.6e+00
1.2e+00
cases:0.71%
controls:0.25%
cases:0.36%
controls:0.08%
cases:0.08%
controls:0.01%
cases:0.14%
controls:0.00%
cases:0.08%
controls:0.01%
cases:0.41%
controls:0.09%
cases:1.14%
controls:0.33%
62
220
8728
87522
32
73
8759
87674
7
11
8784
87736
12
0
8779
87747
7
13
8776
87595
35
74
8588
85801
89
257
7684
76864
Nuclear Ab [Presence] in Serum
8061-4 [3004616]
4.4e-01
1.4e+00
—
—
2.4e+00
2.2e+00
1.1e+00
cases:0.20%
controls:0.13%
cases:0.22%
controls:0.05%
—
—
—
—
cases:0.09%
controls:0.01%
cases:0.34%
controls:0.04%
cases:0.44%
controls:0.15%
18
116
8772
87626
19
47
8772
87700
—
—
8
7
8775
87601
29
31
8594
85844
34
118
7739
77003
Injection of diagnostic or therapeutic substance in knee
TNG11 [2001308222]
1.4e+00
1.9e+00
—
—
—
2.3e+00
1.5e+00
cases:0.15%
controls:0.04%
cases:0.09%
controls:0.01%
—
—
—
—
—
—
cases:0.09%
controls:0.01%
cases:0.21%
controls:0.05%
13
32
8777
87710
8
12
8783
87735
—
—
—
8
8
8615
85867
16
35
7757
77086
Generalized skin eruption due to drugs and medicaments
L27.0 [45538572]
1.3e+00
2.6e+00
—
—
—
3.2e+00
1.0e+00
cases:0.16%
controls:0.04%
cases:0.14%
controls:0.01%
—
—
—
—
—
—
cases:0.17%
controls:0.01%
cases:0.18%
controls:0.07%
14
38
8776
87704
12
9
8779
87738
—
—
—
15
6
8608
85869
14
51
7759
77070
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
3.1e-01
5.7e-01
1.3e+00
2.3e+00
1.1e+00
8.5e-01
7.2e-01
cases:16.99%
controls:13.06%
cases:13.41%
controls:8.04%
cases:5.39%
controls:1.55%
cases:0.60%
controls:0.06%
cases:4.17%
controls:1.46%
cases:17.20%
controls:8.17%
cases:31.65%
controls:18.38%
1493
11457
7297
76285
1179
7054
7612
80693
474
1364
8317
86383
53
56
8738
87691
366
1279
8417
86329
1483
7012
7140
78863
2460
14174
5313
62947
Pain in joint
M25.5 [45586941]
5.9e-01
1.1e+00
1.6e+00
—
1.7e+00
1.2e+00
8.4e-01
cases:5.46%
controls:3.11%
cases:3.47%
controls:1.17%
cases:0.67%
controls:0.13%
—
—
cases:0.82%
controls:0.15%
cases:4.20%
controls:1.33%
cases:9.69%
controls:4.43%
480
2728
8310
85014
305
1029
8486
86718
59
117
8732
87630
—
72
129
8711
87479
362
1140
8261
84735
753
3420
7020
73701
Crohn disease [regional enteritis]
K50 [45755435]
1.4e+00
1.8e+00
—
—
—
2.0e+00
1.9e+00
cases:0.26%
controls:0.06%
cases:0.13%
controls:0.02%
—
—
—
—
—
—
cases:0.09%
controls:0.01%
cases:0.33%
controls:0.05%
23
57
8767
87685
11
18
8780
87729
—
—
—
8
11
8615
85864
26
40
7747
77081
Skin symptom/complaint other
S29 [2002000993]
6.9e-01
1.6e+00
2.1e+00
—
1.4e+00
5.9e-01
6.6e-01
cases:3.20%
controls:1.63%
cases:2.55%
controls:0.53%
cases:0.48%
controls:0.06%
—
—
cases:0.22%
controls:0.05%
cases:1.08%
controls:0.60%
cases:4.43%
controls:2.33%
281
1428
8509
86314
224
466
8567
87281
42
53
8749
87694
—
19
45
8764
87563
93
516
8530
85359
344
1798
7429
75323
Chronic ulcer of skin, not elsewhere classified
L98.4 [45533667]
5.5e-01
1.4e+00
2.3e+00
—
2.9e+00
1.7e+00
9.6e-01
cases:0.16%
controls:0.09%
cases:0.18%
controls:0.05%
cases:0.06%
controls:0.01%
—
—
cases:0.10%
controls:0.01%
cases:0.20%
controls:0.04%
cases:0.37%
controls:0.14%
14
81
8776
87661
16
40
8775
87707
5
5
8786
87742
—
9
5
8774
87603
17
32
8606
85843
29
110
7744
77011
Physiotherapist
Z3226 [2001311560]
5.6e-01
1.0e+00
1.1e+00
—
1.9e+00
1.3e+00
1.0e+00
cases:3.04%
controls:1.75%
cases:1.26%
controls:0.46%
cases:0.20%
controls:0.07%
—
—
cases:0.30%
controls:0.04%
cases:1.48%
controls:0.42%
cases:3.71%
controls:1.40%
267
1537
8523
86205
111
400
8680
87347
18
60
8773
87687
—
26
37
8757
87571
128
362
8495
85513
288
1080
7485
76041
Outpatient Hospital
22 [8756]
2.4e-01
3.8e-01
6.0e-01
3.8e+00
8.6e-01
5.2e-01
4.5e-01
cases:25.87%
controls:21.56%
cases:8.77%
controls:6.18%
cases:1.39%
controls:0.77%
cases:1.35%
controls:0.03%
cases:1.66%
controls:0.71%
cases:9.01%
controls:5.57%
cases:24.62%
controls:17.27%
2274
18913
6516
68829
771
5426
8020
82321
122
675
8669
87072
119
26
8672
87721
146
620
8637
86988
777
4782
7846
81093
1914
13316
5859
63805
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
5.6e-01
1.1e+00
2.2e+00
—
1.3e+00
1.5e+00
1.5e+00
cases:0.64%
controls:0.37%
cases:0.35%
controls:0.12%
cases:0.16%
controls:0.02%
—
—
cases:0.09%
controls:0.02%
cases:0.38%
controls:0.08%
cases:1.05%
controls:0.24%
56
321
8734
87421
31
105
8760
87642
14
15
8777
87732
—
8
21
8775
87587
33
72
8590
85803
82
187
7691
76934
Hypothyroidism, unspecified
E03.9 [45537945]
3.4e-01
2.2e-01
2.5e-01
4.4e+00
9.3e-01
6.2e-01
5.8e-01
cases:1.65%
controls:1.18%
cases:0.72%
controls:0.58%
cases:0.15%
controls:0.12%
cases:0.47%
controls:0.01%
cases:0.30%
controls:0.12%
cases:1.21%
controls:0.65%
cases:3.23%
controls:1.84%
145
1035
8645
86707
63
505
8728
87242
13
101
8778
87646
41
5
8750
87742
26
103
8757
87505
104
561
8519
85314
251
1419
7522
75702
Counselling and guidance which enhance independent living
R2130 [2001310196]
3.1e-01
1.0e+00
1.0e+00
1.0e+50
2.9e+00
1.8e+00
1.2e+00
cases:1.06%
controls:0.78%
cases:0.77%
controls:0.28%
cases:0.14%
controls:0.05%
cases:1.07%
controls:0.00%
cases:0.56%
controls:0.03%
cases:1.74%
controls:0.29%
cases:3.14%
controls:1.00%
93
686
8697
87056
68
248
8723
87499
12
43
8779
87704
94
0
8697
87747
49
28
8734
87580
150
251
8473
85624
244
768
7529
76353
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
6.5e-01
9.6e-01
1.9e+00
—
1.5e+00
1.0e+00
7.6e-01
cases:2.51%
controls:1.33%
cases:1.47%
controls:0.57%
cases:0.44%
controls:0.06%
—
—
cases:0.27%
controls:0.06%
cases:1.44%
controls:0.53%
cases:3.94%
controls:1.88%
221
1166
8569
86576
129
499
8662
87248
39
56
8752
87691
—
24
52
8759
87556
124
457
8499
85418
306
1453
7467
75668
miconazole
D01AC02 [21601921]
9.2e-01
1.7e+00
—
—
2.4e+00
1.1e+00
7.9e-01
cases:2.13%
controls:0.86%
cases:0.99%
controls:0.19%
—
—
—
—
cases:0.19%
controls:0.02%
cases:0.52%
controls:0.17%
cases:1.49%
controls:0.69%
187
756
8603
86986
87
165
8704
87582
—
—
17
16
8766
87592
45
150
8578
85725
116
529
7657
76592
Juvenile rheumatoid arthritis
M08.0 [45586848]
1.4e+00
1.9e+00
—
—
2.3e+00
1.7e+00
1.9e+00
cases:0.11%
controls:0.03%
cases:0.13%
controls:0.02%
—
—
—
—
cases:0.06%
controls:0.01%
cases:0.13%
controls:0.02%
cases:0.24%
controls:0.04%
10
25
8780
87717
11
17
8780
87730
—
—
5
5
8778
87603
11
20
8612
85855
19
29
7754
77092
Crohn disease of small intestine
K50.0 [45596324]
1.3e+00
1.1e+00
1.0e+00
—
1.6e+00
1.4e+00
1.5e+00
cases:0.51%
controls:0.14%
cases:0.28%
controls:0.09%
cases:0.08%
controls:0.03%
—
—
cases:0.10%
controls:0.02%
cases:0.37%
controls:0.10%
cases:0.68%
controls:0.16%
45
125
8745
87617
25
82
8766
87665
7
25
8784
87722
—
9
19
8774
87589
32
82
8591
85793
53
120
7720
77001
desloratadine; oral
R06AX27 [21603526]
3.2e-01
6.7e-01
8.5e-01
3.4e+00
6.9e-01
4.5e-01
3.6e-01
cases:5.57%
controls:4.09%
cases:3.99%
controls:2.09%
cases:0.83%
controls:0.36%
cases:0.25%
controls:0.01%
cases:0.67%
controls:0.34%
cases:3.47%
controls:2.24%
cases:6.99%
controls:4.98%
490
3592
8300
84150
351
1834
8440
85913
73
312
8718
87435
22
7
8769
87740
59
297
8724
87311
299
1922
8324
83953
543
3844
7230
73277
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
64084-7 [40766800]
1.4e+00
7.2e-01
—
—
—
2.6e+00
2.8e+00
cases:0.49%
controls:0.12%
cases:0.09%
controls:0.04%
—
—
—
—
—
—
cases:0.39%
controls:0.03%
cases:1.30%
controls:0.08%
43
109
8747
87633
8
39
8783
87708
—
—
—
34
25
8589
85850
101
63
7672
77058
Osmolality of Urine
2695-5 [3026782]
2.6e-01
3.6e-01
1.1e+00
2.5e+00
1.1e+00
7.3e-01
7.2e-01
cases:3.62%
controls:2.82%
cases:1.66%
controls:1.17%
cases:0.52%
controls:0.17%
cases:0.08%
controls:0.01%
cases:0.42%
controls:0.14%
cases:2.18%
controls:1.06%
cases:5.88%
controls:2.96%
318
2470
8472
85272
146
1024
8645
86723
46
150
8745
87597
7
6
8784
87741
37
122
8746
87486
188
909
8435
84966
457
2283
7316
74838
prednisone; oral
H02AB07 [21602735]
8.8e-01
1.2e+00
1.2e+00
—
1.4e+00
1.1e+00
8.9e-01
cases:2.95%
controls:1.24%
cases:1.44%
controls:0.45%
cases:0.24%
controls:0.07%
—
—
cases:0.31%
controls:0.08%
cases:1.29%
controls:0.43%
cases:2.68%
controls:1.12%
259
1088
8531
86654
127
395
8664
87352
21
61
8770
87686
—
27
66
8756
87542
111
367
8512
85508
208
865
7565
76256
prednisone
A07EA03 [21600655]
8.8e-01
1.2e+00
1.2e+00
—
1.4e+00
1.1e+00
8.9e-01
cases:2.95%
controls:1.24%
cases:1.44%
controls:0.45%
cases:0.24%
controls:0.07%
—
—
cases:0.31%
controls:0.08%
cases:1.29%
controls:0.43%
cases:2.68%
controls:1.12%
259
1088
8531
86654
127
395
8664
87352
21
61
8770
87686
—
27
66
8756
87542
111
367
8512
85508
208
865
7565
76256
Feet X-ray examination with load
NH3EA [2001308283]
8.8e-01
1.9e+00
—
—
-1.0e+50
1.8e+00
2.1e+00
cases:0.25%
controls:0.10%
cases:0.17%
controls:0.03%
—
—
—
—
cases:0.00%
controls:0.01%
cases:0.19%
controls:0.03%
cases:0.59%
controls:0.07%
22
91
8768
87651
15
22
8776
87725
—
—
0
6
8783
87602
16
27
8607
85848
46
55
7727
77066
Social worker
Z2446 [2001311559]
6.4e-01
1.1e+00
—
—
2.3e+00
1.5e+00
1.1e+00
cases:1.00%
controls:0.53%
cases:0.42%
controls:0.14%
—
—
—
—
cases:0.10%
controls:0.01%
cases:0.52%
controls:0.12%
cases:1.31%
controls:0.43%
88
466
8702
87276
37
124
8754
87623
—
—
9
9
8774
87599
45
101
8578
85774
102
328
7671
76793
Band form neutrophils/Leukocytes in Blood
26508-2 [3004809]
9.2e-01
1.0e+00
1.3e+00
—
2.5e+00
1.5e+00
7.5e-01
cases:0.36%
controls:0.14%
cases:0.18%
controls:0.06%
cases:0.06%
controls:0.02%
—
—
cases:0.08%
controls:0.01%
cases:0.31%
controls:0.07%
cases:0.51%
controls:0.24%
32
127
8758
87615
16
57
8775
87690
5
14
8786
87733
—
7
6
8776
87602
27
60
8596
85815
40
188
7733
76933
Seborrhoea capitis
L21.0 [45586766]
1.8e+00
3.3e+00
—
1.0e+50
1.0e+50
1.6e+00
2.6e-01
cases:0.22%
controls:0.04%
cases:0.31%
controls:0.01%
—
—
cases:0.11%
controls:0.00%
cases:0.06%
controls:0.00%
cases:0.09%
controls:0.02%
cases:0.10%
controls:0.08%
19
33
8771
87709
27
10
8764
87737
—
10
0
8781
87747
5
0
8778
87608
8
16
8615
85859
8
61
7765
77060
fusidic acid
D09AA02 [21602265]
5.6e-01
1.2e+00
1.5e+00
—
1.8e+00
9.7e-01
6.4e-01
cases:4.53%
controls:2.64%
cases:2.58%
controls:0.81%
cases:0.35%
controls:0.08%
—
—
cases:0.50%
controls:0.08%
cases:2.19%
controls:0.84%
cases:5.62%
controls:3.04%
398
2318
8392
85424
227
711
8564
87036
31
70
8760
87677
—
44
72
8739
87536
189
724
8434
85151
437
2341
7336
74780
fusidic acid; ointment
D06AX01 [21602062]
5.6e-01
1.2e+00
1.5e+00
—
1.8e+00
9.7e-01
6.4e-01
cases:4.53%
controls:2.64%
cases:2.58%
controls:0.81%
cases:0.35%
controls:0.08%
—
—
cases:0.50%
controls:0.08%
cases:2.19%
controls:0.84%
cases:5.62%
controls:3.04%
398
2318
8392
85424
227
711
8564
87036
31
70
8760
87677
—
44
72
8739
87536
189
724
8434
85151
437
2341
7336
74780
Pure hypercholesterolaemia
E78.01 [2000501514]
2.3e-01
2.6e-01
4.8e-01
4.8e+00
1.1e+00
4.8e-01
2.6e-01
cases:2.57%
controls:2.05%
cases:1.39%
controls:1.08%
cases:0.33%
controls:0.20%
cases:1.10%
controls:0.01%
cases:0.66%
controls:0.22%
cases:1.96%
controls:1.22%
cases:5.09%
controls:3.99%
226
1799
8564
85943
122
945
8669
86802
29
179
8762
87568
97
8
8694
87739
58
194
8725
87414
169
1048
8454
84827
396
3079
7377
74042
Primary gonarthrosis, bilateral
M17.0 [45562648]
5.6e-01
5.9e-01
7.2e-01
3.2e+00
1.1e+00
7.6e-01
4.1e-01
cases:2.07%
controls:1.20%
cases:1.01%
controls:0.56%
cases:0.15%
controls:0.07%
cases:0.14%
controls:0.01%
cases:0.30%
controls:0.09%
cases:1.19%
controls:0.56%
cases:2.70%
controls:1.81%
182
1050
8608
86692
89
494
8702
87253
13
63
8778
87684
12
5
8779
87742
26
83
8757
87525
103
483
8520
85392
210
1394
7563
75727
Skin texture symptom/complaint
S21 [2002000986]
7.2e-01
1.6e+00
1.8e+00
—
1.1e+00
6.2e-01
7.6e-01
cases:2.20%
controls:1.08%
cases:2.16%
controls:0.43%
cases:0.30%
controls:0.05%
—
—
cases:0.17%
controls:0.05%
cases:0.79%
controls:0.43%
cases:3.33%
controls:1.58%
193
950
8597
86792
190
374
8601
87373
26
45
8765
87702
—
15
48
8768
87560
68
366
8555
85509
259
1218
7514
75903
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.6e-01
4.2e-01
1.2e+00
2.6e+00
1.2e+00
6.4e-01
3.4e-01
cases:26.50%
controls:23.56%
cases:24.47%
controls:17.53%
cases:9.78%
controls:3.12%
cases:1.82%
controls:0.14%
cases:9.55%
controls:2.98%
cases:29.75%
controls:18.27%
cases:44.31%
controls:36.16%
2329
20670
6461
67072
2151
15379
6640
72368
860
2740
7931
85007
160
119
8631
87628
839
2611
7944
84997
2565
15690
6058
70185
3444
27888
4329
49233
Granulocytes/Leukocytes in Synovial fluid
26522-3 [3006571]
9.9e-01
1.7e+00
2.1e+00
—
—
2.4e+00
1.5e+00
cases:0.34%
controls:0.13%
cases:0.20%
controls:0.04%
cases:0.06%
controls:0.01%
—
—
—
—
cases:0.34%
controls:0.03%
cases:0.62%
controls:0.14%
30
111
8760
87631
18
33
8773
87714
5
6
8786
87741
—
—
29
25
8594
85850
48
111
7725
77010
Dyspnoea
R06.0 [45558449]
3.8e-01
5.6e-01
9.3e-01
2.6e+00
9.3e-01
6.0e-01
5.6e-01
cases:3.42%
controls:2.38%
cases:1.57%
controls:0.90%
cases:0.24%
controls:0.09%
cases:0.08%
controls:0.01%
cases:0.26%
controls:0.10%
cases:1.51%
controls:0.84%
cases:5.49%
controls:3.22%
301
2085
8489
85657
138
794
8653
86953
21
83
8770
87664
7
5
8784
87742
23
91
8760
87517
130
718
8493
85157
427
2480
7346
74641
Left sided colitis
K51.5 [45533604]
8.7e-01
8.5e-01
1.4e+00
—
1.3e+00
1.1e+00
1.1e+00
cases:0.84%
controls:0.36%
cases:0.58%
controls:0.25%
cases:0.28%
controls:0.07%
—
—
cases:0.22%
controls:0.06%
cases:0.73%
controls:0.24%
cases:1.20%
controls:0.40%
74
312
8716
87430
51
218
8740
87529
25
64
8766
87683
—
19
54
8764
87554
63
207
8560
85668
93
306
7680
76815
lymecycline; oral, parenteral
J01AA04 [21602802]
5.1e-01
9.8e-01
1.6e+00
—
1.9e+00
1.0e+00
5.2e-01
cases:2.04%
controls:1.23%
cases:0.90%
controls:0.34%
cases:0.18%
controls:0.04%
—
—
cases:0.26%
controls:0.04%
cases:0.89%
controls:0.32%
cases:1.69%
controls:1.00%
179
1080
8611
86662
79
299
8712
87448
16
33
8775
87714
—
23
33
8760
87575
77
276
8546
85599
131
775
7642
76346
desoximetasone
D07AC03 [21602122]
1.6e+00
1.9e+00
—
—
—
1.7e+00
1.3e+00
cases:0.59%
controls:0.12%
cases:0.20%
controls:0.03%
—
—
—
—
—
—
cases:0.21%
controls:0.04%
cases:0.40%
controls:0.11%
52
105
8738
87637
18
27
8773
87720
—
—
—
18
32
8605
85843
31
83
7742
77038
tofacitinib; oral
L04AF01 [955219]
2.0e+00
2.1e+00
—
—
—
1.3e+00
2.5e+00
cases:0.11%
controls:0.02%
cases:0.10%
controls:0.01%
—
—
—
—
—
—
cases:0.06%
controls:0.02%
cases:0.18%
controls:0.02%
10
14
8780
87728
9
11
8782
87736
—
—
—
5
14
8618
85861
14
12
7759
77109
Supplier / Service Provider
OMOP5117446 [33004]
-9.7e-01
-8.4e-01
-1.6e-01
1.2e+00
2.4e+00
2.8e+00
3.1e+00
cases:12.08%
controls:26.63%
cases:3.78%
controls:8.37%
cases:0.67%
controls:0.79%
cases:0.09%
controls:0.03%
cases:0.61%
controls:0.05%
cases:5.39%
controls:0.36%
cases:14.81%
controls:0.77%
1062
23364
7728
64378
332
7342
8459
80405
59
692
8732
87055
8
25
8783
87722
54
47
8729
87561
465
307
8158
85568
1151
591
6622
76530
miconazole
S02AA13 [21605159]
9.7e-01
1.6e+00
—
—
2.1e+00
1.2e+00
7.1e-01
cases:1.60%
controls:0.62%
cases:0.67%
controls:0.14%
—
—
—
—
cases:0.13%
controls:0.02%
cases:0.42%
controls:0.13%
cases:0.98%
controls:0.48%
141
540
8649
87202
59
120
8732
87627
—
—
11
14
8772
87594
36
113
8587
85762
76
374
7697
76747
IgE [Units/volume] in Serum or Plasma
19113-0 [3005322]
2.9e-01
1.1e+00
2.0e+00
—
2.1e+00
6.6e-01
6.1e-01
cases:1.16%
controls:0.87%
cases:0.86%
controls:0.30%
cases:0.24%
controls:0.03%
—
—
cases:0.27%
controls:0.03%
cases:0.52%
controls:0.27%
cases:1.81%
controls:1.00%
102
761
8688
86981
76
261
8715
87486
21
28
8770
87719
—
24
29
8759
87579
45
233
8578
85642
141
768
7632
76353
Crohn disease, unspecified
K50.9 [45562490]
1.6e+00
1.7e+00
1.8e+00
—
—
1.5e+00
1.7e+00
cases:0.53%
controls:0.11%
cases:0.28%
controls:0.05%
cases:0.07%
controls:0.01%
—
—
—
—
cases:0.22%
controls:0.05%
cases:0.49%
controls:0.09%
47
99
8743
87643
25
46
8766
87701
6
10
8785
87737
—
—
19
43
8604
85832
38
69
7735
77052
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
2.7e-01
4.6e-01
1.2e+00
2.1e+00
1.1e+00
7.1e-01
6.0e-01
cases:13.96%
controls:11.01%
cases:8.51%
controls:5.57%
cases:2.58%
controls:0.80%
cases:0.25%
controls:0.03%
cases:2.20%
controls:0.77%
cases:10.80%
controls:5.60%
cases:24.03%
controls:14.78%
1227
9664
7563
78078
748
4885
8043
82862
227
699
8564
87048
22
27
8769
87720
193
678
8590
86930
931
4808
7692
81067
1868
11399
5905
65722
Other seborrhoeic dermatitis
L21.8 [45548192]
1.5e+00
1.6e+00
—
1.0e+50
—
2.1e+00
1.2e+00
cases:0.30%
controls:0.07%
cases:0.11%
controls:0.02%
—
—
cases:0.19%
controls:0.00%
—
—
cases:0.26%
controls:0.03%
cases:0.26%
controls:0.08%
26
60
8764
87682
10
21
8781
87726
—
17
0
8774
87747
—
22
26
8601
85849
20
59
7753
77062
General Practice
1 [38004446]
3.0e-01
3.4e-01
7.2e-01
3.4e+00
6.6e-01
5.0e-01
4.3e-01
cases:12.18%
controls:9.33%
cases:4.99%
controls:3.61%
cases:0.96%
controls:0.47%
cases:0.73%
controls:0.02%
cases:0.98%
controls:0.51%
cases:6.16%
controls:3.82%
cases:16.54%
controls:11.43%
1071
8188
7719
79554
439
3165
8352
84582
84
412
8707
87335
64
21
8727
87726
86
444
8697
87164
531
3283
8092
82592
1286
8813
6487
68308
Upper gastrointestinal surgery
106 [44777669]
3.0e-01
4.2e-01
6.4e-01
3.3e+00
7.6e-01
5.0e-01
4.4e-01
cases:9.02%
controls:6.83%
cases:4.04%
controls:2.70%
cases:0.78%
controls:0.41%
cases:0.33%
controls:0.01%
cases:0.92%
controls:0.43%
cases:4.37%
controls:2.69%
cases:12.13%
controls:8.14%
793
5993
7997
81749
355
2371
8436
85376
69
363
8722
87384
29
11
8762
87736
81
378
8702
87230
377
2306
8246
83569
943
6276
6830
70845
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
3.4e-01
4.8e-01
1.5e+00
2.3e+00
9.6e-01
5.2e-01
2.9e-01
cases:3.94%
controls:2.84%
cases:2.53%
controls:1.58%
cases:0.85%
controls:0.20%
cases:0.13%
controls:0.01%
cases:0.63%
controls:0.24%
cases:3.06%
controls:1.84%
cases:7.74%
controls:5.89%
346
2490
8444
85252
222
1388
8569
86359
75
176
8716
87571
11
11
8780
87736
55
211
8728
87397
264
1584
8359
84291
602
4544
7171
72577
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
6.9e-01
8.5e-01
1.3e+00
—
1.3e+00
1.1e+00
1.0e+00
cases:1.44%
controls:0.73%
cases:0.74%
controls:0.32%
cases:0.15%
controls:0.04%
—
—
cases:0.15%
controls:0.04%
cases:0.92%
controls:0.29%
cases:2.15%
controls:0.80%
127
639
8663
87103
65
278
8726
87469
13
34
8778
87713
—
13
36
8770
87572
79
251
8544
85624
167
616
7606
76505
Erythema intertrigo
L30.4 [45601221]
1.2e+00
1.6e+00
—
1.0e+50
—
2.3e+00
1.3e+00
cases:0.20%
controls:0.06%
cases:0.17%
controls:0.04%
—
—
cases:0.14%
controls:0.00%
—
—
cases:0.17%
controls:0.02%
cases:0.30%
controls:0.08%
18
56
8772
87686
15
31
8776
87716
—
12
0
8779
87747
—
15
15
8608
85860
23
65
7750
77056
Other urticaria
L50.8 [45562540]
-3.1e-01
1.3e+00
2.1e+00
1.0e+50
2.6e+00
1.6e+00
8.3e-01
cases:0.08%
controls:0.11%
cases:0.16%
controls:0.04%
cases:0.06%
controls:0.01%
cases:0.13%
controls:0.00%
cases:0.09%
controls:0.01%
cases:0.20%
controls:0.04%
cases:0.30%
controls:0.13%
7
95
8783
87647
14
38
8777
87709
5
6
8786
87741
11
0
8780
87747
8
6
8775
87602
17
35
8606
85840
23
100
7750
77021
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
2.8e-01
4.6e-01
1.3e+00
2.6e+00
7.7e-01
5.6e-01
3.5e-01
cases:7.52%
controls:5.77%
cases:4.49%
controls:2.90%
cases:1.43%
controls:0.39%
cases:0.15%
controls:0.01%
cases:0.88%
controls:0.41%
cases:5.24%
controls:3.08%
cases:12.58%
controls:9.22%
661
5066
8129
82676
395
2541
8396
85206
126
340
8665
87407
13
10
8778
87737
77
358
8706
87250
452
2641
8171
83234
978
7108
6795
70013
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
3.3e-01
5.2e-01
1.3e+00
2.1e+00
9.1e-01
6.3e-01
4.2e-01
cases:8.87%
controls:6.56%
cases:5.98%
controls:3.65%
cases:1.96%
controls:0.52%
cases:0.19%
controls:0.02%
cases:1.33%
controls:0.54%
cases:7.29%
controls:4.02%
cases:16.93%
controls:11.83%
780
5758
8010
81984
526
3202
8265
84545
172
452
8619
87295
17
20
8774
87727
117
473
8666
87135
629
3456
7994
82419
1316
9123
6457
67998
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
3.1e-01
5.2e-01
1.3e+00
2.1e+00
9.2e-01
6.3e-01
4.2e-01
cases:8.96%
controls:6.71%
cases:6.09%
controls:3.70%
cases:1.97%
controls:0.52%
cases:0.19%
controls:0.02%
cases:1.38%
controls:0.55%
cases:7.40%
controls:4.10%
cases:17.19%
controls:11.99%
788
5884
8002
81858
535
3245
8256
84502
173
457
8618
87290
17
20
8774
87727
121
483
8662
87125
638
3517
7985
82358
1336
9248
6437
67873
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
2.1e-01
5.4e-01
1.1e+00
2.4e+00
9.5e-01
6.3e-01
4.5e-01
cases:24.41%
controls:20.70%
cases:20.38%
controls:13.03%
cases:7.17%
controls:2.50%
cases:1.62%
controls:0.15%
cases:6.08%
controls:2.44%
cases:22.70%
controls:13.49%
cases:39.83%
controls:29.60%
2146
18165
6644
69577
1792
11433
6999
76314
630
2198
8161
85549
142
132
8649
87615
534
2134
8249
85474
1957
11587
6666
74288
3096
22825
4677
54296
Ankle joint ultrasound examination
NH1AE [2001308237]
1.4e+00
—
—
—
—
2.9e+00
2.0e+00
cases:0.11%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.15%
controls:0.01%
cases:0.19%
controls:0.03%
10
25
8780
87717
—
—
—
—
13
7
8610
85868
15
21
7758
77100
Helicobacter pylori Ab [Units/volume] in Serum
7900-4 [3017895]
3.3e-01
6.9e-01
2.1e+00
1.0e+50
2.7e+00
7.7e-01
5.9e-01
cases:0.61%
controls:0.44%
cases:0.25%
controls:0.13%
cases:0.13%
controls:0.01%
cases:0.08%
controls:0.00%
cases:0.16%
controls:0.01%
cases:0.29%
controls:0.13%
cases:0.93%
controls:0.51%
54
390
8736
87352
22
110
8769
87637
11
13
8780
87734
7
0
8784
87747
14
9
8769
87599
25
115
8598
85760
72
397
7701
76724
Triglyceride [Moles/volume] in Serum or Plasma
14927-8 [3025839]
3.0e-02
1.3e-01
1.2e+00
3.4e+00
1.1e+00
4.0e-01
1.7e-01
cases:1.99%
controls:1.93%
cases:1.96%
controls:1.72%
cases:0.72%
controls:0.22%
cases:0.23%
controls:0.01%
cases:0.66%
controls:0.22%
cases:3.37%
controls:2.28%
cases:9.19%
controls:7.83%
175
1696
8615
86046
172
1512
8619
86235
63
189
8728
87558
20
7
8771
87740
58
194
8725
87414
291
1959
8332
83916
714
6037
7059
71084
Synovial lining cells/cells in Synovial fluid
35651-9 [3034891]
9.9e-01
1.8e+00
—
—
—
2.8e+00
1.6e+00
cases:0.13%
controls:0.05%
cases:0.11%
controls:0.02%
—
—
—
—
—
—
cases:0.19%
controls:0.01%
cases:0.27%
controls:0.05%
11
41
8779
87701
10
16
8781
87731
—
—
—
16
10
8607
85865
21
41
7752
77080
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
3.1e-01
5.0e-01
1.3e+00
2.1e+00
9.1e-01
6.3e-01
4.2e-01
cases:9.10%
controls:6.83%
cases:6.01%
controls:3.73%
cases:1.96%
controls:0.53%
cases:0.19%
controls:0.02%
cases:1.37%
controls:0.56%
cases:7.45%
controls:4.11%
cases:17.23%
controls:12.04%
800
5989
7990
81753
528
3269
8263
84478
172
468
8619
87279
17
20
8774
87727
120
487
8663
87121
642
3529
7981
82346
1339
9287
6434
67834
lithium; oral
N05AN01 [21604556]
8.8e-01
1.1e+00
9.3e-01
—
1.2e+00
1.1e+00
1.0e+00
cases:0.76%
controls:0.32%
cases:0.67%
controls:0.23%
cases:0.19%
controls:0.08%
—
—
cases:0.19%
controls:0.06%
cases:0.63%
controls:0.22%
cases:0.75%
controls:0.27%
67
280
8723
87462
59
201
8732
87546
17
67
8774
87680
—
17
49
8766
87559
54
188
8569
85687
58
210
7715
76911
clindamycin; oral, parenteral
J01FF01 [21602985]
5.2e-01
1.1e+00
1.6e+00
—
1.6e+00
7.7e-01
6.6e-01
cases:5.15%
controls:3.14%
cases:2.38%
controls:0.84%
cases:0.49%
controls:0.10%
—
—
cases:0.47%
controls:0.09%
cases:1.91%
controls:0.90%
cases:6.03%
controls:3.20%
453
2757
8337
84985
209
739
8582
87008
43
89
8748
87658
—
41
83
8742
87525
165
770
8458
85105
469
2471
7304
74650
pH of Urine
2756-5 [3015736]
3.1e-01
5.0e-01
1.4e+00
2.2e+00
9.1e-01
5.8e-01
3.5e-01
cases:7.29%
controls:5.47%
cases:4.47%
controls:2.77%
cases:1.40%
controls:0.36%
cases:0.16%
controls:0.02%
cases:1.00%
controls:0.41%
cases:5.21%
controls:3.00%
cases:12.59%
controls:9.24%
641
4798
8149
82944
393
2427
8398
85320
123
320
8668
87427
14
16
8777
87731
88
355
8695
87253
449
2574
8174
83301
979
7124
6794
69997
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
2.8e-01
3.1e-01
7.2e-01
2.5e+00
1.2e+00
6.3e-01
5.2e-01
cases:6.47%
controls:4.99%
cases:3.19%
controls:2.36%
cases:0.65%
controls:0.32%
cases:0.07%
controls:0.01%
cases:0.90%
controls:0.27%
cases:4.16%
controls:2.27%
cases:11.09%
controls:6.91%
569
4376
8221
83366
280
2067
8511
85680
57
279
8734
87468
6
5
8785
87742
79
237
8704
87371
359
1948
8264
83927
862
5328
6911
71793
Dermatographic urticaria
L50.3 [45596376]
8.9e-01
1.6e+00
—
1.0e+50
—
2.3e+00
1.4e+00
cases:0.22%
controls:0.09%
cases:0.18%
controls:0.04%
—
—
cases:0.13%
controls:0.00%
—
—
cases:0.26%
controls:0.03%
cases:0.40%
controls:0.10%
19
78
8771
87664
16
33
8775
87714
—
11
0
8780
87747
—
22
23
8601
85852
31
77
7742
77044
Low back pain
M54.5 [45553207]
3.7e-01
4.7e-01
7.1e-01
2.7e+00
8.1e-01
6.4e-01
4.5e-01
cases:6.04%
controls:4.26%
cases:2.43%
controls:1.54%
cases:0.39%
controls:0.19%
cases:0.15%
controls:0.01%
cases:0.41%
controls:0.18%
cases:2.96%
controls:1.59%
cases:8.63%
controls:5.71%
531
3736
8259
84006
214
1347
8577
86400
34
168
8757
87579
13
9
8778
87738
36
160
8747
87448
255
1362
8368
84513
671
4402
7102
72719
Emergency Room and Inpatient Visit
ERIP [262]
2.1e-01
2.4e-01
7.1e-01
3.4e+00
9.7e-01
4.3e-01
4.0e-01
cases:3.55%
controls:2.89%
cases:2.09%
controls:1.66%
cases:0.43%
controls:0.21%
cases:0.36%
controls:0.01%
cases:0.52%
controls:0.20%
cases:2.81%
controls:1.84%
cases:8.65%
controls:5.98%
312
2532
8478
85210
184
1456
8607
86291
38
186
8753
87561
32
11
8759
87736
46
174
8737
87434
242
1579
8381
84296
672
4609
7101
72512
Other lichen planus
L43.8 [45577038]
3.0e+00
—
—
1.0e+50
1.0e+50
—
3.1e+00
cases:0.22%
controls:0.01%
—
—
—
—
cases:0.16%
controls:0.00%
cases:0.08%
controls:0.00%
—
—
cases:0.44%
controls:0.02%
19
9
8771
87733
—
—
14
0
8777
87747
7
0
8776
87608
—
34
16
7739
77105
dapsone; oral
J04BA02 [21603124]
—
2.1e+00
—
—
—
1.8e+00
2.2e+00
—
—
cases:0.10%
controls:0.01%
—
—
—
—
—
—
cases:0.12%
controls:0.02%
cases:0.21%
controls:0.02%
—
9
11
8782
87736
—
—
—
10
17
8613
85858
16
18
7757
77103
Lymphocytes/Leukocytes in Synovial fluid
26483-8 [3003329]
8.3e-01
1.6e+00
—
—
—
2.0e+00
1.5e+00
cases:0.25%
controls:0.11%
cases:0.18%
controls:0.04%
—
—
—
—
—
—
cases:0.24%
controls:0.03%
cases:0.58%
controls:0.13%
22
96
8768
87646
16
31
8775
87716
—
—
—
21
27
8602
85848
45
102
7728
77019
Adalimumab Ab [Units/volume] in Serum or Plasma
87742-3 [36304052]
1.8e+00
2.1e+00
—
—
—
1.6e+00
2.1e+00
cases:0.22%
controls:0.04%
cases:0.10%
controls:0.01%
—
—
—
—
—
—
cases:0.06%
controls:0.01%
cases:0.36%
controls:0.05%
19
31
8771
87711
9
11
8782
87736
—
—
—
5
10
8618
85865
28
35
7745
77086
Hip joint ultrasound examination
NF1AE [2001307895]
1.0e+00
1.2e+00
—
1.0e+50
—
2.1e+00
1.6e+00
cases:0.44%
controls:0.16%
cases:0.23%
controls:0.07%
—
—
cases:0.09%
controls:0.00%
—
—
cases:0.39%
controls:0.05%
cases:0.76%
controls:0.16%
39
139
8751
87603
20
59
8771
87688
—
8
0
8783
87747
—
34
40
8589
85835
59
122
7714
76999
Clonic hemifacial spasm
G51.3 [45562098]
1.8e+00
2.0e+00
—
—
—
2.2e+00
1.4e+00
cases:0.09%
controls:0.01%
cases:0.09%
controls:0.01%
—
—
—
—
—
—
cases:0.08%
controls:0.01%
cases:0.09%
controls:0.02%
8
13
8782
87729
8
11
8783
87736
—
—
—
7
8
8616
85867
7
18
7766
77103
Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
71368-5 [42870308]
9.2e-01
2.4e+00
—
—
—
2.0e+00
1.6e+00
cases:0.13%
controls:0.05%
cases:0.24%
controls:0.02%
—
—
—
—
—
—
cases:0.14%
controls:0.02%
cases:0.36%
controls:0.07%
11
44
8779
87698
21
20
8770
87727
—
—
—
12
16
8611
85859
28
57
7745
77064
Differential panel - Synovial fluid
29582-4 [3021788]
1.1e+00
1.6e+00
—
1.0e+50
2.0e+00
1.9e+00
1.3e+00
cases:0.50%
controls:0.17%
cases:0.32%
controls:0.06%
—
—
cases:0.06%
controls:0.00%
cases:0.06%
controls:0.01%
cases:0.39%
controls:0.06%
cases:0.84%
controls:0.23%
44
153
8746
87589
28
54
8763
87693
—
5
0
8786
87747
5
7
8778
87601
34
52
8589
85823
65
175
7708
76946
Hematology
82 [38004501]
2.8e-01
4.5e-01
4.6e-01
3.3e+00
9.4e-01
6.1e-01
6.1e-01
cases:1.07%
controls:0.81%
cases:0.81%
controls:0.52%
cases:0.31%
controls:0.19%
cases:0.18%
controls:0.01%
cases:0.43%
controls:0.17%
cases:1.03%
controls:0.57%
cases:1.89%
controls:1.03%
94
712
8696
87030
71
454
8720
87293
27
170
8764
87577
16
6
8775
87741
38
149
8745
87459
89
486
8534
85389
147
798
7626
76323
Juvenile arthritis
M08 [45538642]
1.3e+00
—
—
—
—
2.5e+00
2.1e+00
cases:0.15%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.07%
controls:0.01%
cases:0.13%
controls:0.02%
13
36
8777
87706
—
—
—
—
6
5
8617
85870
10
12
7763
77109
Other healthcare associate professional
Z3229 [2001311561]
4.0e-01
8.1e-01
8.0e-01
—
2.3e+00
1.4e+00
9.7e-01
cases:1.21%
controls:0.81%
cases:0.50%
controls:0.22%
cases:0.07%
controls:0.03%
—
—
cases:0.24%
controls:0.03%
cases:0.87%
controls:0.21%
cases:1.75%
controls:0.67%
106
709
8684
87033
44
195
8747
87552
6
27
8785
87720
—
21
22
8762
87586
75
181
8548
85694
136
515
7637
76606
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83.9 [45547252]
1.4e-01
1.0e+00
2.5e+00
—
—
1.3e+00
1.0e+00
cases:0.24%
controls:0.21%
cases:0.17%
controls:0.06%
cases:0.08%
controls:0.01%
—
—
—
—
cases:0.20%
controls:0.05%
cases:0.45%
controls:0.16%
21
183
8769
87559
15
54
8776
87693
7
6
8784
87741
—
—
17
44
8606
85831
35
127
7738
76994
Reactive arthropathy, unspecified
M02.9 [45591683]
1.4e+00
2.0e+00
—
—
2.1e+00
1.5e+00
9.5e-01
cases:0.33%
controls:0.08%
cases:0.26%
controls:0.04%
—
—
—
—
cases:0.06%
controls:0.01%
cases:0.14%
controls:0.03%
cases:0.23%
controls:0.09%
29
73
8761
87669
23
32
8768
87715
—
—
5
6
8778
87602
12
26
8611
85849
18
69
7755
77052
Joint injection with ultrasound guidance not elsewhere classified
NK5AT [2001308540]
1.7e+00
2.0e+00
—
—
—
2.2e+00
2.0e+00
cases:0.26%
controls:0.05%
cases:0.06%
controls:0.01%
—
—
—
—
—
—
cases:0.09%
controls:0.01%
cases:0.23%
controls:0.03%
23
43
8767
87699
5
7
8786
87740
—
—
—
8
9
8615
85866
18
25
7755
77096
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
5.5e-01
9.1e-01
1.5e+00
—
—
1.3e+00
1.5e+00
cases:2.05%
controls:1.19%
cases:0.93%
controls:0.38%
cases:0.14%
controls:0.03%
—
—
—
—
cases:1.09%
controls:0.30%
cases:3.09%
controls:0.69%
180
1048
8610
86694
82
331
8709
87416
12
26
8779
87721
—
—
94
257
8529
85618
240
531
7533
76590
FEV1 --post bronchodilation
20155-8 [3023550]
5.5e-01
9.1e-01
1.5e+00
—
—
1.3e+00
1.5e+00
cases:2.05%
controls:1.19%
cases:0.93%
controls:0.38%
cases:0.14%
controls:0.03%
—
—
—
—
cases:1.09%
controls:0.30%
cases:3.09%
controls:0.69%
180
1048
8610
86694
82
331
8709
87416
12
26
8779
87721
—
—
94
257
8529
85618
240
531
7533
76590
FEV1 percent change
69983-5 [42868472]
5.5e-01
9.1e-01
1.5e+00
—
—
1.3e+00
1.5e+00
cases:2.05%
controls:1.19%
cases:0.93%
controls:0.38%
cases:0.14%
controls:0.03%
—
—
—
—
cases:1.09%
controls:0.30%
cases:3.09%
controls:0.69%
180
1048
8610
86694
82
331
8709
87416
12
26
8779
87721
—
—
94
257
8529
85618
240
531
7533
76590
FVC percent change Respiratory system
69982-7 [42868471]
5.5e-01
9.1e-01
1.5e+00
—
—
1.3e+00
1.5e+00
cases:2.05%
controls:1.19%
cases:0.93%
controls:0.38%
cases:0.14%
controls:0.03%
—
—
—
—
cases:1.09%
controls:0.30%
cases:3.09%
controls:0.69%
180
1048
8610
86694
82
331
8709
87416
12
26
8779
87721
—
—
94
257
8529
85618
240
531
7533
76590
FEV1/FVC --post bronchodilation
69970-2 [42868459]
5.5e-01
9.1e-01
1.5e+00
—
—
1.3e+00
1.5e+00
cases:2.05%
controls:1.19%
cases:0.93%
controls:0.38%
cases:0.14%
controls:0.03%
—
—
—
—
cases:1.09%
controls:0.30%
cases:3.09%
controls:0.69%
180
1048
8610
86694
82
331
8709
87416
12
26
8779
87721
—
—
94
257
8529
85618
240
531
7533
76590
Varicella zoster virus Ab [Titer] in Serum
21594-7 [3014148]
6.8e-01
3.6e-01
—
—
2.4e+00
1.4e+00
1.3e+00
cases:0.35%
controls:0.18%
cases:0.08%
controls:0.06%
—
—
—
—
cases:0.10%
controls:0.01%
cases:0.23%
controls:0.05%
cases:0.63%
controls:0.18%
31
157
8759
87585
7
49
8784
87698
—
—
9
8
8774
87600
20
47
8603
85828
49
138
7724
76983
Cell count panel - Synovial fluid
34559-5 [3044941]
1.1e+00
1.6e+00
1.6e+00
1.0e+50
—
1.8e+00
1.3e+00
cases:0.44%
controls:0.15%
cases:0.30%
controls:0.06%
cases:0.06%
controls:0.01%
cases:0.09%
controls:0.00%
—
—
cases:0.34%
controls:0.05%
cases:0.89%
controls:0.26%
39
132
8751
87610
26
51
8765
87696
5
10
8786
87737
8
0
8783
87747
—
29
46
8594
85829
69
197
7704
76924
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
4.6e-01
4.7e-01
9.8e-01
—
1.6e+00
1.2e+00
1.1e+00
cases:2.57%
controls:1.64%
cases:1.00%
controls:0.63%
cases:0.17%
controls:0.06%
—
—
cases:0.39%
controls:0.08%
cases:1.90%
controls:0.57%
cases:4.76%
controls:1.72%
226
1440
8564
86302
88
550
8703
87197
15
56
8776
87691
—
34
67
8749
87541
164
491
8459
85384
370
1325
7403
75796
Leukocytes [#/volume] in Urine
30405-5 [3018095]
2.6e-01
4.3e-01
1.1e+00
1.9e+00
8.8e-01
6.5e-01
5.4e-01
cases:5.61%
controls:4.39%
cases:3.78%
controls:2.48%
cases:1.15%
controls:0.37%
cases:0.14%
controls:0.02%
cases:0.89%
controls:0.37%
cases:4.82%
controls:2.58%
cases:11.53%
controls:7.04%
493
3854
8297
83888
332
2176
8459
85571
101
324
8690
87423
12
18
8779
87729
78
325
8705
87283
416
2218
8207
83657
896
5429
6877
71692

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1238
3258
4.25
307.65
1.3
1.2
—
—
—
0
0
6110
37010
3.08
307.65
13.0
6.6
8.94
8.86
%
1.59
5959
34771
6148
37949
3.01
307.65
12.9
6.5
28.02
27.83
%
0.73
6017
36015
6591
40336
3.45
307.65
12.5
6.3
0.04
0.04
e9/l
16.50
6041
34601
6591
40220
3.46
307.65
12.4
6.3
0.61
0.59
e9/l
9.80
6042
34514
2545
11168
2.79
307.65
1.4
1.4
387.11
496.80
titre
2.85
509
2279
6096
36913
3.07
307.65
13.0
6.6
0.74
0.68
%
20.06
5936
34624
6105
36926
3.08
307.65
12.9
6.5
2.96
2.85
%
3.81
5947
34663
6658
41595
3.39
307.65
12.7
6.5
0.21
0.19
e9/l
7.87
6163
36341
6788
44839
3.17
307.65
15.1
9.9
4.13
4.12
e9/l
0.14
6233
38818
6088
37238
3.01
307.65
12.6
6.4
57.42
57.22
%
0.77
5983
35622
320
163
20.33
307.65
1.6
1.5
9.34
9.14
ug/l
0.18
320
163
6624
41156
3.39
307.65
12.6
6.4
1.94
1.92
e9/l
1.00
6144
36219
2533
13448
2.24
230.67
1.4
1.3
7.33
11.60
u/ml
2.92
942
5334
5065
34898
2.05
229.32
17.4
11.4
0.00
0.00
e9/l
0.51
4419
28299
1505
6364
2.64
227.72
1.4
1.5
—
—
—
0
0
2007
9706
2.38
227.57
1.6
1.5
—
—
—
0
0
7238
57266
2.42
227.02
7.2
4.2
13.20
11.48
mm/h
19.53
6965
53905
1604
7018
2.57
226.14
6.1
4.5
0.68
0.94
%
3.20
447
2178
952
3155
3.26
224.80
1.5
1.8
6.94
6.50
iu/ml
0.10
172
765
1552
6703
2.59
224.66
6.2
4.6
0.06
0.11
%
2.44
399
1872
1547
6691
2.59
223.15
5.7
4.3
0.46
0.71
%
5.05
414
2072
7431
59666
2.49
222.18
11.6
8.5
80.50
78.66
u/l
3.02
7231
56919
1534
6794
2.52
209.46
6.5
4.7
0.13
0.29
%
0.83
359
1782
2612
14549
2.13
206.83
1.4
1.3
52.62
31.24
iu/ml
0.74
704
4402
3010
17955
2.02
195.82
7.7
4.6
—
—
—
0
0
1902
9542
2.26
194.38
1.6
1.7
—
—
—
0
0
245
293
8.57
189.43
1.7
1.6
2304.76
2913.33
titre
0.40
21
48
2246
12287
2.11
182.96
1.6
1.7
—
—
—
0
0
1885
10068
2.11
160.93
3.4
3.3
4.52
4.50
e9/l
0.03
1683
8802
3271
21339
1.84
153.79
3.0
2.7
347.82
344.52
umol/l
1.12
2981
19064
6522
52450
1.91
152.48
5.8
4.4
1.91
2.63
—
5
74
190
234
8.28
143.33
1.8
2.3
8.62
9.29
mg/l
0.66
153
201
5406
41461
1.77
142.51
4.7
3.7
5.03
4.62
estimate
0.06
1383
8535
5428
41717
1.77
141.64
4.7
3.8
0.01
0.18
estimate
0.71
1285
8024
5357
41024
1.77
141.46
4.7
3.7
0.00
0.00
estimate
0.01
1368
8379
1718
9345
2.04
137.15
2.0
1.8
—
—
—
0
0
723
2716
2.81
134.51
1.1
1.1
—
—
—
0
0
2369
14715
1.83
125.36
1.8
2.0
—
—
—
0
0
147
168
8.88
117.71
1.5
1.8
259.18
124.44
au/ml
1.28
26
24
4377
33126
1.63
107.69
4.1
3.3
6.22
6.19
ph
0.74
2376
18822
5213
41380
1.63
104.13
6.8
6.9
11.17
11.64
umol/l
2.09
5002
39589
3739
27542
1.62
100.27
3.9
3.4
36.24
34.64
u/l
0.56
3539
26070
3913
29219
1.61
98.64
4.7
4.0
71.06
87.87
e6/l
0.88
2811
20729
703
3028
2.44
98.07
1.2
1.2
0.58
0.83
u/ml
0.37
35
254
3294
23846
1.61
92.86
9.5
6.5
—
—
—
0
0
4496
34999
1.58
92.77
5.9
5.4
35.48
35.89
g/l
5.02
4252
32978
504
1917
2.73
90.79
1.8
1.6
8390.15
13880.84
e6/l
2.56
388
1326
3012
21591
1.60
87.05
5.0
4.5
—
—
—
0
0
411
1447
2.93
85.53
1.7
1.5
—
1.00
—
0
7
1799
11424
1.72
83.11
2.4
2.1
—
—
—
0
0
1324
7757
1.83
80.46
2.6
2.4
0.21
0.21
g/l
0.46
1242
7266
285
852
3.42
78.09
1.8
1.5
51.18
59.49
%
2.59
179
531
3055
22389
1.56
78.08
4.9
3.9
0.00
0.00
estimate
0.33
1275
7713
4431
35204
1.52
77.63
2.8
2.5
74.64
76.41
nmol/l
3.77
4119
32239
436
1699
2.65
74.68
3.8
3.3
56.73
57.77
%
0.98
436
1699
8240
76223
2.10
72.85
23.1
15.8
21.25
24.46
mg/l
19.16
7400
62759
234
653
3.65
71.21
1.9
1.5
39.91
29.36
%
3.43
138
389
3386
25744
1.51
71.17
3.9
3.4
36.71
73.09
e6/l
4.80
2689
19635
533
2357
2.34
69.53
1.3
1.3
15.55
38.39
u/ml
2.15
16
125
4743
38736
1.48
69.19
8.3
7.7
1.21
1.21
mmol/l
0.95
4188
33624
3414
26238
1.49
66.85
4.6
4.3
11.43
8.78
mg/mmol
1.86
2293
16719
1087
6328
1.82
66.55
2.5
2.8
11.07
10.56
g/l
3.20
1007
5861
897
4922
1.91
66.17
1.8
2.0
1.34
1.31
g/l
0.13
831
4571
2267
16031
1.56
65.56
1.6
1.5
2.89
2.44
g/l
10.48
1429
10180
498
2194
2.35
65.46
1.3
1.3
5.40
4.32
u/ml
0.14
39
202
498
2195
2.34
65.39
1.3
1.3
4.14
6.53
u/ml
1.10
61
329
2140
14953
1.57
65.20
3.4
3.0
543.06
538.47
mosm/kgh2o
0.42
1937
13167
526
2395
2.27
63.99
1.3
1.3
106.67
142.09
titre
0.43
45
239
432
1810
2.46
63.50
1.2
1.2
2.07
3.97
u/ml
0.66
22
108
517
2360
2.26
62.49
1.2
1.3
960.00
867.54
titre
—
5
69
2443
17744
1.52
61.80
3.1
2.8
5.29
5.13
e6/l
0.26
2282
16204
3558
27908
1.46
61.10
3.8
3.5
7.67
7.90
mmol/l
2.33
3064
23853
2481
18145
1.51
60.47
1.4
1.3
1.98
1.82
u/ml
0.20
691
5039
4388
35924
1.44
59.21
15.0
14.4
1.22
1.24
inr
1.83
3719
29974
3321
25836
1.46
58.91
3.8
3.6
61.47
49.97
mg/l
1.75
2273
16826
2928
22251
1.47
58.59
3.7
3.3
0.44
0.40
e6/l
0.23
2261
16256
1383
8933
1.65
57.61
2.8
2.7
1.82
1.79
%
0.83
1251
8012
408
1741
2.41
57.56
1.2
1.2
35.67
42.12
u/ml
0.29
24
162
2683
20174
1.47
56.12
2.7
2.3
2.86
2.76
mg/l
1.42
2366
17529
7120
64219
1.54
55.94
29.2
19.3
13.83
13.57
%
48.29
7086
63410
128
274
4.73
55.59
3.5
3.6
7.18
8.99
mg/l
2.09
92
230
299
1127
2.71
54.61
1.1
1.2
—
—
—
0
0
2519
18791
1.48
54.54
4.5
3.7
0.39
0.19
0.37
28
174
1930
13643
1.53
54.26
2.9
2.7
13.10
13.35
umol/l
0.74
1817
12809
3233
25316
1.44
54.04
3.1
2.8
72.82
62.97
u/l
0.52
3002
23602
1824
12755
1.54
53.84
2.9
2.7
2.34
2.33
g/l
0.64
1702
11862
118
243
4.91
53.68
2.9
2.8
177.24
117.95
au/ml
0.49
19
40
3859
31272
1.41
52.85
4.8
3.6
0.02
0.21
estimate
1.16
1152
6930
1696
11756
1.55
51.86
3.0
2.8
22.61
23.08
%
0.67
1576
11010
5375
46211
1.41
51.80
5.9
5.3
6.87
6.71
mmol/l
5.65
5110
43869
2898
22484
1.43
49.94
4.1
3.2
0.04
0.13
estimate
0.88
1134
6664
4201
34759
1.40
49.89
7.7
7.1
1.21
1.21
mmol/l
0.29
3953
32350
687
3780
1.89
49.74
2.1
2.1
0.00
0.23
estimate
0.56
223
1189
2908
22601
1.43
49.52
3.4
2.8
0.07
0.05
0.20
68
464
138
346
4.04
48.97
1.7
1.4
6.00
3.05
%
0.97
25
76
2750
21208
1.43
48.70
3.6
3.2
0.00
204.59
estimate
0.63
16
76
1516
10411
1.55
47.92
3.3
2.5
153.02
132.53
ug/g
1.57
1248
8387
5689
49724
1.40
47.58
5.3
4.5
1163.12
1404.82
e6/l
0.15
91
665
2957
23316
1.40
45.37
4.7
4.5
7.40
7.40
ph
0.35
2164
16639
1142
7435
1.61
45.20
2.1
2.1
0.02
0.02
estimate
0.02
288
1541
856
5215
1.71
43.77
1.4
1.3
315.01
245.13
u/ml
0.87
813
4864
4091
34154
1.37
43.72
2.4
2.1
92.97
95.93
pmol/l
4.30
2467
18458
197
678
2.95
42.69
1.6
1.3
52334.28
116871.52
e6/l
1.12
138
454
1059
6864
1.62
42.52
2.4
2.7
71.62
70.08
e9/l
0.70
773
5035
167
526
3.22
42.14
1.7
1.5
21.10
24.88
u/ml
0.55
30
100
148
449
3.34
39.71
1.3
1.3
80.00
68.33
titre
0.19
13
30
2740
21751
1.38
38.88
3.5
3.1
—
—
—
0
0
2728
21704
1.37
37.97
1.8
1.7
19.38
19.89
nmol/l
1.07
2384
18601
997
6536
1.59
37.92
2.7
2.5
0.35
0.45
e6/l
1.10
965
6247
148
468
3.20
37.15
1.3
1.3
889.17
553.24
titre
0.33
12
37
410
2092
2.01
36.92
1.2
1.3
—
—
—
0
0
993
6560
1.58
36.47
2.1
2.7
67.15
66.47
g/l
1.95
920
6084
1662
12249
1.44
35.88
1.8
1.7
1105.97
1157.00
nmol/l
1.54
1266
9401
2768
22246
1.35
35.57
3.2
3.2
1382.36
1293.98
ng/l
0.43
2357
19103
408
2129
1.96
34.45
2.8
3.3
1.96
2.27
index
0.30
191
1127
228
946
2.45
34.23
1.2
1.3
64.18
63.20
u/ml
0.01
11
52
54
82
6.62
33.93
1.9
1.8
1.52
1.60
mg/l
0.14
45
72
2983
24377
1.34
33.88
2.3
2.3
198.15
219.41
u/l
0.79
2818
23157
1157
8030
1.51
33.78
4.7
4.1
5.81
5.82
kpa
0.15
1125
7831
1106
7608
1.52
33.68
2.3
2.4
355.20
374.58
nmol/l
2.45
1028
7084
326
1598
2.08
32.77
4.1
3.9
—
—
—
0
0
1787
13546
1.40
32.50
3.7
3.7
0.80
0.82
mmol/l
9.84
1694
12828
1168
8213
1.49
31.85
4.8
4.1
7.38
7.38
ph
0.85
729
4686
135
445
3.07
31.65
1.1
1.1
1381.11
1495.89
miu/ml
0.72
135
445
1455
10690
1.43
31.50
7.2
6.7
1.05
1.04
mmol/l
0.95
1375
10035
621
3784
1.69
31.42
1.9
1.8
0.35
0.32
mg/l
0.60
336
1863
1122
7858
1.49
31.17
4.7
4.1
1.68
1.78
mmol/l
0.33
976
6896
8127
77453
1.57
30.53
23.4
18.5
139.49
139.71
mmol/l
13.09
8010
76071
1320
9580
1.44
30.46
3.2
2.9
8.34
8.49
umol/l
0.08
1161
8439
6476
59382
1.33
30.26
4.7
4.3
14.70
14.72
pmol/l
0.28
6024
54990
969
6642
1.51
29.80
3.9
3.4
4.66
4.61
kpa
0.36
939
6464
573
3471
1.70
29.60
1.6
1.6
4.08
14.89
iu/ml
3.26
15
98
8436
81266
1.73
28.83
30.7
20.2
78.51
78.25
umol/l
0.27
8391
80425
1813
14015
1.37
28.79
3.2
3.0
1.03
1.07
e6/l
0.15
1016
7421
3471
29490
1.29
28.16
4.1
3.6
48.38
67.95
ng/l
0.57
2417
20044
427
2413
1.81
28.14
1.5
1.7
0.26
0.24
g/l
5.40
410
2293
6022
54874
1.30
28.07
4.4
3.4
62.92
48.20
u/l
18.19
5706
51966
8128
77661
1.54
27.93
23.6
18.7
3.97
3.97
mmol/l
0.02
8005
76136
1670
12823
1.37
27.50
3.4
3.1
2.62
2.27
e6/l
0.83
865
6188
8390
80815
1.67
27.22
22.0
11.9
29.76
27.38
u/l
24.39
8302
78752
7502
70682
1.39
27.06
5.8
5.2
1.86
1.88
mu/l
1.08
7061
65913
433
2489
1.78
26.95
1.5
1.7
1.27
1.20
g/l
5.13
418
2369
7650
72376
1.41
26.38
7.7
6.2
40.21
39.16
mmol/mol
18.29
7242
68331
261
1292
2.05
25.60
3.4
3.6
1.18
1.65
%
1.07
230
1170
114
388
2.96
25.36
2.1
1.7
—
—
—
0
0
878
6135
1.48
24.35
4.5
3.9
—
—
—
0
0
566
3598
1.61
24.15
1.8
1.8
1.62
1.52
g/l
1.47
487
3119
515
3200
1.65
24.09
2.0
2.0
2.30
2.34
ug/l
0.03
460
2864
4223
37209
1.26
23.98
3.6
3.1
145.30
132.66
ug/l
1.73
3956
34960
1975
15887
1.31
23.23
1.8
1.7
52450512.09
31022108.74
pmol/l
0.54
1653
13468
1432
11054
1.35
22.29
1.3
1.3
—
—
—
0
0
2212
18206
1.29
21.62
5.0
3.9
1.02
1.10
kg/l
0.49
1611
12040
506
3219
1.61
21.51
1.8
2.3
4.14
3.70
g/l
2.97
470
2982
507
3227
1.61
21.50
1.8
2.3
7.63
7.31
g/l
3.81
470
2986
506
3224
1.60
21.37
1.8
2.3
4.32
4.21
g/l
2.49
469
2987
234
1192
1.99
21.26
1.1
1.1
1.59
1.51
g/l
2.44
222
1092
757
5276
1.48
21.17
4.2
3.6
5.22
5.14
kpa
1.77
726
5057
2146
17635
1.29
21.16
1.8
1.8
1.13
1.23
mg/l
0.84
1708
13664
462
2888
1.63
21.09
2.2
2.4
470.27
554.29
ug/l
0.36
423
2736
470
2966
1.62
20.65
1.3
1.3
—
—
—
0
0
474
2999
1.61
20.60
1.6
1.6
15.40
15.44
u/ml
0.01
84
745
562
3707
1.55
20.43
3.7
3.2
1.02
1.02
ratio
2.56
504
3348
1226
9388
1.35
19.93
1.5
1.4
—
—
—
0
0
2457
20680
1.26
19.62
5.3
4.3
88.97
89.82
%
0.92
2402
20244
7597
72444
1.33
19.53
5.4
4.3
1.46
1.31
mmol/l
46.50
7167
67494
322
1873
1.75
19.28
3.8
2.8
36.59
34.26
umol/l
0.67
292
1707
439
2771
1.61
19.27
1.9
2.3
10.64
10.14
g/l
1.38
394
2508
711
4993
1.46
19.09
3.8
3.4
129.61
130.36
g/l
0.37
695
4851
473
3047
1.58
19.07
1.8
2.3
3.00
2.88
g/l
1.86
436
2809
578
3894
1.52
19.06
1.1
1.1
37.02
10.07
u/ml
—
9
40
7676
73360
1.34
19.02
5.7
5.0
6.13
5.93
mmol/l
28.47
7166
68144
725
5123
1.45
18.83
4.3
3.6
7.41
7.42
ph
1.04
609
4265
523
3457
1.54
18.83
3.9
3.6
25.42
25.18
mmol/l
0.78
513
3327
3061
26510
1.24
18.70
3.3
3.7
2.35
2.35
mmol/l
0.29
2821
24218
1001
7503
1.38
18.56
8.7
8.3
10.59
9.69
mmol/l
3.30
967
7216
416
2617
1.62
18.52
2.3
3.5
55.05
72.27
mg/l
0.38
339
2236
578
8329
0.67
18.41
1.3
1.4
—
—
—
0
0
415
2614
1.62
18.38
2.3
3.5
55.18
51.17
mg/l
0.10
340
2233
113
456
2.50
18.21
1.4
1.5
14.42
22.93
umol/l
4.24
106
420
986
7410
1.37
17.95
8.3
8.5
1.45
1.32
mmol/l
2.38
964
7275
864
6356
1.40
17.91
1.2
1.2
—
—
—
0
0
260
1455
1.81
17.78
1.1
1.1
—
—
—
0
0
3784
33638
1.22
17.59
2.4
1.9
1.53
1.39
mmol/l
13.82
3303
28561
1097
8444
1.34
17.06
8.9
8.9
95.38
95.69
%
1.02
1064
8174
367
2288
1.63
16.97
1.7
1.5
5.53
13.56
iu/ml
—
7
44
7921
76267
1.35
16.96
6.4
5.1
4.56
4.64
mmol/l
10.74
7571
72055
948
7160
1.36
16.68
10.1
9.9
—
—
—
0
0
65
205
3.19
16.61
1.6
1.3
44.94
53.08
%
0.98
52
174
189
991
1.93
15.89
1.3
1.3
—
—
—
0
0
254
1465
1.76
15.73
1.6
1.6
0.79
0.80
g/l
0.05
204
1148
1199
9472
1.31
15.43
8.8
8.5
7.41
7.42
ph
0.58
656
5141
234
1326
1.79
15.40
1.3
1.4
3.66
10.82
u/ml
—
5
26
57
174
3.29
15.38
1.4
1.2
48.23
36.94
%
1.22
43
118
268
1583
1.71
15.26
1.4
1.7
—
—
—
0
0
2997
26349
1.21
14.82
3.7
3.6
1.00
0.74
—
5
70
1194
9478
1.30
14.79
8.7
8.5
11.92
12.54
kpa
3.93
1148
9148
392
2566
1.55
14.77
2.2
2.3
4417.90
5530.04
u/l
0.33
138
996
1194
9481
1.30
14.75
8.7
8.5
5.21
5.10
kpa
3.18
1150
9153
782
5841
1.37
14.70
4.5
4.3
89.55
93.05
ng/l
0.44
673
5111
510
3540
1.47
14.52
5.1
5.4
1.67
1.65
%
0.15
485
3346
162
834
1.96
14.42
1.2
1.2
56.36
65.85
u/l
1.41
145
726
1182
9411
1.30
14.28
8.7
8.4
0.99
0.90
mmol/l
0.34
996
7776
362
2351
1.56
14.14
2.3
3.3
2.40
2.85
ratio
0.30
198
1343
248
1473
1.70
13.87
1.1
1.1
—
—
—
0
0
246
1464
1.70
13.67
1.3
1.2
594.12
349.02
titre
0.49
17
102
5821
54538
1.19
13.61
4.2
4.0
0.30
3862.46
—
10
112
368
2420
1.54
13.60
1.4
1.4
277.31
275.48
ug/g
0.06
208
1426
229
1340
1.73
13.53
1.1
1.1
25.28
7857.01
iu/ml
0.54
46
298
594
4301
1.41
13.44
1.3
1.2
—
—
—
0
0
656
4838
1.38
13.32
5.1
4.2
24.01
24.22
mmol/l
0.96
642
4791
137
690
2.00
13.03
1.1
1.1
298.64
284.89
mg/l
0.94
124
633
999
7872
1.30
12.99
3.1
2.6
35.56
47.05
u/l
0.97
883
6700
27
54
5.01
12.86
1.9
1.4
—
—
—
0
0
791
6041
1.34
12.84
4.2
4.2
1.23
1.23
mmol/l
0.22
699
5264
147
763
1.94
12.83
2.4
2.4
1111.81
1207.99
e6/l
0.63
132
670
392
2647
1.50
12.82
3.8
3.5
333.53
423.55
mg/l
0.79
206
1269
1495
12397
1.25
12.80
2.1
2.2
29.77
29.66
s
0.33
1460
12076
162
870
1.88
12.76
1.3
1.3
6.61
6.78
g/l
0.27
121
624
7843
75866
1.29
12.71
5.8
5.0
1.38
1.44
mmol/l
32.67
7416
71284
161
870
1.87
12.45
1.3
1.3
0.41
0.41
g/l
0.02
119
623
161
871
1.86
12.41
1.3
1.3
3.23
2.95
g/l
1.15
120
625
339
2236
1.54
12.39
1.9
2.1
11.06
11.63
mg/l
0.62
320
2096
156
837
1.88
12.34
3.4
3.6
57.46
57.75
%
0.06
130
731
7962
77212
1.30
12.31
6.6
5.7
2.68
2.73
mmol/l
7.08
7542
72671
133
681
1.97
12.10
1.3
1.2
77.00
228.17
titre
3.94
30
115
997
7925
1.29
12.10
9.6
9.4
121.83
122.17
g/l
0.20
978
7755
157
853
1.86
11.96
1.3
1.3
—
—
—
0
0
137
724
1.91
11.39
1.2
1.1
—
—
—
0
0
177
1013
1.76
11.38
2.5
2.8
—
—
—
0
0
494
3585
1.40
11.06
4.3
3.8
—
—
—
0
0
260
1659
1.58
11.04
2.0
2.1
0.92
0.87
nmol/l
0.48
205
1424
84
375
2.25
10.98
1.1
1.1
3.86
3.42
iu/ml
—
7
24
73
307
2.39
10.94
2.2
2.1
29.99
31.76
%
0.41
73
307
453
3249
1.42
10.85
5.6
5.7
0.83
0.88
%
2.49
432
3071
713
5499
1.32
10.80
8.9
8.9
24.84
24.79
mmol/l
0.13
713
5470
507
3713
1.39
10.76
1.2
1.1
220.94
183.22
titre
0.16
16
115
758
9623
0.77
10.65
1.9
2.0
3.74
3.55
ratio
3.51
596
7435
4001
36754
1.16
10.58
3.0
2.8
—
—
estimate
—
0
0
22
45
4.90
10.24
2.1
1.4
0.47
0.58
%
0.12
14
33
8486
83293
1.41
10.20
36.8
23.9
254.73
250.42
e9/l
7.51
8400
81762
647
4970
1.33
10.08
10.4
10.6
24.37
24.26
mmol/l
0.37
632
4886
153
873
1.77
10.00
1.3
1.3
1.79
1.49
nmol/l
2.03
138
786
8486
83317
1.40
9.94
36.7
23.8
30.54
30.35
pg
18.97
8449
82548
8488
83340
1.40
9.94
36.9
23.9
7.06
6.70
e9/l
31.24
8377
81555
8486
83318
1.40
9.93
36.7
23.8
91.79
90.98
fl
47.73
8450
82548
8486
83325
1.40
9.86
37.4
24.4
40.83
41.31
%
2.09
8447
82511
8486
83327
1.40
9.84
36.8
23.8
4.51
4.53
e12/l
5.34
8374
81557
8487
83342
1.40
9.80
37.1
24.0
136.54
136.68
g/l
0.38
8449
82578
1769
15331
1.19
9.43
4.1
3.9
418.52
506.63
ng/l
0.45
1313
11779
47
172
2.74
9.41
1.0
1.1
—
—
—
0
0
546
7087
0.76
9.01
1.6
1.7
3.55
3.49
mmol/l
0.49
372
4873
117
645
1.82
8.64
1.2
1.2
110.80
108.46
pmol/l
0.18
117
645
2816
25527
1.15
8.32
2.8
2.5
—
—
—
0
0
215
1414
1.53
8.11
1.6
1.4
58.10
61.97
mmol/l
0.72
153
1134
184
1169
1.59
8.08
7.1
6.6
11.97
11.54
mg/l
0.56
174
1089
367
2691
1.38
7.81
1.3
1.3
—
—
—
0
0
290
2056
1.42
7.52
1.3
1.2
—
—
—
0
0
215
3150
0.67
7.46
1.1
1.1
0.71
0.64
ratio
1.32
37
411
92
496
1.86
7.36
2.6
2.8
37.88
40.64
%
0.72
49
265
298
2134
1.41
7.32
3.6
3.4
63.24
62.33
%
0.30
281
2078
677
5458
1.26
7.29
11.0
10.6
1.41
1.33
%
1.19
670
5430
269
1894
1.43
7.26
2.7
2.2
128.94
130.61
g/l
0.55
212
1454
173
1113
1.57
7.24
2.1
2.1
0.98
0.89
%
0.68
115
746
228
1559
1.47
7.18
3.9
3.4
21.13
27.40
mg/l
2.33
160
1054
1694
14929
1.17
7.17
2.9
3.1
2.46
2.45
mmol/l
2.97
1527
13378
117
689
1.71
6.98
1.1
1.1
—
—
—
0
0
873
7278
1.22
6.92
1.8
1.8
—
—
—
0
0
46
196
2.35
6.84
1.3
1.4
22.78
24.81
g/l
0.36
33
145
50
221
2.27
6.84
1.2
1.1
—
—
—
0
0
50
221
2.27
6.84
1.2
1.1
—
—
—
0
0
50
221
2.27
6.84
1.2
1.1
—
—
—
0
0
99
562
1.77
6.73
2.5
2.7
184.24
235.66
e6/l
2.70
85
479
374
2822
1.34
6.68
4.4
3.7
24.49
24.78
mmol/l
1.15
344
2595
319
2349
1.37
6.67
2.8
3.1
—
—
—
0
0
115
684
1.69
6.64
2.8
3.1
58.35
57.36
mg/l
0.01
81
504
343
2570
1.35
6.43
3.9
3.5
1.61
1.52
mg/l
0.98
319
2379
118
718
1.65
6.27
3.3
3.5
15.70
13.04
index
0.67
69
436
17
43
3.96
6.16
1.1
1.1
—
—
—
0
0
481
3802
1.28
6.14
2.4
2.4
—
—
—
0
0
595
4825
1.25
6.12
11.1
10.9
16.12
16.11
%
0.03
578
4662
604
4907
1.25
6.12
8.3
7.3
24.90
24.51
mmol/l
1.68
579
4705
87
493
1.77
6.00
14.6
13.7
0.61
0.62
mmol/l
0.21
80
451
102
606
1.69
5.96
1.2
1.2
—
—
—
0
0
740
6163
1.22
5.93
2.9
2.5
6.00
6.06
ph
1.12
474
4100
225
1598
1.42
5.87
1.6
1.5
155.17
151.79
au/ml
0.14
52
456
94
549
1.72
5.85
2.7
2.7
0.66
0.69
e9/l
0.25
88
532
148
969
1.54
5.82
2.2
2.3
1.09
0.45
mmol/l
1.31
142
933
247
1789
1.39
5.77
4.5
3.9
—
—
—
0
0
108
658
1.65
5.75
1.2
1.2
—
—
—
0
0
87
502
1.74
5.67
1.3
1.5
5.43
6.19
u/l
0.80
78
438
244
1774
1.39
5.58
1.5
1.5
—
—
—
0
0
60
314
1.92
5.36
2.5
2.1
340.05
3221.78
e6/l
0.58
37
210
110
1721
0.63
5.36
1.7
1.6
—
—
—
0
0
91
542
1.69
5.31
2.5
2.5
440.19
523.32
e6/l
1.05
72
443
371
2906
1.29
5.14
2.7
2.7
—
—
—
0
0
123
797
1.55
5.12
1.8
2.1
—
—
—
0
0
31
127
2.45
5.10
1.0
1.1
0.60
3.21
u/ml
0.66
25
108
30
121
2.48
5.10
1.2
1.4
—
—
—
0
0
284
2149
1.33
5.07
1.2
1.1
—
—
—
0
0
458
3694
1.25
5.00
5.6
4.7
36.93
36.92
°c
0.21
451
3659
197
1410
1.41
4.99
1.8
1.9
4.95
5.11
mmol/24h
0.24
178
1268
231
1698
1.37
4.99
1.3
1.3
286.71
266.89
u/ml
0.51
158
1068
629
5258
1.21
4.89
1.3
1.3
55.70
53.16
au/ml
0.08
26
357
323
2504
1.30
4.86
2.8
2.8
3.72
3.58
g/l
0.87
311
2391
201
1453
1.39
4.82
2.8
2.9
—
—
—
0
0
80
475
1.69
4.77
1.9
2.7
979.66
1205.55
u/ml
0.45
80
469
675
5695
1.20
4.77
2.4
2.4
17.97
20.62
au/ml
0.40
69
641
243
1816
1.35
4.74
2.3
2.4
165.22
111.05
ug/min
0.74
144
1123
29
120
2.42
4.70
1.0
1.5
13.29
330309.83
nmol/l
0.91
18
99
38
177
2.15
4.70
2.3
2.8
234.29
205.32
ug/l
0.04
38
177
90
554
1.63
4.68
1.1
1.1
—
—
—
0
0
328
2566
1.29
4.63
1.3
1.3
226.43
220.14
miu/ml
0.09
112
1163
820
7066
1.18
4.56
4.3
4.4
7.36
7.35
ph
0.53
629
5104
753
6447
1.18
4.52
2.5
2.3
6.49
7.95
ug/l
1.68
660
5740
40
194
2.07
4.48
1.0
1.1
1.28
1.63
u/ml
0.11
19
106
117
775
1.52
4.46
1.8
1.5
1.43
1.28
promille
0.46
97
615
635
5364
1.20
4.44
1.2
1.2
—
—
—
0
0
323
4083
0.78
4.44
1.6
1.7
—
—
—
0
0
78
470
1.67
4.43
1.7
1.5
1.44
1.22
nmol/l
0.80
56
344
44
223
1.98
4.38
1.4
1.2
39.51
39.67
g/l
0.03
25
109
182
1321
1.39
4.30
1.2
1.2
—
—
—
0
0
38
184
2.07
4.29
1.2
1.2
—
—
—
0
0
19
67
2.84
4.21
2.8
1.7
62.38
54.65
%
—
8
46
45
235
1.92
4.13
1.8
1.4
12.28
12.99
g/l
0.20
33
173
56
317
1.77
4.01
1.8
2.3
10.80
9.59
%
0.38
51
297
96
625
1.54
4.01
1.1
1.1
—
—
—
0
0
50
274
1.83
3.98
2.0
2.0
—
—
—
0
0
626
5338
1.19
3.97
1.2
1.2
109.80
142.95
u/ml
1.72
221
2005
306
2424
1.27
3.96
6.2
6.4
1.33
1.30
mmol/l
0.28
274
2141
39
197
1.98
3.95
1.4
1.5
0.38
0.35
mmol/l
—
8
35
261
2027
1.30
3.95
1.1
1.1
2.48
7.10
eliau/ml
2.71
22
268
689
5928
1.18
3.93
3.0
3.0
218.33
182.61
ng/l
1.08
620
5408
315
2518
1.26
3.80
3.9
4.0
7.41
7.41
ph
0.35
315
2492
103
692
1.49
3.74
1.1
1.2
—
—
—
0
0
49
274
1.79
3.68
1.1
1.1
—
—
—
0
0
15
50
3.00
3.68
1.1
1.1
—
—
—
0
0
107
728
1.48
3.66
1.2
1.1
—
—
—
0
0
179
1334
1.35
3.65
1.8
1.6
—
—
—
0
0
335
2711
1.24
3.65
2.4
2.2
—
—
—
0
0
144
1037
1.40
3.63
2.4
2.6
—
—
—
0
0
90
593
1.52
3.60
1.2
1.3
2.35
2.05
u/ml
0.05
45
343
416
3454
1.21
3.55
2.2
2.1
—
—
—
0
0
88
579
1.53
3.55
1.3
1.3
14.91
13.47
u/l
0.29
80
539
575
4931
1.18
3.45
3.1
3.5
4.49
4.50
pmol/l
0.08
519
4446
115
804
1.44
3.45
2.8
2.7
—
—
—
0
0
102
697
1.47
3.44
1.3
1.3
10.91
8.87
mmol/l
3.21
95
657
48
273
1.76
3.43
2.4
1.9
4316.67
14075.88
e6/l
0.63
21
138
123
876
1.41
3.34
1.5
1.4
278.53
279.15
mosm/kgh2o
0.10
88
683
89
596
1.50
3.33
2.0
2.4
667.14
652.84
ml
0.10
57
417
61
375
1.63
3.31
2.3
2.1
145.06
173.50
ug/min
0.13
18
92
313
2547
1.24
3.28
4.9
4.1
1.44
1.40
mmol/l
0.28
305
2509
410
3430
1.20
3.27
2.2
2.0
—
—
—
0
0
72
463
1.56
3.25
1.5
1.5
7.73
7.87
ug/l
0.03
67
422
388
3233
1.21
3.23
2.3
2.1
—
—
—
0
0
415
3482
1.20
3.21
2.2
2.1
—
—
—
0
0
414
3473
1.20
3.21
2.2
2.0
—
—
—
0
0
123
884
1.40
3.19
1.2
1.1
—
—
—
0
0
265
2124
1.26
3.19
1.8
2.0
2.52
6.49
iu/l
0.90
108
896
65
411
1.59
3.16
1.4
2.1
75.79
132.15
umol/l
1.49
34
209
85
1226
0.69
2.95
1.5
1.5
1.28
1.27
mm
0.12
66
869
90
621
1.45
2.95
1.5
1.4
—
—
—
0
0
8
17
4.71
2.91
1.0
1.5
1.96
2.42
g/l
—
8
17
67
436
1.54
2.91
1.9
2.0
8.41
7.96
mmol/l
0.47
67
436
125
917
1.37
2.90
1.9
2.5
11.73
10.89
%
1.34
125
912
157
1193
1.32
2.89
1.8
1.5
66.13
64.38
mu/l
0.04
137
1079
87
1244
0.70
2.89
1.6
1.5
—
—
—
0
0
80
543
1.48
2.86
1.9
1.9
2.81
1.67
u/field
0.72
47
294
142
1066
1.34
2.85
1.6
1.5
—
—
—
0
0
142
1066
1.34
2.85
1.6
1.5
—
—
—
0
0
134
1777
0.75
2.79
1.2
1.2
—
—
—
0
0
19
84
2.26
2.76
2.1
2.2
—
—
—
0
0
169
1307
1.30
2.76
3.0
3.1
0.85
0.81
nmol/l
0.41
138
1040
65
427
1.53
2.73
1.3
1.3
—
—
—
0
0
141
1066
1.33
2.71
1.6
1.5
—
—
—
0
0
141
1066
1.33
2.71
1.6
1.5
—
—
—
0
0
56
356
1.58
2.71
1.5
1.7
1.83
3.20
u/field
1.06
42
253
117
863
1.36
2.66
7.1
13.1
8.01
7.31
mmol/l
0.94
105
734
136
1027
1.33
2.65
2.5
2.4
1.75
1.33
g/24h
0.45
81
626
114
839
1.36
2.63
1.6
1.5
32296.38
56341.88
e6/l
0.98
63
467
38
221
1.72
2.60
1.2
1.5
—
—
—
0
0
403
3448
1.18
2.56
1.9
1.9
—
—
—
0
0
137
1042
1.32
2.55
2.3
2.0
10746.67
1711.19
titre
0.88
12
59
158
1226
1.29
2.55
1.4
1.3
—
—
—
0
0
39
230
1.70
2.54
1.7
2.2
0.24
0.27
e9/l
0.06
22
109
58
379
1.53
2.52
1.2
1.3
158.50
170.26
mmol/24h
0.48
58
379
93
1280
0.72
2.51
1.6
1.6
—
—
—
0
0
151
1167
1.30
2.51
1.2
1.2
—
—
—
0
0
126
950
1.33
2.50
1.6
1.5
4772.22
3386.13
e6/l
0.36
85
659
71
490
1.45
2.39
1.9
2.0
112.14
110.91
ng/l
0.03
71
490
64
433
1.48
2.38
1.8
2.3
505.62
496.69
min
0.30
45
335
15
64
2.35
2.38
1.0
1.2
2.01
1.71
iu/ml
—
7
32
156
1221
1.28
2.38
5.3
5.6
337.24
364.17
umol/l
1.53
132
1062
77
542
1.42
2.34
1.3
1.2
33.33
35.13
mmol/l
0.30
68
479
140
1083
1.30
2.34
1.6
1.5
33.33
33.16
g/l
0.05
125
981
43
268
1.61
2.31
1.0
1.0
—
—
—
0
0
211
1718
1.23
2.31
2.1
1.9
—
—
—
0
0
491
4309
1.15
2.27
1.1
1.1
—
—
—
0
0
41
254
1.62
2.26
1.1
1.2
—
—
—
0
0
86
623
1.38
2.24
3.3
2.6
27.22
30.39
mg/l
0.40
69
442
124
951
1.31
2.22
2.4
2.5
22.40
26.62
iu/ml
0.27
15
102
61
418
1.46
2.16
1.2
1.2
314.82
398.82
u/l
0.30
56
384
79
568
1.39
2.16
2.5
1.8
7.91
6.56
mmol/l
3.03
61
400
125
1606
0.78
2.14
1.5
1.5
55.84
59.96
ug/l
0.66
111
1334
69
487
1.42
2.10
1.1
1.0
8.77
1.92
u/ml
0.38
26
144
143
1128
1.27
2.09
1.3
1.3
25.41
27.42
u/l
0.34
121
927
201
1649
1.22
2.08
4.5
4.3
8.29
8.69
kpa
3.09
201
1619
65
455
1.43
2.07
1.2
1.2
—
—
—
0
0
14
62
2.26
2.07
1.1
1.2
—
—
—
0
0
9
31
2.91
2.07
1.1
1.1
211.67
273.78
nmol/l
—
9
31
194
2356
0.82
2.04
14.1
9.5
—
—
—
0
0
36
567
0.63
2.03
1.0
1.0
300.21
317.50
ng/l
0.15
24
416
59
408
1.45
2.02
1.2
1.6
—
—
—
0
0
13
57
2.28
1.97
1.5
1.5
—
—
—
0
0
166
1345
1.24
1.95
1.1
1.1
25.30
14.46
au/ml
0.86
42
346
62
436
1.42
1.95
2.0
2.3
16.38
16.21
%
0.16
62
436
5
11
4.55
1.94
2.0
2.0
—
—
—
0
0
37
570
0.65
1.91
1.0
1.0
888.29
735.30
ng/l
0.94
24
404
140
1116
1.26
1.91
1.4
1.3
293.46
425.82
pmol/l
0.76
120
948
24
135
1.78
1.90
2.0
3.3
50.02
39.61
mg/l
—
6
29
23
128
1.80
1.89
1.1
1.1
—
52.76
—
0
5
198
1641
1.21
1.88
4.5
4.3
5.07
5.00
kpa
0.59
198
1612
34
212
1.61
1.87
1.1
1.2
11.37
13.81
pmol/l
0.27
13
85
53
365
1.45
1.87
1.5
5.6
63.00
732.00
mg/l
0.52
33
260
12
52
2.31
1.87
1.0
1.2
0.90
0.67
iu/ml
—
5
28
103
792
1.30
1.87
1.5
1.4
6.05
6.22
mmol/l
0.30
98
735
29
174
1.67
1.85
1.6
2.2
—
—
—
0
0
16
79
2.03
1.85
1.2
1.1
0.05
0.03
u/ml
0.39
16
79
105
814
1.29
1.80
1.6
1.5
—
—
—
0
0
197
1641
1.21
1.80
4.4
4.2
2.33
2.47
mmol/l
0.28
148
1105
144
1163
1.24
1.77
1.3
1.3
6.41
4.15
nmol/l
0.15
138
1130
13
60
2.17
1.77
1.2
1.2
—
—
—
0
0
71
956
0.74
1.77
3.5
3.6
5.35
5.91
nmol/l
0.07
65
931
40
264
1.52
1.75
1.1
1.1
—
—
—
0
0
24
139
1.73
1.75
1.9
1.9
—
—
—
0
0
111
872
1.28
1.73
2.1
2.1
34.74
23.45
mg/l
0.76
39
321
148
1204
1.23
1.72
1.3
1.3
0.13
0.24
nmol/l
—
6
73
1133
10574
1.08
1.71
1.3
1.3
—
—
—
0
0
152
1241
1.23
1.71
2.8
2.4
12.50
11.80
titre
0.02
12
41
0
48
0.00
1.69
0.0
1.4
—
0.17
—
0
48
87
665
1.31
1.68
1.2
1.3
1.96
2.07
mmol/l
0.56
80
625
100
779
1.29
1.68
1.6
1.5
—
—
—
0
0
198
1664
1.19
1.67
7.8
7.7
11.41
11.26
mmol/l
0.18
180
1497
198
1665
1.19
1.66
7.8
7.7
104.53
105.19
mmol/l
1.20
180
1498
7
25
2.80
1.65
1.9
2.2
250.43
275.20
ug/l
—
7
25
14
69
2.03
1.64
2.1
2.4
0.57
0.58
u/field
0.01
14
69
10
41
2.44
1.64
1.1
1.0
—
—
—
0
0
41
277
1.48
1.63
2.5
2.9
29.21
27.94
umol/l
0.21
28
199
114
907
1.26
1.63
2.5
2.4
—
—
—
0
0
180
1504
1.20
1.62
1.3
1.3
23.87
32.69
u/l
0.80
159
1313
44
302
1.46
1.62
5.0
4.8
—
—
—
0
0
109
864
1.26
1.61
2.5
2.0
7.86
7.59
umol/l
0.06
88
626
355
3138
1.14
1.57
2.3
2.2
21.33
21.00
s
0.27
324
2763
45
314
1.44
1.54
3.4
2.6
0.60
0.61
mmol/l
0.71
45
314
30
192
1.56
1.53
1.5
1.9
—
2.00
—
0
6
86
668
1.29
1.51
2.0
1.8
3.13
4.14
mg/l
3.55
79
647
34
225
1.51
1.51
1.4
1.2
209.65
316.36
ug/l
0.18
23
105
245
2825
0.86
1.49
1.6
1.6
883.89
1002.84
mu/l
1.43
205
2357
291
2552
1.15
1.47
1.9
1.9
186.16
207.19
pmol/l
3.48
275
2428
289
2539
1.14
1.43
1.5
1.4
9.61
9.53
u/l
0.04
226
2027
123
1007
1.22
1.40
1.3
1.3
0.17
0.21
nmol/l
1.43
91
801
13
238
0.55
1.39
2.1
3.1
45.62
43.95
%
0.11
13
238
13
237
0.55
1.38
4.2
6.2
10.62
8.62
%
0.68
13
237
43
305
1.41
1.37
3.5
2.7
—
—
—
0
0
315
2793
1.13
1.37
1.7
1.8
291.42
290.18
mu/l
0.02
277
2554
18
104
1.73
1.36
1.4
1.6
—
—
—
0
0
5
17
2.94
1.36
1.0
1.1
—
—
—
0
0
8
162
0.49
1.35
3.8
2.9
79.38
1833.60
u/l
—
8
149
41
290
1.42
1.34
1.2
1.1
—
—
—
0
0
10
47
2.13
1.33
1.1
1.1
48.30
49.00
u/l
—
10
41
63
483
1.31
1.26
2.9
3.4
42.11
27.35
mu/l
1.28
58
457
124
1030
1.21
1.26
1.8
1.9
—
—
—
0
0
49
363
1.35
1.24
1.1
1.1
1.17
14.92
u/ml
—
6
38
101
824
1.23
1.23
1.7
1.6
—
—
—
0
0
12
63
1.91
1.22
1.4
1.6
61.92
45.30
umol/l
0.55
12
63
824
8790
0.93
1.19
1.5
1.5
—
—
—
0
0
740
6913
1.08
1.16
1.4
1.4
—
—
—
0
0
55
421
1.31
1.14
1.5
1.3
7.41
7.40
ph
0.08
34
283
0
36
0.00
1.14
0.0
5.2
—
16.62
—
0
31
65
512
1.27
1.10
1.1
1.1
9.60
10.98
nmol/l
0.07
11
98
14
81
1.73
1.08
1.1
1.1
—
—
—
0
0
23
152
1.51
1.08
1.0
1.3
1.04
110.92
mg/l
1.46
14
108
243
2159
1.13
1.08
1.2
1.3
503.05
530.00
mg/l
0.46
227
2064
69
549
1.26
1.08
1.2
1.2
—
—
—
0
0
32
227
1.41
1.07
1.3
1.2
—
—
—
0
0
53
408
1.30
1.07
1.5
1.6
4.74
12.27
nmol/l
0.59
42
327
43
321
1.34
1.07
1.3
1.2
—
—
—
0
0
23
153
1.50
1.06
2.9
2.3
—
—
—
0
0
3137
32183
0.96
1.05
3.5
3.1
—
—
—
0
0
52
401
1.30
1.04
1.9
2.3
1894.55
1958.32
ml
0.18
47
364
38
280
1.36
1.03
1.2
1.4
70.29
310.79
nmol/24h
1.48
38
280
10
53
1.89
1.01
1.0
1.0
—
—
—
0
0
117
992
1.18
1.00
1.3
1.3
—
—
nmol/l
—
0
0
52
405
1.29
0.98
2.2
2.3
74.28
19.05
umol/l
—
5
40
50
388
1.29
0.97
2.1
2.4
—
—
—
0
0
15
92
1.63
0.97
1.1
1.2
5.30
5.77
mmol/l
—
6
46
43
328
1.31
0.95
6.0
3.1
—
—
—
0
0
36
479
0.75
0.95
8.8
7.0
20.09
109.66
ug/l
1.11
26
315
128
1103
1.16
0.92
1.1
1.1
2.53
3.28
eliau/ml
0.51
46
536
6
28
2.14
0.91
1.3
1.3
—
—
—
0
0
214
1912
1.12
0.91
1.1
1.3
3.77
3.79
mmol/l
0.07
196
1811
71
581
1.22
0.90
1.1
1.1
10.18
9.55
iu/ml
0.07
17
161
11
63
1.75
0.90
1.2
1.2
—
—
—
0
0
37
279
1.33
0.89
1.9
2.0
61.63
63.90
ug/l
0.08
37
271
2917
28463
1.04
0.89
5.0
5.2
2.09
2.77
ug/l
2.16
2633
26002
211
2353
0.89
0.88
1.1
1.1
—
—
—
0
0
49
386
1.27
0.87
26.3
27.6
126.15
113.25
ug/l
0.52
39
307
6
30
2.00
0.87
1.2
1.1
0.06
0.05
u/ml
—
6
30
8
46
1.74
0.82
1.0
1.0
—
—
—
0
0
10
58
1.72
0.79
1.2
1.3
—
—
—
0
0
34
259
1.31
0.79
1.2
1.1
—
—
—
0
0
2223
22821
0.97
0.76
4.2
4.3
22.59
21.94
%
1.01
941
10720
212
1921
1.11
0.74
1.3
1.4
388.13
3157.26
e6/l
0.79
160
1514
73
614
1.19
0.74
1.3
1.5
13.67
12.72
umol/l
0.47
68
578
90
1047
0.86
0.74
1.6
1.5
43.42
59.69
ug/l
4.50
90
1047
52
423
1.23
0.74
1.3
1.3
69.50
68.06
%
—
6
52
10
60
1.67
0.72
1.0
1.0
—
—
—
0
0
5
26
1.92
0.70
14.6
5.1
—
—
—
0
0
70
591
1.19
0.70
1.2
1.2
344.49
371.87
nmol/l
0.49
53
511
17
118
1.44
0.69
1.2
1.4
37.12
42.78
mg/l
0.28
12
101
47
382
1.23
0.68
1.8
1.7
—
—
—
0
0
41
328
1.25
0.68
1.1
1.1
3.88
7.20
u/ml
—
9
59
45
365
1.23
0.67
5.8
3.0
—
—
—
0
0
16
111
1.44
0.65
3.9
6.7
8.11
8.22
mmol/l
0.05
16
111
6593
65394
1.03
0.65
30.9
19.9
332.30
332.91
g/l
6.06
6572
65054
10
62
1.61
0.65
1.1
1.0
—
3.79
—
0
7
207
1892
1.10
0.64
1.3
1.4
30.76
25.39
e6/l
0.14
144
1396
62
732
0.85
0.64
1.3
1.4
142.16
183.94
pmol/l
1.45
62
732
145
1302
1.12
0.63
1.3
1.3
4.37
4.30
u/ml
0.03
68
595
42
341
1.23
0.63
1.0
1.1
547.00
342.27
ng/l
0.15
15
86
24
181
1.33
0.63
1.2
1.2
500.28
294.04
pmol/l
0.33
18
135
317
2957
1.07
0.61
3.7
3.8
450.39
2405.19
u/ml
1.26
275
2574
2360
23091
1.03
0.61
1.5
1.4
—
—
—
0
0
24
182
1.32
0.61
1.7
2.2
17.90
16.39
umol/l
0.23
24
182
35
281
1.25
0.59
2.9
2.4
0.53
0.96
ug/l
2.39
30
265
57
483
1.18
0.57
1.0
1.0
4.15
1.40
u/ml
0.33
16
110
39
319
1.22
0.56
1.5
1.9
40.19
40.34
g/l
0.06
39
319
349
3287
1.06
0.54
1.9
1.9
42.29
40.18
nmol/l
0.57
336
3209
104
929
1.12
0.53
1.5
1.3
—
—
—
0
0
32
259
1.24
0.52
1.0
1.0
7.16
9.43
u/ml
0.28
19
172
835
8057
1.04
0.51
3.9
4.5
33.78
24.18
ug/l
0.34
702
6579
407
3862
1.06
0.50
1.5
1.4
26.39
28.07
iu/l
0.48
338
3294
34
279
1.22
0.49
1.3
1.2
27.59
28.62
s
0.67
34
279
33
270
1.22
0.49
1.3
1.2
566.67
1070.00
titre
—
6
60
12
84
1.43
0.49
1.3
1.4
—
—
—
0
0
94
840
1.12
0.49
1.3
1.5
3.09
3.72
ug/l
0.62
77
730
1669
17073
0.97
0.48
3.0
3.1
0.68
0.75
ug/l
1.74
1094
10752
63
721
0.87
0.48
5.7
5.4
33.18
70.85
u/ml
1.01
25
235
13
93
1.40
0.48
24.9
7.3
0.29
0.19
%
0.77
13
93
17
128
1.33
0.47
1.1
1.1
0.38
1.87
u/ml
0.80
11
87
34
281
1.21
0.47
1.5
1.6
0.00
0.03
estimate
1.08
34
281
10
68
1.47
0.47
1.0
1.1
—
—
—
0
0
104
939
1.11
0.46
2.4
2.3
—
—
—
0
0
115
1264
0.91
0.45
1.5
1.5
0.24
0.35
nmol/l
1.74
85
942
18
138
1.30
0.45
1.2
1.7
—
—
—
0
0
43
367
1.17
0.43
1.4
1.7
—
—
—
0
0
856
8300
1.03
0.42
2.4
2.3
12.59
13.66
nmol/l
3.69
754
7577
94
850
1.11
0.42
1.3
1.6
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
14.06
—
0
12
5
35
1.43
0.39
1.6
1.7
2.28
2.07
nmol/l
—
5
35
22
178
1.24
0.38
1.2
1.4
—
—
—
0
0
5
36
1.39
0.38
1.4
1.5
285.66
494.01
nmol/l
—
5
36
5
37
1.35
0.37
1.0
1.1
—
20.84
—
0
8
15
116
1.29
0.37
1.1
1.1
—
—
—
0
0
156
1671
0.93
0.37
1.4
1.3
—
—
—
0
0
40
347
1.15
0.35
1.1
1.1
—
—
—
0
0
19
153
1.24
0.35
1.7
2.3
11.56
7.66
mmol/l
0.57
12
85
6
43
1.40
0.35
2.2
1.5
6.68
33.13
nmol/l
—
6
43
89
814
1.09
0.34
1.3
1.2
—
—
—
0
0
49
433
1.13
0.34
2.3
2.2
1.77
2.34
ug/l
1.26
41
360
169
1588
1.07
0.33
1.2
1.1
—
—
—
0
0
6
45
1.33
0.33
1.3
1.7
—
—
—
0
0
6
46
1.30
0.33
1.3
1.8
—
—
—
0
0
26
220
1.18
0.31
1.6
1.6
0.52
0.51
e9/l
0.10
26
220
139
1483
0.94
0.31
1.1
1.1
1.22
1.63
u/ml
0.38
81
736
18
147
1.22
0.30
1.2
1.1
0.57
0.72
umol/24h
—
10
71
11
84
1.31
0.30
1.0
1.1
—
—
—
0
0
932
9116
1.02
0.29
5.2
4.9
30.45
31.85
%
3.43
674
6218
113
1054
1.07
0.29
1.4
1.3
7.75
7.20
mmol/l
1.12
102
943
42
373
1.13
0.29
2.2
2.4
60.35
53.46
umol/l
0.62
36
333
21
247
0.85
0.27
1.0
1.0
—
—
—
0
0
41
366
1.12
0.26
3.2
1.7
26.50
28.85
umol/l
1.30
41
340
12
95
1.26
0.26
1.4
1.5
—
—
—
0
0
10
77
1.30
0.26
1.0
1.1
17.56
17.79
g/l
—
10
67
167
1587
1.05
0.26
1.2
1.1
—
—
—
0
0
9
73
1.23
0.25
1.3
1.2
1.84
1.67
umol/24h
—
9
73
97
907
1.07
0.25
1.9
1.7
392.66
341.01
mu/l
0.46
82
711
6
81
0.74
0.24
1.5
1.2
7.17
10.63
mg/l
—
6
71
5
38
1.32
0.23
5.0
9.2
105.60
105.13
g/l
—
5
38
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
2.3
—
9.21
—
0
7
10
80
1.25
0.20
1.0
1.1
—
—
—
0
0
178
1711
1.04
0.19
3.3
3.8
213.40
719.27
u/ml
1.81
162
1561
17
146
1.16
0.19
1.4
1.1
—
—
—
0
0
17
146
1.16
0.19
1.4
1.1
—
—
—
0
0
17
146
1.16
0.19
1.4
1.1
—
—
—
0
0
164
1576
1.04
0.18
1.1
1.1
2.76
5.29
u/ml
1.75
80
827
61
570
1.07
0.18
1.1
1.1
20.68
18.21
u/ml
0.24
20
237
7
61
1.15
0.17
2.3
3.2
2.27
2.60
mg/l
—
7
50
24
214
1.12
0.17
6.5
7.4
5.23
5.38
kpa
0.20
24
214
20
176
1.14
0.17
2.9
4.7
47.25
66.72
u/l
0.75
20
170
58
543
1.07
0.17
1.6
1.5
76.07
82.27
umol/l
0.68
58
543
107
1119
0.96
0.16
1.1
1.1
0.18
0.55
u/ml
1.16
45
349
9
79
1.14
0.15
1.1
1.1
96.00
97.22
titre
—
9
79
77
807
0.95
0.13
1.3
1.2
—
—
—
0
0
54
510
1.06
0.13
1.3
1.2
0.58
0.61
ratio
0.25
35
303
9
110
0.82
0.13
1.1
1.1
6.87
8.12
u/ml
—
9
110
186
1812
1.03
0.12
1.1
1.1
3.29
1.75
u/ml
0.56
100
956
43
405
1.06
0.11
1.2
1.2
12.86
9.72
mm/h
0.59
43
405
117
1208
0.97
0.11
1.1
1.1
3.45
4.30
u/ml
0.19
52
523
19
174
1.09
0.09
1.0
1.1
26.34
40.04
iu/ml
0.43
19
174
5
48
1.04
0.09
4.8
2.5
0.74
0.60
ug/l
—
5
48
14
155
0.90
0.09
1.0
1.1
—
—
—
0
0
5
63
0.79
0.08
1.0
2.9
—
93.11
—
0
22
156
1528
1.02
0.08
1.1
1.1
0.76
1.12
u/ml
0.44
72
665
50
481
1.04
0.07
1.2
1.2
1.03
1.06
ratio
2.48
43
386
14
153
0.91
0.07
1.1
1.4
—
103.04
—
0
24
9
85
1.06
0.07
1.4
1.2
6.22
6.00
mmol/l
—
9
85
15
163
0.92
0.07
1.1
1.2
1.28
1.64
mmol/l
—
10
106
16
173
0.92
0.06
2.9
3.0
—
—
—
0
0
16
173
0.92
0.06
1.1
1.1
—
—
—
0
0
368
3650
1.01
0.05
2.6
3.7
35.91
60.47
u/ml
2.31
354
3519
47
456
1.03
0.04
1.0
1.0
0.46
1.09
u/ml
0.38
19
106
18
170
1.06
0.04
1.5
1.3
122.46
61.21
mu/l
0.65
11
132
13
138
0.94
0.02
1.8
1.9
82.14
41.21
pmol/l
—
8
118
18
172
1.05
0.02
1.4
1.4
—
—
—
0
0
29
283
1.02
0.01
5.7
6.8
24.97
24.87
mmol/l
0.05
24
262
110
1092
1.01
0.01
4.7
2.6
13.34
13.15
%
0.83
110
1076
124
1248
0.99
0.01
1.2
1.1
122.75
115.74
%
1.70
117
1132
12
123
0.98
0.00
1.2
1.2
63.83
65.07
ug/l
0.07
12
123
12
124
0.97
0.00
1.1
1.2
193.09
77.25
ng/l
—
7
87
16
164
0.98
0.00
1.4
2.9
79.12
123.94
ng/l
—
6
73
157
1567
1.00
0.00
1.5
1.5
120.15
167.85
pmol/l
0.68
152
1528
66
664
0.99
0.00
1.1
1.1
279.12
262.83
mg/l
0.19
57
589
16
165
0.97
0.00
1.1
1.1
8.75
7.19
mg/g
0.32
16
156
69
685
1.01
0.00
1.1
1.2
45.94
40.26
mg/l
0.36
55
580
44
442
1.00
0.00
3.6
2.2
218.32
197.85
u/l
0.90
44
436
129
1288
1.00
0.00
1.1
1.1
3.97
3.59
u/ml
0.12
66
627
125
1251
1.00
0.00
1.2
1.2
—
—
—
0
0
28
279
1.00
0.00
1.4
1.2
24.40
24.26
%
—
5
34
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
1.82
—
0
5
0
5
0.00
0.00
0.0
1.0
—
38.60
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
7
72
0.97
-0.00
1.4
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
0.07
—
0
8
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.43
—
0
6
8
84
0.95
-0.00
1.1
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
63.00
—
0
8
7
72
0.97
-0.00
2.0
2.7
218.29
452.79
umol/l
—
7
66
6
59
1.02
-0.00
1.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
13.67
—
0
6
25
250
1.00
-0.00
1.2
1.3
107.71
129.77
nmol/l
0.63
20
192
0
9
0.00
-0.00
0.0
1.1
—
69.37
—
0
9
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
8
83
0.96
-0.00
1.0
1.3
38.50
27.39
%
—
8
59
5
57
0.88
-0.00
1.6
1.6
408.60
329.65
umol/24h
—
5
57
5
58
0.86
-0.00
17.8
10.8
124.00
315.40
e6/l
—
5
43
0
7
0.00
-0.00
0.0
1.1
—
34.50
—
0
7

Mortality – FinRegistry

↥

Association

Association between endpoint L12_PSORI_VULG and mortality.

Females

Parameter HR [95% CI] p-value
L12_PSORI_VULG 1.432 [1.3, 1.57] < 0.001
Birth year 0.996 [0.99, 1.0] 0.3

During the follow-up period (1.1.1998 — 31.12.2019), 2644 out of 20047 females with L12_PSORI_VULG died.

Males

Parameter HR [95% CI] p-value
L12_PSORI_VULG 1.71 [1.57, 1.86] < 0.001
Birth year 0.987 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 4660 out of 24237 males with L12_PSORI_VULG died.

Mortality risk

Mortality risk for people of age

years, who have L12_PSORI_VULG.

N-year risk Females Males
1 0.154% 0.312%
5 0.84% 1.751%
10 1.978% 4.708%
15 3.966% 9.022%
20 7.083% 14.665%

Relationships between endpoints

↥

Index endpoint: L12_PSORI_VULG – Psoriasis vulgaris

GWS hits: 37

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data